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Abstract 
Immunoglobulin E (IgE) and its high-affinity receptor, FcERI, play a key role in 
the allergic response. Cross-linking of FccRI-bound IgE by multivalent antigen 
leads to receptor aggregation, cell activation and release of inflammatory 
mediators from mast cells and basophils. This can cause the immediate 
hypersensitivity reaction characteristic of many allergic disorders, such as asthma 
and acute anaphylaxis. Research into the binding of IgE to FccRI could lead to 
strategies for blocking this interaction and therefore possible treatments for 
allergic disease. 
FcERI binds the Fc region of IgE. The smallest fragment of IgE-Fc that retains 
native levels of affinity for FccRI is a mammalian-expressed dimer of Fc 
domains Fcs3 and Fcc4 (Fcc3-4). Surprisingly, an isolated and unfolded Fcc3 
domain expressed in E. coli also shows binding, albeit with lower affinity. These 
observations highlight the following questions: What structural units and 
constraints within the mammalian Fcc3-4 fragment are necessary to create a fully 
folded Fcc3 domain, and what are the minimum requirements to produce a 
fragment with high affinity for FccRI? 
The work described in this thesis addressed these questions by engineering Fc 
fragments that lack particular structural features. Site directed mutagenesis and 
refolding of sub-fragments of Fcs3-4 expressed in E. coli, followed by 
biophysical characterisation, indicated that "longitudinal contacts" with a folded 
Fcc4 domain were sufficient to stabilise Fcc3. However, to achieve full folding, 
some form of "lateral" contact was required between the two Fc chains. When 
expressed in isolation the Fcc4 domain folded as part of a dimer, indicating that 
Fcc4 does not require Fcc3 for stabilisation. Therefore, Fcc4 was found to be the 
key to Fcc3 folding, by dimerising the Fc and providing stabilising longitudinal 
contacts through its intra-chain interface with the FcE3 domain. Furthermore, it 
was discovered that the folding of FcE3 domains in the context of an Fcc3-4 
fragment is not dependent on glycosylation or disulphide linkage. However, 
circular dichroism spectroscopy, surface plasmon resonance and analytical 
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ultracentrifugation studies of fragments lacking these elements indicated that, 
although not essential for folding, they were necessary to maintain stability and 
fiill affinity for FcERI. Surprisingly, in the absence of inter-chain disulphide 
linkage at the N-terminus of Fcc3-4, the fragment was found to bind two FcgRI 
molecules. This enabled the affinity of a single Fcs3 domain for FccRI to be 
estimated; the value was found to be no greater than that previously measured for 
a single unfolded Fcc3 domain. 
These studies have identified structural features that are required for Fcc3 
domain folding, stability and high affinity binding to FccRI. The individual 
contributions from interdomain contacts, glycosylation and dimerisation have 
been quantified. The results described within this thesis further our knowledge of 
IgE structure and function, and provide a structural basis for rational design of 
inhibitors of the allergic response. 
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Chapter 1: Introduction 
1.1 Back round 
Over 80 years ago Prausnitz and Kiistner were able to demonstrate that a 
factor in the blood of allergic individuals could be transferred to the skin of a 
non-allergic, and render that individual sensitive to the same allergen (Prausnitz 
and Kästner, 1921). This cytophilic serum factor was named "reagin". It took 
another 46 years before the molecule was confirmed as an antibody. It was 
named Immunoglobulin E (IgE) after the erythema that the allergens provoke in 
sensitive skin. At the time the concentration of the antibody was below that 
detectable by protein assays, although it could be distinguished from the other 
known antibody isotypes: IgM, IgG and IgA (Ishizaka and Ishizaka, 1967). 
However, the discovery of a novel myeloma (Ig "ND") that could inhibit the 
classical Prausnitz Kästner reaction, and was shown to be immunochemically 
distinct from the other known antibodies, confirmed the existence of a new 
antibody class (Johannson and Bennich, 1967). The discovery of this myeloma 
enabled larger amounts of the antibody to become available for examination, and 
subsequently the cDNA from this cell line was cloned (Kenten et al, 1982). 
Recombinant preparations of IgE from cloned cDNA have formed the basis of 
more complex structural and functional studies aimed at understanding the nature 
of this molecule. This introduction aims to provide a brief overview of the 
structural and functional information currently available regarding IgE and its 
receptors, and in doing so highlight questions that have arisen from these 
findings and that form the basis of the research described in this thesis. 
1.2 ICE structure (I) 
Initial studies of IgE based on the Ig (ND) myeloma protein (reviewed in 
Dorrington and Bennich, 1978) demonstrated the existence of a molecule of 
nearly 190 kDa molecular weight, approximately 12% of which was composed 
of carbohydrate. The basic four-chain structure of other immunoglobulins was 
maintained, i. e. two light chains and two heavy chains. However, the heavy 
epsilon (c) chain was shown to be nearer in size to the five domain IgM p-chain, 
rather than the four domain structures of IgA, IgD and IgG. This domain 
-`- -` -- was confirmed by protein sequencing, as was the presence of six 
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putative glycosylation sites (Asn 145,173,219,265,371,383 and 394). IgE, as 
other antibodies, is susceptible to papain digestion, and can be cleaved into Fc 
(crystallisable fragment) and Fab (antigen binding fragment) sub-fragments. 
Digestion with pepsin yields an additional Fc" fragment that corresponds to the 





Figure 1.1: Schematic representation of IgE. Each rectangle represents a separate 
immunoglobulin domain; blue lines indicate disulphide bonds and black dots putative 
glycosylation sites. Sidebars indicate fragments generated by protease digestion. 
1.3 IgE conformation 
Subsequent to the initial biochemical characterisation of IgE, more 
detailed biophysical analyses were carried out in an attempt to determine the 
conformation of IgE both in solution, and when receptor-bound. The first studies 
used fluorescence depolarisation as an indicator of IgE flexibility. This technique 
relies on the measurement of re-emitted depolarised light after initial excitation 
from a polarised source, with the size, shape and flexibility of the protein 
determining the rate of depolarisation. This rate can be modelled based on the 
assumption that the molecule is a rigid body; therefore the degree of deviation 
from the model is an indication of flexibility. The source of the fluorescence was 
a chromophore such as dansyl, used either as a hapten or covalently coupled. The 
first study of this type (Nezlin et al, 1973) used steady state fluorescence 
depolarisation to show that IgE myeloma protein was much less flexible than 
IgM or IgG monomers. This was later confirmed using time resolved 
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fluorescence depolarisation (Cathou, 1978). Thus, it was shown that IgE was 
significantly more rigid than any IgG. Further work, using a panel of mouse anti- 
dansyl monoclonal antibodies with different constant regions, showed IgE to be 
more rigid than mouse IgGI (Oi et al, 1984). This antibody has a shortened hinge 
region (whereas IgE completely lacks a hinge region) and had previously been 
noted for its lack of flexibility compared to other IgG sub-classes. Eventually X- 
ray solution scattering, allied to model fitting, provided further evidence 
regarding the native conformation of IgE and IgE-Fc in solution (Beavil et al, 
1995). These experiments confirmed IgE to be bent, and that the bend was likely 
to be the result of a significant shift in the position of the Fcs2 domains in 
relation to Fce3, and a more modest shift in the position of the Fcc3 domains 
relative to one another. These changes in position were based on comparisons to 
models available at the time (Padlan and Davies, 1986; Helm et al, 1991), which 
had been produced using the IgG-Fc crystal structure (Deisenhofer, 1981). 
Several fluorescence depolarisation experiments have also been carried 
out on receptor-bound IgE. The first set of data collected indicated there to be 
little difference between the receptor-bound form of IgE and that found in 
solution (Slattery et al, 1985). Subsequently, nanosecond experiments were 
performed (Holowka et al, 1990). These enable a dissection of the modes of 
motion (as opposed to an average of all modes seen previously). These 
experiments painted a slightly more complex picture, with a variation in 
correlation times obtained that was attributed to different features of the bound 
and unbound molecule. The fastest correlation times were concluded to be 
representative of Fab motion, with cross-linking completely abrogating these. 
The difference between measurements for these motions in solution and receptor- 
bound was small. However, a second longer correlation time was also observed 
for receptor-bound IgE. This appeared to be distinct from the Fab movements, 
and was suggested to be the product of a reduction in segmental flexibility, 
probably in the Fcc2-3 region. Therefore this study concluded that the receptor- 
bound and solution forms of IgE could be different. 
As well as the depolarisation studies of IgE, Forster resonance energy 
transfer (FRET) was also applied to the study of IgE conformation. The 
technique relies on energy transfer between fluorescent molecules with 
overlapping emission and excitation spectra. If a given molecule is excited at the 
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correct wavelength, emission occurs at a longer wavelength. If this emission 
spectrum overlaps with the excitation spectrum of a second fluorescent molecule, 
energy transfer can take place between the first and the second. If energy transfer 
is efficient enough, emission from the second molecule can be detected, as can a 
reciprocal decrease in the intensity of the emission of the first due to the transfer 
of energy to the second. The efficiency of this transfer is highly dependent on the 
distance between the probes, and thus the technique can be used as a "molecular 
ruler". If enough site-specific fluorescent probes with overlapping spectra can be 
incorporated, it is possible to map a protein of interest at the nanometre scale. A 
number of measurements were made for IgE using such probes, leading to a 
model of the receptor: IgE complex based upon distances between both the N- 
and C- termini of IgE, and the distance of receptor-bound molecule to the plasma 
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Figure 1.2: Schematic representation of receptor-bound IgE based on an illustration from Zheng 
et a! (1991) showing distances measured by FRET between site-specific probes. 
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The overall conclusion derived from these FRET studies was that IgE is 
bent in solution, and that there is a degree of loss in the flexibility of the 
molecule on engagement with receptor (Baird and Holowka, 1985; Zheng et al, 
1991). Furthermore, the difference in flexibility between IgG and IgE was again 
noted (Zheng et al, 1992). However, there was a degree of disagreement in the 
findings with respect to the overall conformation when receptor-bound. Initial 
experiments suggested a conformational change on receptor engagement (Baird 
and Holowka, 1985); however later observations using a chimeric IgE molecule 
indicated that the bent conformation was maintained on binding to receptor 
(Zheng et al, 1991). Further clues as to the real nature of the receptor-bound form 
of IgE, as compared to its solution conformation, were not to emerge until the 
elucidation of higher resolution structures. 
1.4 IgE structure (II) 
Cloning of the Fc region and expression in a variety of cell lines has led 
to the availability of IgE fragments for detailed structural analysis. Currently, 
structures exist for three different Fc constructs: the IgG-Fc homologue (Fcs3-4 - 
Wurzburg et al, 2000), the domain that replaces the IgG hinge, (Fcc2 - 
McDonnell et al, 2001) and the full Fc (Fcc2-4 - Wan et al, 2002). 
1.4.1 Fcc3-4 
The truncated Fcc3-4 crystal structure (Wurzburg et al, 2000) confirmed 
that this domain pair resembles that of Fcy2-Fcy3 in the IgG-Fc, with the two- 
fold axis of symmetry seen in all IgG-Fc structures maintained for the Fcc3-4 
fragment. However, differences were apparent when the relative disposition of 
the Fcs3 domains was compared to that of the Fcy2 domains in IgG-Fc (see 
figure 1.3). If the two structures are placed side-by-side, Fcs3-4 appears much 
more compact than the IgG-Fc. This is the result of a significant decrease in the 
angle between the Fcc3 domains and Fcc4 compared with Fcy2-Fc73. It has been 
proposed that the difference is the result of flexibility within Fcs3 (Wurzburg et 
al, 2000). It is thought that Fcy2 and Fcy3 exhibit flexibility about their domain 
interface, whereas Fcc3 and Fcs4 can move with respect to one another as a 
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result of structural changes within Fcc3. The FcE3-4 structure also confirmed the 
presence of a core of glycosylation in the cavity between opposing Fcc3 
domains, as density was recorded in this region, although it could not be 
determined definitively. The carbohydrate chains are attached at Asn 394 of Fcc3 
and mask a hydrophobic patch of -100 A2 within this region, however, the 
density was not clear enough to resolve the separate residues, and therefore it 
was not included in the published model. The glycosylation site at Asn 394 is 
homologous to Asn 297 in Fcy2 of IgG-Fc. 
Fcc3-4 IgG Fc 
Figure 1.3: Ribbon representation of the IgG Fc (Deisenhofer et al, 1981) and FcE3-4 (Wurzburg 
et al, 2000) fragments. Each chain is coloured separately, with the arrows at the N-terminus of 
each indicating the difference in positioning of the Fce3 and Fcy2 domains with respect to one 
another. 
1.4.2 Fcc2 
Shortly after the publication of the Fcs3-4 structure, that of the "extra" 
domain was also described (McDonnell et al, 2001). This was for an Fcc2 
monomer, with the inter-chain disulphides mutated to serine (to aid refolding 
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from E. coli inclusion bodies). This structure was determined in solution by 
nuclear magnetic resonance (NMR). The structure, combined with other 
biophysical analyses, revealed many interesting clues to the nature of IgE's 
interaction with its receptor; these will be dealt with later in this chapter. 
Regarding the structure of the Fc, it was observed that the Fcs2 domains do not 
dimerise in solution, a result that was not predicted by modelling based on the 
comparisons between IgE and IgG-Fc (Padlan and Davies, 1986; Helm et al, 
1991). Furthermore, it was also shown by McDonnell at el that in the analytical 
ultracentrifuge a single Fcc2 can bind to the Fcc3-4 fragment with a moderate 
affinity (- 2x 105 M"1), which is equal to that of IgG-Fc binding to FcyRIII. This 
observation implied that at least one Fcs2 domain interacted directly with Fce3-4, 
suggesting a compact structure for an uncomplexed IgE-Fc. This was consistent 
with the solution experiments described in section 1.3. 
1.4.3 Fcc2-4 
The following year the structure of the full Fc was determined (Wan et al, 
2002). This enabled the Fcc2 pair to be seen for the first time. This structure 
confirmed the bent configuration suggested by previous work, with one Fcc2 
making extensive contacts with not only Fcc3, but also some contact with Fce4. 
The second Fcc2 in contrast made very few contacts, thus explaining the 
observation of only a single Fcc2 bound to FcE3-4 in the analytical 
ultracentrifugation experiments (McDonnell et al, 2001). The structure also 
revealed an FcE2: Fc82 interface very different to that predicted by earlier 
modelling (Padlan and Davies, 1986; Helm et al, 1991). A much smaller area of 
contact was seen compared with other Fcc domain interactions (Fcc4: Fcc4, for 
example), mediated mostly by hydrogen bonds and electrostatic interactions and 
stabilised by the two inter chain disulphides (see panel A figure 1.4). This 
explained the lack of interaction between Fcc2 domains seen in the NMR 
experiments. Finally, when the packing of the Fcc2 domains against Fcc3 was 
examined, it was clear that this led to a distortion of the symmetry seen for the 
Fcc3 domains in the Fcc3-4 fragment. The result of this was that one Fcc3 
domain in the Fcc2-4 structure did not assume the compact structure seen for 
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both Fcc3 domains in Fcs3-4. However, in the other chain FcE3 did adopt the 













Figure 1.4: Part A represents side and front views of the full IgE-Fc structure in ribbon form 
with schematics included to indicate positioning of the domains relative to one another, and the 
position of the inter-chain disulphides. Part B represents the backbone structure of uncomplexed 
Fcr3-4 compared to the Fcc3-4 domains of the full Fc structure. Adapted from Wan et al, 2002. 
1.4.4 IgE glycosylation 
All the structures described above showed that the glycosylation of the Fc 
was of a high mannose type. This represents a key difference compared to IgG, 
which has a complex-type carbohydrate composition. The affinity of the IgG-Fc 
for its receptors is highly dependent on glycosylation state (Tao and Morrison, 
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IgE Fc. E. coli expressed IgE-Fc shows clear receptor binding capability (Geha et 
al, 1985; Helm et al, 1988; Vercelli et al 1989), as does deglycosylated 
mammalian expressed material (Basu et al, 1993; Bjorklund et al, 1999). 
However, expression of IgE in mammalian systems is dependent on 
glycosylation at Asn 394, but not other sites (Nettleton and Kochan, 1995), and 
small structural changes have been mapped crudely with antibodies to indicate 
that the absence of carbohydrate can bring about minor conformational shifts 
(Bjorklund et al, 1999). This represents an intriguing difference between the two 
Fc fragments given their otherwise broad structural similarities. 
1.4.5 The c-chain inter-domain disulphide bridges 
Another difference between IgG and IgE is the disulphide arrangement 
between the two heavy chains. The Fcc3-4 domain is a truncated Fc, and as such 
includes only a single disulphide at the N-terminus (between residues 328 in each 
chain). However, in the full Fc there are two disulphide bridges between residues 
241 and 328, and when the X-ray structure was determined it was found that 
these formed a "crossed" disulphide pairing. The hinge regions of the IgG 
subclasses contain parallel disulphide bridges (Kessler et al, 1991), although 
IgG4 is thought to form infra-chain linker disulphides (Aalberse and Schuurman, 
2002). The IgE disulphide arrangement would simply represent a curiosity if it 
were not for the fact that the linker region has been implicated in receptor 
binding (see section 1.7), and therefore its arrangement could be a critical matter 
with respect to affinity and receptor recognition. It is already known that changes 







Figure 1.5: Schematic and electron density (with stick representation of residues) to indicate 
nature of the interdomain disulphides seen in the full Fc structure. Adapted from Wan et al, 2002. 
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1.4.6 Fcs3 
In addition to those fragments for which atomic structures have been 
determined, a number of other IgE-Fc sub fragments have been produced 
(reviewed in Vangelista, 2003). In particular, one construct yielded surprising 
results; this was an E. coli expressed single Fcs3 domain (Henry et al, 2000). 
Although this domain was unable to fold as judged by circular dichroism (CD, 
see figure 1.6; for comparison standard profiles for random coil, beta sheet and 
alpha helix can be found in section 2.4.1), it nevertheless maintained the ability 
to bind an IgE receptor (FccRI) with an affinity close to that observed for the 
interaction of IgG with analogous receptors (5 x 106 M"'). This result will be 







Figure 1.6: Circular dichroism spectrum of Fce3 construct described by Henry et al, 2000; 
source Naomi Price (Laboratory of Biophysics, Oxford University). 
1.5 IgE receptors 
Two receptors capable of binding IgE-Fc have been characterised 
extensively. These belong not only to distinct structural but also functional 
families (Reviewed by Sutton and Gould, 1993; Kinet, 1999; Novak et al, 2001; 
Gould et al, 2003). Firstly there is FccRI, referred to as the "high affinity" IgE 
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receptor. This binds IgE with an affinity of -' 1010 M"1 and is an Immunoglobulin 
type (Ig-type) receptor. The second receptor is FcsRII, or CD23, which is also 
referred to as the "low affinity" IgE receptor (KA -' 107 M"1), and is a C-type 
lectin. 
1.5.1 FccRI 
FcERI is the receptor present on the surface of mast cells and basophils, 
and lies at the heart of the allergic reaction observed in the kind of experiment 
carried out by Prausnitz and Kästner. The cross-linking of FccRI-bound IgE by 
multivalent antigen on the surface of these cells leads to the release of pro- 
inflammatory mediators that are responsible for the symptoms of an immediate 
hypersensitivity reaction. This reaction has a broad range of outcomes, serious in 
the case of anaphylactic shock, or relatively mild in the case of hayfever. 
FccRI is expressed at a relatively high level on mast cells and basophils 
(200,000 molecules per cell), but it is also present at a much lower level on 
dendritic cells, Langerhans cells, platelets, monocytes and eosinophils. Its 
function on these cells is less well defined. It is thought that platelets and 
eosinophils may use the receptor for IgE-dependent killing of parasites 
(Dombrowicz and Capron, 2001), presenting an evolutionary justification for the 
existence of IgE. Furthermore, monocytes have also been shown to be capable of 
harnessing IgE in antibody-dependent phagocyte-mediated killing (Karagiannis 
et al, 2003). 
In addition to "killing", data has also been produced to show that FccRI 
on the surface of monocytes, dendritic cells and Langerhans cells allows IgE 
antibody-dependent antigen presentation to T helper cells. T-cells activated by 
antigen presenting cells, and allergen-activated mast cells, can provide the 
necessary signals for switching to IgE production (specifically IL-4 and CD40 
ligand). This in turn promotes further sensitisation of effector cells and antigen 
presenting cells. The overall outcome of this positive feedback loop is a 
perpetuation of the allergic state. See figure 1.7. 
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Figure 1.7: The regulation of IgE synthesis (adapted from Gould et al, 2003): Positive feedback 
occurs as a result of allergen uptake, mediated by FccRI (and CD23 - see section 1.5.3) on 
antigen presenting cells, and activation of effector cells such as mast cells and basophils bearing 
FccRi. Activated effector cells and T-cells can provide the necessary signals (IL-4 and CD40L) 
for induction of the switching of B-cells to IgE production. In addition, cross-linking of CD21 
and membrane IgE (mlgE) on B-cells by trimeric CD23 can also up-regulate IgE synthesis, 
whereas cross-linking of CD23 only, or mCD23 and mlgE can down-regulate IgE synthesis (see 
section 1.4.3). 
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Another key feature of the FcERI: IgE complex is its ability to increase 
survival of the receptor on mast cells without any other additional signal. One 
reason for this may be the avoidance of protease digestion (Borkowski et al, 
2001), however increased cell survival is also observed (Asai et al, 2001; 
Kalesnikoff et al, 2001). The process by which this happens is not yet clear, 
although it has been suggested that it is dependent on FccRI aggregation (Kitaura 
et al, 2003). Therefore, in addition to the immediate hypersentivity reaction, the 
interaction of IgE with FccRI has an important role to play in the perpetuation of 
the allergic response by positive feedback mechanisms with respect to antigen 
presentation and cell survival. 
1.5.2 FcERI structure 
Structurally, differences exist for FccRI dependent on the cell type. FccRl 
is expressed as a heterotetramer (a 0 and two y chains - see figure 1.8) on mast 
cells, basophils and possibly eosinophils, whereas it is expressed as a 
heterotrimer in monocytes and platelets (a and two y chains only). It is the a 
chain, a type I integral membrane protein, that contains the Fc binding site in its 
N-terminal extracellular region (Riske at al, 1991; Hulett et al, 1993, Kochan et 
al, 1994). The 0 and y chains in comparison are principally cytoplasmic in their 
function, acting in cell signalling pathways. Both the 0 and y chains contain 
immunoreceptor tyrosine-based activation motifs (ITAMs) which can be 
phosphorylated by associated enzymes (normally Lyn) on receptor aggregation. 
These tyrosine phosphorylated ITAMs then acts as scaffolds for the binding of 
additional cytoplasmic signalling molecules with Src homology 2 (SH2) 
domains, such as Syk. Activation of Syk leads to a phosphorylation of a 
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multitude of signalling mediators and eventually the release of histamine or 
archidonic acid, or transcriptional activation leading to cytokine production, 
depending on the pathway followed (reviewed in Siraganian, 2003). 





Figure 1.8: Schematic illustrating the domain structure of FccRJ relative to the plasma 
membrane. The extracellular portion is shown as two ellipses representative of the 
immunoglobulin like domains (Dl and D2) that form the IgE binding portion of the receptor. 
The ectodomain of the FcERla chain (referred to as soluble FccRIa, or 
sFcERIa) consists of two Ig-like domains. It is this region that has been most 
closely examined structurally, as it forms the platform for interaction with IgE, 
and therefore the bridge between the allergen binding antibody and its effector 
cell. To date the structures of five different crystal forms of sFcERIa have been 
solved (Garman et al, 2001). These show the two immunoglobulin domains (DI 
and D2) arranged in an almost anti-parallel fashion, placing the N- and C- 
termini at the same end of the molecule (see figure 1.9). An extensive packing 
interface is seen between the two molecules, leading to a "wedge" shaped 
structure. The domain arrangement is apparently crucial, as it is preserved with 
minor variations not only throughout the differing crystal forms, but also across 
the domains of related IgG receptors (FcyRIIa, FcyRIIb and FcyRIII). A notable 
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feature of the sFccRIa "wedge" is a "ridge" of surface exposed tryptophans at the 
top of the D1 - D2 interface (shown in red in figure 1.9). This region is also 
conserved in receptor structures related to FccRIa, and is thought to represent a 
common structural motif in antibody recognition. 
Figure 1.9: Ribbon representation of the FccRI soluble alpha chain structure (Garman et al, 
1998) with the surface exposed tryptophans of domain D2 important for antibody recognition 
coloured red (side chains shown). 
1.5.3 CD23 
CD23 has also been extensively characterised (Reviewed by Sutton and 
Gould, 1993; Novak et al, 2001; Gould et al, 2003). CD23 binds IgE with an 
affinity of _107 M-' and is not a member of the Ig superfamily like FccRI and the 
Fcy receptors, but a type II integral membrane protein composed of a calcium 
dependent C-type lectin head and an alpha helical stalk. The stalk has the 
potential to form a coiled-coil with other CD23 monomers to form trimers at the 
cell surface (Beavil et al, 1992). The role of this receptor is distinct from that of 
FccRI, and there are two variants that differ in their N-termini by 7 amino acids 
(termed CD23a and CD23b). These differences alter signalling motifs that 
modify function. CD23b expression is induced by IL-4 on a broad range of cell 
types, whereas CD23a is only expressed on B cells. CD23a can facilitate antigen 
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presentation, and thus for example, CD23 on human B cells mediates IgE- 
dependent presentation of the Der p II allergen to Der pII specific T cell clones in 
vitro (van der Heijden et al, 1993). Furthermore, in human B cells, CD23 has 
been shown to undergo endocytosis and recycling alongside HLA-DR 
(Karagiannis et al, 2001). This may represent a method of facilitated antigen 
presentation due to the preferential transfer of allergenic peptides to MHC class 
II in recycling endosomes, ultimately resulting in the up-regulation of IgE 
production. 
Antigen presentation, resulting in positive feedback and IgE synthesis, is 
not the only role CD23 has been attributed. A key function appears to be the 
direct regulation of IgE levels (reviewed in Gould et al, 1997). In a 
straightforward fashion, it can simply act as a buffer for IgE, mopping up 
unbound antibody. However, it appears that its function is more complex than 
this, as cross-linking of CD23, or IgE and CD23, on the surface of B cells results 
in the down-regulation of IgE synthesis. In vivo this regulatory potential has been 
confirmed as CD23 knock-out mice over-express IgE, whereas those engineered 
to over-express CD23 are deficient in IgE (Lamers and Yu, 1995; Payet and 
Conrad 1999). Furthermore, not only can CD23 act as a cell surface receptor, it 
can be cleaved from the cell surface to yield a number of soluble sub-fragments. 
These fragments show a complex behaviour, with an apparent role to play in the 
regulation of IgE synthesis. The potential of these fragments is dependent on 
their size and oligomeric status. The picture is complicated further by the fact 
that CD23 can also bind another cell surface receptor, CD21. It is known, for 
example, that surface cleaved CD23 acts as a B-cell growth factor up-regulating 
the production, but only when it is trimeric. It has been proposed that this is 
because trimeric CD23 has the potential to cross-link membrane IgE and CD21 
on B-cells committed to IgE synthesis, leading to an up regulation of IgE 
production. On the other hand membrane-bound CD23 can deliver a down 
regulatory signal for IgE synthesis by B-cells when engaged by an allergen: IgE 
complex. 
1.6 IgE: A therapeutic target 
It is clear from the summary above that both FccRI and CD23 have key 
roles to play in allergic disease. However, in this thesis, only the interaction of 
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IgE-Fc with FccRI will be discussed further. The binding of IgE to FcERI 
represents the first common step in the allergic cascade and thus presents a 
unique point for intervention in allergic disease. An increase in understanding of 
both the structure of the IgE-Fc, and how this affects binding to FccRI, is key to 
progress in this area. In fact, some success in targeting this interaction has 
already been achieved with the development of an anti-IgE monoclonal antibody 
(mAb) (reviewed in Hamelmann et al, 2002). This mAb is directed to the Fcs3 
domain of IgE and appears to reduce allergic symptoms markedly. Although the 
mode of action is unknown, the qualities of the mAb have been established; it 
binds serum IgE, blocks FcsRI binding and blocks degranulation of mast cells in 
vitro and in vivo, but does not bind to receptor-bound IgE. After treatment there 
is a drop in serum IgE, and therefore it appears that not only can it interfere with 
sensitisation, but also prevent some of the positive feedback loops described 
previously (Sutton et al, 2000). Therefore, a precedent has been set for treatment 
by the blocking of the IgE: FccRI complex, confirming IgE as a valid target in 
allergic disease. However, more research is required, as whole antibodies cannot 
provide a broad range therapeutic due to their cost of production and method of 
administration (intra-venous). Ideally a smaller molecule is required. To enable 
the rational design of such a molecule, specific targets are also needed. To 
establish these targets a detailed knowledge of the components required to form 
the IgE: FccRl interface is essential. 
1.7 The IgE: Fc&RI complex 
An enormous amount of data has been collected with respect to the 
interaction of IgE with FccRI. Early research concentrated on mapping the 
binding site with peptides that corresponded to fragments of the whole IgE Fc 
(Hamburger, 1975; Geha et al, 1985; Helm et al, 1989; reviewed in Beavil et al, 
1993). These experiments led to the Fcc3 domains and the linker region between 
Fcs3 and Fcs2 being proposed as the main area of interaction with FccRI. The 
binding of IgE to FccRI through Fcs3 was further confirmed by domain 
swapping experiments. Utilising the observation that human IgE cannot bind 
rodent FccRI, but human and murine IgE bind equally well to human FccRI, it 
was found that replacement of human IgE with the Fcc3 domain of murine IgE 
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enabled binding to the rodent receptor. In the same study it was also 
demonstrated that deletion of the Fc£2 domain from this mutated IgE did not 
impair binding capacity, or its ability to mediate mast cell degranulation (Nissim 
et al, 1991). In a similar experiment, but this time using human Fcy domains, it 
was also confirmed that Fcc4 was not essential for receptor binding (Weetal et al, 
1990). The Fcs3 binding site was mapped to a finer degree by the use of site 
directed mutagenesis (Henry et al, 1997; Presta et al, 1994). The result of this 
was the prediction of an extensive surface area of interaction with FccRI that 
covered both Fcc3 domains. This surface could be split into two distinct regions 
based on the two-fold axis of symmetry. At the same time studies using 
analytical ultracentrifugation determined the stoichiometry of the interaction, 
confirming it as 1: 1 for both the full IgE-Fc (Keown et al, 1995) and Fcc3-4 
(Keown et al, 1997). This was crucial, as degranulation of mast cells and 
basophils occurs in response to receptor cross-linking. It is therefore essential 
that non-antigen bound antibody (i. e. that with a single IgE-Fc region) is unable 
to cross-link receptor, otherwise allergic reactions could proceed in the absence 
of allergen. 
The equilibrium affinity constant for the complex between Fc and FccRI 
is extraordinarily high (1010 M"1) (Ravetch and Kinet, 1991). This is especially 
striking when compared to those for similar IgG interactions with their Fcy 
receptors: IgG 1 binds FcyRIII with an affinity of around 105 M"1 (Maenaka et al, 
2001). These measurements do vary slightly depending on the method of 
measurement and construct used to obtain them, but the smallest fragment that 
appeared to maintain close to full affinity for FccRI was the IgE-Fc sub fragment 
Fce3-4. The Fcc3-4 fragment shows an affinity from 2x 108 M"' (McDonnell et 
al 2001) to 1010 M'1 (Keown et al, 1997), dependent on assay format. Eventually, 
a crystal structure of the complex between Fcc3-4 and FcsRIa was determined 
(Garman et al, 2000). This revealed the basis of the 1: 1 stochiometry, confirming 
the large surface area of interaction with both Fcc3 domains, and provided 
structural evidence for the high affinity between FccRI and IgE. 
As had been predicted, the surface area of interaction of Fcc3-4 with 
FccRI could be split broadly into two sites by mapping contacts between Fcc3-4 
and FccRI in the complex crystal structure. These sites cover residues on both 
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Fcc3 domains and the Fcc2-3 linker. The contact surface is large, 1830 A2, and 
covers a range of electrostatic and hydrophobic residues, providing a strong 
indication as to why the affinity between Fce3-4 and FceRI is so high. In total 
twenty-two residues in the Fc are involved in the binding of FccRI, of which four 
residues are common to both interaction sites. This is because Fcs3-4 is a 
homodimer, and therefore a particular residue in chain A can make a certain 
contact in site 1, whilst the same residue in chain B makes another in site 2. Due 
to the fact that contact of each Fcc3 domain with the receptor involves four 
identical residues (along with additional site specific interactions) an equivalent 
second receptor-binding site does not exist. Therefore the crystal structure of the 
Fcc3-4: FccRI complex was able to explain the 1: 1 stoichiometry seen between 
IgE and FceRI. However, this was not the only reason why IgE is unable to 
engage two FccRI receptors. Alongside the "shared" residues, the engagement of 
an additional receptor is sterically blocked because Fc&RIa binds across the Fc 
symmetry axis, with the Fcc2-Fcc3 linker also bound asymmetrically. 
In the complex, what is commonly referred to as binding site I consists of 
four contiguous segments and 12 residues from chain 1 of the Fcc3-4 
homodimer. It is dominated by a set of loops at the top of Fc63 that form a 
binding pocket for tyrosine 131 of FccRI. These loops have been compared to the 
CDR loops of antibody variable domains and T cell receptors (Wurzburg and 
Jardetzky, 2002). Binding site 2 is formed from two segments made up of 10 
residues from chain 2. This binding site is involved in the interaction with the 
tryptophan ridge previously described on FccRI (see section 1.5.2). Two of these 
tryptophans (W87 and W110 in FccRIa) form a pocket for proline 426 of the 
IgE-Fc, also known as a "proline sandwich", whereas the two other tryptophans 
interact with the Fcs2-3 linker. In fact, 7 of the 15 FccRI contact residues are 
aromatic (including the surface exposed tryptophans) and it is thought these 
residues contribute greatly to the stability of the complex. In the Fcc3-4: FccRI 
structure very little of the buried surface area is accounted for by interactions due 
to glycosylation at Asn 394 (-100 A). 
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Figure 1.10: The crystal structure of the FCs3-4: FceRl complex (Garman et al, 2000). Soluble 
FcsRI alpha chain is shown in green (ribbon format). Fcs3-4 is shown in yellow and red 
(coloured by chain, ribbon format). Carbohydrate at Asn 394 is also coloured yellow. Proline 
426 and interacting FceRI residues, and tyrosine 131 of FcsRI and interacting residues, are 
shown space filled on the left and right hand side of the binding site respectively. 
1.8 IgE: Conformational change 
If the unbound (Wurzburg et al, 2000) and bound (Garman et al, 2000) 
forms of the Fcc3-4 are compared, many contact residues are found not to be 
fully accessible in the unbound state. It has therefore been predicted that a large 
conformational change is required for the full engagement of FcsRI. It is 
suggested that this is possible due to flexibility encoded within the Fcc3 domains 
(Wurzburg et al, 2000). The bound conformation of Fcc3 is very similar to that 
of the "open" chain Fcc3 in the full Fc crystal structure (Wan et al, 2002). 
However, for full engagement of the full Fc (Fcc2-4) both Fcs3 domains would 
need to "open". For this to happen with respect to the conformation observed in 
the Wan et al crystal structure, the Fcc2 of the opposite chain would need to be 
displaced, i. e. a gross conformational change is also required with respect to the 
positioning of Fcc2. In fact, the determination of the structure of the full Fc (Wan 
et al, 2002), and Fcc2 (McDonnell et al, 2001), has led to an extension of the 
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hypothesis regarding conformational change and the formation of the IgE: FccRI 
complex. In NMR experiments, chemical shifts were observed for Fc82 when a 
N15 labelled Fcc2 domain was titrated into an FccRI preparation (McDonnell et 
al, 2001). This indicated that not only do the Fcc2 domains show affinity for 
Fcc3 (as indicated in the analytical ultracentrifuge studies described earlier), but 
also FcERI. Thus, it appears that not only does the Fca2 move away from the 
opposite Fcs3 domain to allow it to bind FccRI, but it also engages with FccRI. 
Therefore an extension of the molecule must take place from the compact 
structure seen in the uncomplexed Fcc2-4 crystal structure, to a more elongated 
form in the complex in which Fca2 can make contact with FceRI (see figure 
1.11). 
Evidence for a specific role for Fcs2 in the interaction between IgE and 
FccRI came from surface plasmon resonance data (McDonnell et al, 2001). 
These data show that the off-rate of the full Fc is slower than that of the Fcc3-4. 
However, the on-rate is also slower, so that the overall K. remains the same, 
although the kinetics of interaction are altered. Therefore, while the high affinity 
constant for the IgE-Fc and FccRI is mainly a result of the interaction of FccRI 
with the Fcc3 domain pair, the kinetics of the interaction are markedly altered by 
the presence of Fcc2. This is particularly important if the in vivo role of IgE is 
considered. The immediate hypersensitivity reaction requires basophils and mast 
cells to be continuously primed, ready to be triggered by allergen, with the 
equilibrium of the IgE: FccRI interaction in vivo such that it strongly favours full 
receptor residency (Smurthwaite et al, 2001). This is quite unlike IgG, which 
forms complexes in solution that then bind to cells triggering effector 
mechanisms via cross-linking receptor. Therefore, for IgE, anything that alters 
the rate at which the receptor ligand complex dissociates is critical. Furthermore, 
as outlined in section 1.5.1, it is clear that IgE: FccRI complexes enhance receptor 
and cell survival. It is not known how the half-life of the complex affects these 
signals, nor the intensity of the immediate hypersensitivity reaction. Therefore 
the role of Fcs2 in slowing in the off-rate of IgE could be far more important 
than the small differences in affinity constants first indicate. 
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Figure 1.11: Section A shows ribbon outline of the full IgE Fc and soluble FcERI alpha chain 
structures oriented on the cell surface. Residues in the Fcc2 domain predicted to interact with 
FceRI are shown space filled in green. Section B represents this change in conformation in 
cartoon 
. 
form at. Adaptedfrom Wan et a!, 2002. 
1.9 The role of Fcc3-4 
Although knowledge of the Fce2 domain structure suggests a functional 
role, and therefore novel possibilities for inhibiting the FccRI: IgE interaction, the 
Fce3-4: FccRI complex still provides the foundation for the extraordinarily high 
affinity seen between these two molecules. Therefore, further investigation of 
how the Fcc3-4 sub-fragment maintains the majority of the binding energy for 
the interaction is key to discovering ways of interrupting the process of receptor 
binding. The IgG complex with FcyRIII is very similar to that of Fcs3-4 with 
FcsRI, but with an affinity that is almost five orders of magnitude less than that 
of IgE. Thus, there must be elements that distinguish the latter complex, and that 
enable such a large binding affinity to be achieved. A comparison of IgG and IgE 
receptor binding could therefore yield important clues as to possibilities for 
lowering the affinity of IgE for FccRI. 
1.10 A comparison of the IgE and IgG receptor complexes 
At the time of publication of the Fcc3-4: FccRI complex structure, a 
crystal complex between the IgG-Fc and one its receptors, FcyRIII, was also 
described (Sondermann et al, 2000; and subsequently by Radaev et al, 2001). If 
the complexed structures of Fcc3-4 and IgG-Fc are compared, they can be 
virtually overlaid, with the mode of binding replicated closely between the two. 
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In fact, the buried surface area of each is within 130 A2 of the other (Fcc3- 
4: FccRI is 1850 A2, IgG Fc: FcyRIII is 1720 A2). However, if the affinities of 
Fec3-4 for FcF-RI and IgG Fc and FcyRIII are compared the difference is 





Figure 1.12: Front and side views of both the FccRI: Fce3-4 complex (top, Fce3-4 coloured blue; 
Garman et al, 2000) and the IgG-Fc: FcyR! I1 complex (bottom, IgG-Fc coloured red; 
Sondermann et al, 2000). Carbohydrate for both complexes is shown in yellow, receptors are in 
green. 
A closer examination of the structures revealed some small but significant 
differences (Radaev and Sun, 2002; Wurzburg and Jadetzsky, 2001). If the two 
sites described in section 1.7 are compared, it is clear that in site 2 the tryptophan 
"ridge", although conserved, involves more hydrophobic contacts for IgE than 
for the IgG-Fc. This is because in addition to the proline sandwich that is formed 
in both Fc complexes, a further two of the exposed tryptophans of FccRI make 
contact with the N-terminal region of Fcc3-4. This region in the full Fc 
represents the linker between Fcs2 and Fcs3 domains. In fact, linker residues 
(predominantly classified as site 2) contribute 130 A2 more buried surface area to 
the IgG Fc interaction. However, the IgE Fc compensates for the differences by 
increasing the number of hydrophobic interactions and adding a salt bridge 
(R334-E132). This could lead to a significant increase in the binding energy 
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relative to IgG Fc, despite the reduced contact area in the IgE complex. 
Furthermore, the CDR-like site 1 has a much greater area of contact, with the 
surface area of Fcs3 domain interactions larger by 360 A2. It has been suggested 
that this region, as well as being responsible for some of the difference in affinity 
between IgE and IgG, also fine-tunes the affinity of all Fc type receptors 
(Wurzburg and Jardetzky, 2001). Therefore, although the buried surface areas are 
similar, the type and number of contacts, and where they arise, is markedly 
different. In addition to those described, there are further subtle differences, such 
as the number of H-bonds, and whether these are made between main chain or 
side chain atoms. 
1.11 What is the smallest functional receptor-binding fragment of IgE? 
It therefore appears that the interfaces between IgG and IgE fragments 
and their receptors are similar, and that the difference in affinity lies in the type 
and number of contacts within defined regions. Which of these interactions are 
crucial, and what is the necessary structural scaffold to enable them to take 
place? The crystal structures have highlighted conserved regions, and extra areas 
of contact, but they cannot quantify the relative contributions of individual 
structural features. This could be achieved by removing certain structural 
elements in a series of fragments to ascertain which are the most important. It is 
worth noting again here that an E. coli expressed fragment of a monomeric, 
unglycosylated Fcc3 domain that is unfolded, retains much of the binding 
capacity seen for a folded, glycosylated Fcc3-4 domain pair, and indeed has the 
same receptor affinity as IgG Fc has for FcyRIII (Henry et al, 2000). Defining 
the essential structural components required for the full, uniquely high affinity of 
the native IgE for FccRI, may thus contribute to the wider aim of designing 
inhibitors of this interaction. 
A great deal of work has been carried out to address this question for IgG 
(reviewed in Jefferis and Lund, 2002). In fact, despite the striking similarities in 
binding mode, and buried surface area in the complex structures (see section 
1.10), the studies on IgG are notable for highlighting subtle, but possibly crucial 
differences in comparison to IgE. A key area of focus, and one that would appear 
to contrast strongly with findings for IgE, is the effect of glycosylation on 
receptor binding. Current results indicate that the minimal functional fragment of 
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IgG requires glyscosylation (reviewed in Jefferis and Lund, 2002), but IgE does 
not (Geha et al, 1985; Basu et al, 1993). As stated earlier, it has been known for 
some time that the absence of glycosylation at Asn 297 for IgG prevents receptor 
recognition, but this is not the case for IgE (see section 1.4.4). In fact, the IgG 
studies have progressed to a point at which different glycoforms have been 
analysed for stability and binding (Mimura et al, 2001), leading to a definition of 
the minimal carbohydrate requirement for full receptor binding. The crystal 
structures of some of these truncated glycoforms have been solved, and 
arguments put forward as to why differences in binding are seen (Krapp et al, 
2003). To summarise, it is thought that a closing of the Fcy2 domains occurs 
when carbohydrate is removed completely, thus preventing receptor engagement, 
and that disorder in the hinge proximal loops occurs for truncated glycoforms (in 
the C'-E loop). These loops are important for receptor recognition. What is 
interesting is that homologous loops in IgE are also involved in FccRI binding (it 
is one of the CDR-like structures, the D-E loop). Furthermore, the closing of the 
"gap" between the Fcc3 domains of the IgE-Fc appears to happen even when 
glycosylated; a "closed" conformation is seen for one Fcc3 in the IgE-Fc crystal 
structure (Wan et al, 2002) and for both Fcs3 domains in the structure of the 
uncomplexed Fcc3-4 fragment (Wurzburg et al, 2000). This represents an 
interesting contradiction. Why, when Fcc3-4 is glycosylated does it adopt a 
closed conformation, and how is it that when it is closed, it can bind receptor 
with such high affinity in comparison to IgG, which in this state cannot bind 
receptor at all? An explanation for this may lie in the differences in flexibility 
and stability of the Fcc3 and Fcy2 domains respectively, enabling Fce3 to adjust 
its shape more easily. Structural differences have already been highlighted 
(Wurzburg et al, 2000, see section 1.4.1), with the suggestion that the flexibility 
of the Fcs3-4 fragment is due to an additional rotation from within the Fcc3 
domain. In contrast, the IgG-Fc only appears to flex around inter domain regions. 
It is also known from differential scanning calorimetry experiments that the 
melting temperatures of these domains differ by 19 °C (Keown, PhD thesis, 1997 
- 52 °C for Fc83,1997; Mimura et al, 2000 - 71 °C for Fcy2), indicating that 
Fcs3 is less stable, and therefore perhaps a more flexible domain. 
Another difference between IgE and IgG concerns the requirement for a 
dimer of the Fcy2 or Fcc3 domains for receptor binding. It has been claimed that 
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the minimal domain requirement for Fey receptor recognition is a native Fc-12 
domain pair (Lund et al, 2000) whereas a monomeric unfolded Fcc3 domain 
retains affinity for FcERI (Henry et al, 2000). However, neither of these 
fragments showed native affinity. The Fc'y2 pair functioned 30% less efficiently 
than full IgG in superoxide assays, and the monomeric Fcc3 domain bound 
FccRI with an affinity -200 fold lower than that of a mammalian expressed 
Fcc3-4 fragment. It was suggested that the difference in binding observed for the 
Fcy2 pair compared to the full IgG-Fc was due to the absence of the Fcy3 
domains, which although they do not make receptor contact, may be required for 
the correct orientation of the Fcy2 domain pair for receptor engagement. In the 
case of Fce3, it is still not clear what components are necessary to yield frill 
affinity for FccRI. For example, it is possible that a single fully folded Fcs3 
domain could show higher, perhaps close to native affinity levels for FcsRI. 
However, if two domains are required, as is strongly indicated by the crystal 
structure of the sFcERla: Fcc3-4 complex, the correct orientation of the Fcc3 
domains could also be important for engagement of FccRI. In IgE-Fc the Fcc4 
domains contact extensively with Fcc3 in the same polypeptide chain, and the 
FcE4 pair also forms the dimer interface between the two homologous chains of 
the IgE-Fc. It may be that the Fc&4 domains play a similar role to Fcy3 in 
presenting the receptor binding domains. It is also possible that the extremely 
high affinity of the Fc83 domain for Fc6RI is the sole determinant of the 
interaction, and that two Fcc3 domains are sufficient for high affinity binding. 
In the paper of Lund et al it was also shown that removing the covalent 
linkage in the hinge region of the IgG-Fc led to a 100-fold drop in effective 
competition with wild type IgG in cell binding assays. This led to the conclusion 
that linkage of the receptor binding domains is also critical for high affinity 
binding. This reveals yet another intriguing contrast with IgE, as disulphide 
linkage in the equivalent fragment of IgE (Fcc3-4) has been suggested to be not 
as important for receptor recognition (Basu et al, 1993). This is despite the linker 
region representing a critical binding motif (Garman et al, 2000), and the fact 
that it tethers the relatively unstable and flexible Fcc3 domains that constitute the 
two halves of the binding site. 
The nature and importance of the inter-domain contacts of IgE needs to 
be assessed further if the structural scaffold necessary for full engagement of 
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FccRI is to be understood. The comparisons and apparent contrasts with IgG 
provide an important insight into the factors contribute to the uniquely high 
affinity of IgE for FccRI, and also highlight possible areas for further 
investigation in the attempt to determine the smallest fully functional receptor 
binding fragment of IgE. 
1.12 The aims of this thesis 
Prior to undertaking the studies described in this thesis, the smallest fully 
characterised high affinity fragment of IgE was a mammalian expressed dimer of 
domains Fc83 and Fcs4 (affinity -109M'1). In addition, an isolated Fcg3 fragment 
had also been produced in E. coli. This fragment possessed an affinity of -107M"' 
for its receptor FccRI, and was unfolded as judged by circular dichroism and 
fluorescence spectroscopy. This represented a remarkable affinity for an 
unstructured peptide and highlighted two questions regarding IgE-Fc and its 
interaction with FccRI: 
a) What determines the correct folding of the Fcc3 domain in the IgE 
molecule? 
b) What are the minimal structural requirements for a fully active Fcc3 
domain? 
These two questions formed the basis for the studies described in this thesis. In 
the course of the work, the effect of three different structural features on the 
folding and binding affinity of Fc63 were examined: 
i) presence of adjacent Fcc4 domains 
ii) dimerisation and disulphide linkage of Fcc3 
iii) glycosylation of Fcc3 at Asn 394. 
The contribution that each of these features made to the structuring of Fcs3 and 
binding to FcERI was assessed by circular dichroism spectroscopy, analytical 
ultracentrifugation and surface plasmon resonance. This has revealed new 
insights into the basis of IgE antibody domain folding and the formation of the 
FccRI: IgE complex. 
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Materials and Methods 
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Chapter 2: Materials and Methods 
2.1 Materials and stock solutions 
All chemicals were obtained from Sigma unless otherwise stated. 
Acrylamide: A 30% (w/v) acrylamide / 0.8% (w/v) NN'-methylenebis- 
acrylamide stock was used, purchased from Severn Biotech Ltd. 
APS: Ammonium persulphate was prepared as a 10% (w/v) solution in deionised 
water. 
Coomassie blue stain: 0.05% Coomassie brilliant blue R was dissolved in 
methanol, distilled water and acetic acid mixed at a 5: 5: 1 ratio. 
Coomassie destain: 5% methanol 7.5% acetic acid in deionised water. 
DNA loading buffer (x6): 0.25% bromophenol blue, 0.25% xylene cyanol, 30% 
glycerol in deionised water. 
DNA molecular weight markers: A. DNA (New England Biolabs) was digested 
using Hindill and stored at 200 ng/gl in 20 mM EDTA at 4°C. 
DTT: Dithiothreitol was prepared as aIM stock in deionised water and stored at 
-20°C. 
EDTA: Disodiumethylenediaminetetra-acetate was dissolved in deionised water 
to a final concentration of 0.5 M at pH 8 (adjusted using NaOH). 
Ethidium bromide: 10 mg/ml pre-prepared aqueous solution. 
Extraction solution A: (72 ml) 10 mM Tris-HCL pH 7.9,25% sucrose, 100 mM 
KCI, 2.0 mM DTT, 2.0 mM PMSF. 
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Extraction solution B: (18 ml) 300 mM Tris-HC1 pH 7.9,100 mM EDTA, 4 
mg/ml lysozyme. 
Extraction solution C: (90 ml) 1.0 M LiCI, 20 mM EDTA, 0.5% Igepal. 
Extraction solution D: (200 ml) 10 mM Tris-HCL pH 7.9,0.1 mM EDTA, 0.5M 
LiC1,0.5% Igepal, 1.0 mM DTT, 1.0 mM PMSF. 
Extraction solution E: (200 ml) 10 mM Tris-HCI pH 7.9,0.1 mM EDTA, 0.5% 
Igepal, 1.0 mM DTT, 1.0 mM PMSF. 
dFCS: Dialysed foetal calf serum, supplier Gibco. 
Gel filtration run buffer: Standard buffer used in HPLC (both preparative and 
analytical). 0.5 M Tris-HC1 pH 7.2,250 mM NaCI 0.05% NaN3; degassed and 
0.2µm filtered. 
HBS: Hepes buffer saline used for surface plasmon resonance experiments. 10 
mM HEPES pH 7.4,150 mM NaCl, 3.4 mM EDTA, 0.005% anionic surfactant 
p20. Sterile filtered and degassed. 
IPTG: Isopropyl-beta-D-thiogalactopyranoside, made up as a1M stock in 
deionised water, sterile filtered and stored at -20°C. 
Luria-Bertani broth: (11) 1Og Bactotryptone, 5g yeast extract, IOg NaCl pH 7.5 
(with NaOH), autoclaved to sterilise. 
M9 salts: (10x, 11) lOg NH4C1,30g KH2PO4,60g Na2HPO4.7H20,50g NaCI in 
deionised water pH adjusted to 7.5 (NaOH), autoclaved to sterilise. 
M9 medium: (11) 100 ml M9 salts, casamino acids (Difco) 0.5% (w/v), 0.1 mM 
CaC12,1.0 mM MgSO4,1.0 gg/ml Vitamin B1, glucose 15% (w/v) all sterile 
filtered, adjusted to 11 with autoclaved deionised water. 
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NSO selective medium: Iscove's medium without glutamine supplemented with 
glutamate (6 mg) and asparagine (6 mg); nucleosides (0.7 mg each of adenine, 
guanosine, cytidine uridine, and 0.24 mg thymidine); non-essential amino acids 
(Gibco 100 x stock); 50 ml dFCS; 100 units/ml penicillin and 100 µg/ml 
streptomycin. Filter sterilised. 
PBS: Phosphate buffered saline, 0.14 M NaCl, 2.7 mM KCI, 1.5 mM KH2PO4, 
8.0 mM Na2HPO4 pH 7.4 in deionised water. 
PBS-T: As above except with the addition of 0.05% Tween 20. 
PMSF: Phenylmethylsulphonyl fluoride was prepared as a 100 mM stock in 
isopropanol and stored at 4°C. 
Protein molecular weight standards: For SDS-PAGE Invitrogen Mark 12 (200 
kDa-2.5 kDa) were used (15 µl/lane), for gel filtration chromatography Sigma 
molecular weight standards were used at 1 mg/ ml. 
SDS loading buffer: (4x) 125 mM Tris pH 6.8,2% SDS, 10% glycerol, 0.005% 
bromophenol blue and, for reducing gels, 1 mM DTT or I% ß-mercaptoethanol. 
SDS running buffer: (10x) 30.3g Tris, 144.1g glycine, lOg lauryl sulphate made 
to 11 with deionised water. 
SOC: 2g bactotryptone, 0.55g yeast extract, 10 mM NaCl, 10 mM KC1 in 
deionised water (97 ml). 10 mM MgSO4,10 mM MgC12 and 20 mM glucose 
added and filter sterilised. 
TAE: (10x) 48.4g Tris, 11.4 ml glacial acetic acid, 20 ml 0.5M EDTA made to 
11 with deionised water. 
TBS: Tris buffered saline, 20 mM Tris-HCI pH 8.6,100 mM NaCl. 
TE: 10 mM Tris-HC1 pH 8.0,1 mM EDTA 
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TEMED: NNN'N'-tetramethylethylenediamine 
Tris-acetate: 2.0 M Tris-base was adjusted to pH 8.6 with glacial acetic acid for 
use in protein refolding protocols. 
Western blot: Cathode buffer: 25 mM Tris-Cl pH 9.4,40 mM c-aminocaproic 
acid, 20% methanol. Anode buffer: 0.3 M Tris-Cl pH 10.4,20% methanol. 
2.2 DNA methods 
All sequences coding for the cDNA of either FccRIa or IgE-Fc had already been 
cloned into expression vectors (see tables 2.1 and 2.2). Subsequently the only 
manipulation of these vectors that took place was the introduction of point 
mutations. 
2.2.1 Site directed mutagenesis 
Site directed mutagenesis was carried out using the Quikchange system 










= target site 
:: IIIIEIII: s\1 
0= mutagenic primer 
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(see previous page) 
Figure 2.1: Model for Stratagene Quikchange mutagenesis. 1: Gene is targeted within a plasmid. 
2: After denaturation plasmid is annealed with primers coding for a specific mutation. 3: 
Thermal cycling is carried out to extend and incorporate mutation primers resulting in nicked 
circular strands. 4: The parental DNA template is digested. 5: The resulting double stranded 
nicked plasmids containing the mutation are transformed into competent cells. 6: The XL-10 
strain repairs nicks in the plasmid. 
A mix was prepared according to the manufacturer's instructions using reagents 
supplied with the kit: 
5 gl reaction buffer 
10 ng template plasmid DNA 
125 ng Primer 1 
125 ng Primer 2 
1 µl dNTP mix 
3 µl Quicksolution 
autoclaved deionised water to 50 µl 
added last 
1 µl PfuTurbo 
Temperature cycling (18 cycles of 50 seconds at 95°C; 50 seconds at 60°C; 2 
minutes per kilobase of plasmid at 68°C) enabled extension of the mutagenic 
primers, incorporating the mutation into newly synthesised strands. Because of 
the way primers were designed only replication of the parental strand took place 
in each successive round, with the high fidelity of PfuTurbo severely reducing 
the likelihood of unwanted random mutations appearing. After cycling treatment 
with Dpnl (1µl of supplied stock at 3 7°C for 1 hour) removed dam-methylated 
parental strands leaving only the synthesised material. These nicked mutagenic 
strands were then transformed into XL-10 gold cells. These repaired the nicks 
and allowed normal replication to occur. Transformation was carried out 
according to the same procedure outlined in section 2.3.1. 
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2.2.2 Plasmid purification 
Single colonies were picked and cultured in LB broth supplemented with 
ampicillin (50 tg/m1) overnight at 37°C. Plasmid DNA was prepared using 
QIAGEN plasmid purification kits; mini- midi- or maxi- depending on the 
required amount of DNA, with culture volume adjusted accordingly. 
2.2.3 DNA electrophoresis 
A solution of 0.5-1.5% agarose (dependent on the size of fragment to be 
identified) was prepared in TAE buffer, melted and cooled, then set in a gel tray 
with a plastic comb. Once set the gel was placed into electrophoresis apparatus 
and covered with TAE buffer supplemented with ethidium bromide (1-5µl stock 
solution). Samples (5µl) diluted in DNA loading buffer were separated alongside 
appropriate markers by applying 50 volts across the gel until different sized 
fragments could be resolved; as judged by viewing the incorporation of ethidium 
bromide into the DNA under UV illumination. 
2.2.4 DNA sequencing 
DNA sequencing was carried out by the in-house molecular biology unit using 
the fluorescent DNA dideoxy termination method. Sequencing primer was used 
at 3.2pmol/µl and plasmid DNA at 250ng/gl and the results viewed using ABI 
prism technology (PE biosystems) 
2.2.5 Primers for PCR 
All for pET vectors: 
Sequencing: 
T7 promoter: GTAATACGACTCACTATAGGGC 
T7 terminator: TATGCTAGTTATTGCTCAG 
Mutagenesis: 
F506R (Forward): CCGGCTTCTTCGTCCGCAGCCGCCTGGAGG 
F506R (Reverse): CCTCCAGGCGGCTGGCGACGAAGAAGCCGG 
2.3 Protein methods 
2.3.1 Expression of recombinant protein in E. Coli 
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Fragments of the IgE-Fc s chain were expressed as inclusion bodies in the E. coli 
strain BL21 * (DE3) (Invitrogen) using either the pET 5a or pET 15 vector 
(Invitrogen). The table below details the name, vector and fragment residue 
range: 
Name 6 residues* Vector 
Fcs4 438-547 (plus His tag) pET 15 
Fcs4 F506R (F506R mutation) 438-547 (plus His tag) pET 15 
Fcc3-40C (C328S mutation) 328-547 pET 5a 
Fce3-4AC F506R (C328S F506R mutations) 328-547 pET 5a 
Table 2.1: Constructs used for expression of IgE-Fc subfragments. * Numbered according to 
Dorrington and Bennich (1978). 
For each fragment preparation competent E. coli were transformed with 500pg of 
plasmid DNA using a heat shock method: 
Aliquots of the competent cell line were defrosted from storage at -70°C on ice, 
plasmid was added to the cell suspension and left on ice for a further 30 minutes. 
Cells were then heat shocked (42°C) in a heating block for 1 minute and the left 
to recover for 60 minutes in 30Oµ1 of SOC in a 37°C shaking incubator set to 200 
rpm. The cell suspension was then plated out on LB agar supplemented with 
ampicillin to 50µg/ ml and left overnight in a 37°C oven. Transformed E. coli 
grew up as single colonies due to ampicillin resistance encoded within the 
transformed plasmid DNA. 
The following day a single colony was picked and used to inoculate I ml of M9 
medium supplemented with ampicillin (50µg/ ml); this was grown again at 37°C 
in a shaking incubator. After 10 hours the culture was expanded into a larger 
(500 ml) flask containing Amp+ M9 medium and left overnight under identical 
conditions. The following day the culture was expanded again, using the 
overnight culture (2% of the final volume) to inoculate a larger flask of Amp' 
M9 medium. This culture was grown until mid log density (OD600, n, - 0.6) then 
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induced with 0.4 mM IPTG. Cells were harvested after 5 hours at 6,000g in a 
GSA rotor (Sorvall) at 4°C for 10 minutes and pellets stored at -70°C. 
2.3.2 Purification of recombinant protein from E. Coli 
All protein expressed in E. coli formed inclusion bodies. Isolation was carried 
out using a procedure adapted from Bobmann and Tjian (1989). All solutions 
were kept on ice throughout the procedure and all centrifuge runs were carried 
out at 4°C. 
The cell pellet was resuspended in extraction solution A and incubated for 10 
minutes with extraction solution B. Extraction solution C was then applied to the 
mix and sonication was carried out in pulses for 5 minutes (MSE soniprep) and 
the inclusion body protein pelleted by centrifugation at 16,000g for 10 minutes. 
The pellet was then washed by resuspending in extraction solution D, followed 
by sonicating in pulses for a further 5 minutes and pelleting by centrifugation. 
This procedure was repeated with extraction solution E and the pellet stored at - 
70°C. 
The pellet obtained from the extraction procedure was thawed on ice and 
solubilised in 4 ml of 6M guanidine hydrochloride, 20% sucrose, 1 mM DTT 
by sonicating in pulses for 5 minutes. The protein solution was then centrifuged 
at 12,000g for 15 minutes and the supernatant removed. This supernatant was 
passed over a Sephacryl S300 column (C30 x 100 - Pharmacia) equilibrated with 
6M guanidine hydrochloride at 0.5 ml/min (room temperature) to remove 
contaminating nucleic acids. Elution peaks were monitored by absorbance at 280 
run. Fractions were then selected and analysed by SDS-PAGE with those 
corresponding to the molecular weight of the desired protein pooled for 
refolding. 
2.3.3 Refolding of purified recombinant protein from E. Coll 
Refolding of solubilised inclusion body material was carried out by a mixed 
disulphide rapid dilution method adapted from Taylor et al (1992). Extracted 
protein (2 ml at 10 mg/ ml in 6M GuHCI) was pH adjusted with Tris-acetate 
(final concentration 200 mM) and reduced by addition of DTT (final 
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concentration I mM) at 37°C for 1 hour. Mixed disulphide bonds were formed 
overnight by diluting the protein to 1 mg/ml in 6M GuHCI, 100 mM Tris- 
acetate, pH8.6, containing 0.1 M oxidised glutathione. The following day 
denaturant (GuHC1) was removed and native disulphides formed by rapid 
dilution to 10 µg/ml in 100 mM Tris-acetate, 3 mM L-cysteine, pH 8.6. After 
removal of the denaturant, protein was concentrated to 5 mg/ml. This protein was 
then purified by gel filtration in 0.5 M Tris-HC1,0.25 M NaCl, pH 7.4, on a 
Superdex HR-75 Ix 30 cm gel filtration column. Fractions containing 
monomeric protein units were identified by non-reducing SDS-PAGE. In the 
case of Fce3-4AC this protein was also assessed for integrity by nanospray mass 
spectrometry carried out by the proteomics facility at the Institute of Psychiatry 
(University of London). 
2.3.4 Expression of recombinant protein in mammalian cells 
All mammalian expressed proteins were from stable NSO cell lines established 
using the glutamine synthetase expression system (Bebbington et al 1992). The 
(sFccRIa)2IgG4-Fc chimera is a fusion of an IgG4-Fc with two sFccRIa subunits 
replacing the Fabs. See table 2.2. 
Name Residues Reference 
Fce3-4 328-547 Shi et al (1997) 
sFccRla 1-176 Cook et al (1997) 
(sFcsRla)2IgG4-Fc a= 1-176"IgG-Fc = 235-446 Shi et al (1997) 
Table 2.2: Constructs used for NSO expression of IgE-Fc and FceRl subfragments. 
Cells were grown in NSO selective medium at a cell count of 5x 105/ml in roller 
bottles maintained at 37°C. Every other day cells were gassed with sterile 5% 
CO2 in air for one minute and growth was maintained for up to 2 weeks, cell 
counts were carried out regularly by haemocytometer using 2% v/v trypan blue. 
Supernatant was then harvested by centrifugation at 6,000g to remove cell debris, 
0.2µm filtered and stored at 4°C after supplementation with sodium azide to a 
final concentration of 0.05% to inhibit bacterial growth. 
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2.3.5 Purification of recombinant protein from mammalian cells 
Supernatants from mammalian cell culture were purified in a two-step procedure. 
Firstly, affinity chromatography was used to isolate the desired species; table 2.3 
details the specific capture agents for each protein: 
Protein Capture Source 
Fcc3-4 (sFccRla)2IgG4-Fc Shi et al (1997) 
sFccRla 3B4 monoclonal antibody Prof. P. M. Hogarth 
(Austin Research institute 
- Victoria, Australia) 
(sFccRla)2IgG4-Fc Protein G Amersham 
Fcs3-4(4) Ni+ matrix Qiagen 
Table 2.3: Ligands for affinity purification of IgE-Fc and FcsRJ sub ftagments. 
Monoclonal 3B4 and (sFcERIa)2IgG4-Fc affinity matrices were prepared by 
amine coupling -50mg of capture agent to -12.5ml of either a affi-gel or affi- 
prep 10 support (Biorad) and then packing into a glass column. Identical 
purification procedures were used for Fcc3-4, sFccRla and (sFccRla)2IgG4-Fc. 
Each column was loaded with supernatant by cycling pH adjusted material (pH 
8.6 using 10 x TBS) overnight at 0.5 ml/min followed by thorough washing of 
the column (10 column volumes) with TBS. Captured ligand was then eluted 
using 0.2 M glycine pH 2.5 and immediately neutralised by addition of 1M Tris 
pH 8 (to a final concentration of 100 mM). The column was re-equilibrated by 
cycling with TBS (10 column volumes). Fcc3-4(4) was purified under slightly 
different conditions; the run buffer was changed to 50mM Sodium Phosphate, 
50mM Imidazole, 500mM Sodium Chloride pH 7.4, with elution carried by 
increasing the Imidazole concentration to 0.5M. Eluted materials were 
concentrated using a Amicon (Millipore) stirred cell (fitted with the appropriate 
molecular weight cut-off membrane) and purified on a Gilson HPLC with either 
a Superdex HR-75 (Fcc3-4 and sFcsRIa) or a Superdex HR-S200 
((sFcERIa)2IgG4-Fc) gel filtration column (Pharmacia). Relevant fractions were 
identified by SDS-PAGE. 
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2.3.6 Deglycosylation of mammalian expressed protein 
Native NSO-derived proteins were deglycosylated using PNGaseF (New England 
Biolabs) -1 . tl of enzyme preparation per 20µI (-lmg/ml) of protein sample 
buffered with supplied concentrate. Samples were incubated overnight at 37°C in 
sealed tubes and HPLC purified using either a S75-HR or S200-HR gel filtration 
column. Samples were assessed for carbohydrate removal by SDS-PAGE 
followed by either protein (Coomassie) or glyco (Schiff base) staining (see 
section 2.3.7). Finally, Fcc3-4 samples were also analysed for residual 
carbohydrate by denaturing PNGaseF digestion followed by mass spectrometry 
(R. Boehm, Glycobiology Unit, Department of Biochemistry, Oxford 
University). 
2.3.7 SDS-PAGE 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis was used to 
characterise proteins based on their size. The method applied was based on that 
of Laemmli (1970) and was carried out using Atta protein gel eletrophoresis 
apparatus. Protein gels were prepared from stock solutions, see table 2.4: 
Percentage 
acrylamide 
Acrylamide 2M Tris pH 
8.8 
10% SDS APS Temed 
12.5% 10 ml 4.7 ml 0.25 ml 0.16 m1 20 µl 
15% 12.5 ml 4.7 ml 0.25 ml 0.16 ml 20 µ1 
20% 16.7 ml 4.7 ml 0.25 ml 0.16 ml 20 µ1 
Stack 1 ml 1.25 ml (Tris 
pH 6.8) 
0.1 ml 0.064 ml 15 µl 
Table 2.4: Polyacrylamide gel composition from stock (all made up to 25 ml with deionised 
water, except stack 10 ml; see section 2.1 for APS and acrylamide concentrations). 
Once the gel was prepared and placed in the gel tank, sample (20-30 µl) was 
loaded after boiling (1') in SDS loading buffer (reducing or non-reducing 
depending on requirements). Samples were run (150 volts) alongside markers 
until loading dye had reached the bottom of the gel plate. Separated protein was 
visualised by staining either with Coomassie blue for 2 hours followed by 
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washing with water and incubation overnight with destain or, if identifying 
glycosylation, a Glyco-staining kit was used (Pierce) that applies a Schiff base 
staining method. Western blotting was also carried out to positively identify IgE 
proteins using the Dako HRP conjugated anti-IgE polyclonal antibody P295 and 
semi-dry blotting apparatus onto activated nitrocellulose (0.45 µm pore size, 
Schleicher and Schuell). The blot was developed using SuperSignal (Pierce) 
chemoluminescence reagent and detected using autoradiography film (Kodak) 
and a X-omat developing machine. 
2.3.8 Quantification of proteins 
Purified preparations of recombinant protein were quantified by virtue of their 
molar extinction coefficient (calculated according to Sedenterp - 
ftp: //alpha. bbri. org/rasmb/spin_ms/sednterp). Absorbance at OD280nm was 
measured in a Cary IE UV visible spectrophotometer using al cm. pathlength 
quartz cell. Protein concentration was assessed using the Beer-Lambert law: 
A =scl [2.3.1 ] 
Where absorbance A is equal to the molar extinction coefficient c (units M"'cm ) 
multiplied by the concentration c (mg/ml) and the path length of the cell (cm). 
Therefore the absorbance of 1 mg/ml can be determined by the ratio of e to 
molecular weight i. e in a1 cm cell 1 mg/ml Fcc3-4 of a mw 49,100 and a F. of 
64520 has an absorbance of 1.3. See table below for all values: 








Table 2.5: Absorbance values to obtain mg/ml measurement ofprotein concentration for 
expressed fragments. 
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2.4 Biophysical techniques 
Once fragments of IgE had been expressed and purified they were examined for 
variations in stability and structure. This was carried out using circular dichroism 
(CD) spectroscopy. Fragment preparations were also assessed for homogeneity 
and their molecular weight determined by analytical ultacentrifugation (AUC). 
AUC was also used in addition to surface plasmon resonance (SPR) studies to 
determine the affinity constants for high affinity receptor (FccRI) binding. 
2.4.1 Circular dichroism spectroscopy 
Background: Electromagnetic waves are characterised by the amplitude and 
orientation of their component electric and magnetic fields, with the electric and 
magnetic components always perpendicular to the direction of propagation. It is 
by orientation with respect to an external reference that polarisation can be 
described. In plane-polarised light the oscillations of both the magnetic and 
electric waves occur within a single plane perpendicular to the direction of 




Figure 2.2: Diagram illustrating a single field component of A: Circularly polarised light and B: 
Plane polarised light 
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Circular polarisation can be left- or right-handed depending on the sense of 
rotation about the direction of propagation. If left- and right-handed polarised 
waves of equal amplitude are combined, the result will be plane-polarised light. 
If two circularly polarised components of unequal amplitude are combined, the 
result is elliptically polarised light, characterised both by the ellipticity and the 
direction of the major axis (see figure 2.3). 
EE 
E. Eý E; 
Figure 2.3: Diagram illustrating left and right hand components of plane (left side) and 
elliptically (right side) polarised light as viewed if looking directly at the source. 
CD spectroscopy depends on the ability to detect differences in the absorbance of 
left- and right-handed circularly polarised light by a particular chromophore. The 
CD signal of proteins occurs in two spectral regions, the far UV or amide region 
(170-250nm) that is dominated by contributions of peptide bonds, and the near 
UV region (250-300nm) from aromatic amino acids. Disulphide bonds also give 
rise to a CD signal at several wavelengths. Commonly it is the CD signal within 
the far-UV region that is monitored, as this region can be used to characterise 
secondary structure. The characteristic CD spectra of different secondary 
structural elements is shown overleaf. 
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"1 
Figure 2.4: Circular dichroism of a polypetide (poly-L-lysine) in various conformations - after 
Greenfield and Fasman (1969). 
Method: A Jobin-Yvon CD6 spectrophotometer was used to collect the CD 
spectra presented in this thesis. The Jobin-Yvon CD6 spectrophotometer employs 
a high frequency photoelectric modulator to generate alternately two circularly 
polarised light components. The difference in absorbance of left and right handed 
circularly polarised in protein samples is very small. In the far UV region it is in 
the range 10-4 - 10-6 absorbance units in samples with a total absorbance of 1.0. 
Therefore careful sample preparation is necessary to obtain accurate and 
reproducible results. In the case of IgE fragments, all samples were HPLC 
purified, dialysed into a non-absorbing buffer (20 mM Sodium Phosphate pH 7.4, 
50 mM Sodium Fluoride) and their spectra recorded at a concentration of 
-0.5mg/ml of protein in a 0.5 mm path length cell to obtain a reasonable signal- 
to-noise ratio. Scans were taken in 0.2 nm steps with an integration time of 1 
second. 
The CD6 spectrophotometer measures the CD signal as ellipticity, [Gobs], in 
millidegrees. To enable comparison of values, this measurement can be scaled 
such that it is expressed either as a molar ellipticity [OM] or residue ellipticity 
[O, ý] at a given wavelength 
X and temperature T: 
mrw [®mrw1 
- 100 cd 
[2.4.1] 
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TM 
Mz 100 c"d 
[2.4.2] 
mrw is the mean residue weight, M is the molecular weight of the protein studied, 
c is the concentration of the protein and d is the path length of the cell. The units 
of molar ellipticity are deg"cm2"decimole"'. The factor 100 originates from the 
conversion of molar concentration to the dmol/cm3 concentration unit, as the 
concentration standard for [0] is the rotation in degrees of a1 dmol/cm3 solution, 
and Ac is the differential absorbance of a1 mol/1 solution, both in a 1cm cell. In 
the case of the spectra reported in this thesis, the values were expressed in terms 





where Ac is the differential molar circular dichroic extinction coefficient 
expressed in molar or mean residue terms. 
In addition to providing an estimate of the amount of secondary structure in a 
protein, CD can also be used to monitor transitions in protein structure. This 
means that the stability of one protein relative to another can be determined, and 
the impact of the removal of specific structural elements can be assessed. If the 
[O°bs] at a particular wavelength is monitored (in this case 215nm, a recognised 
minimum with respect to ß structure) and temperature increased incrementally 
(20-80°C in 2°C steps) the denaturation profile of the protein can be plotted. 
Readings can be normalised for comparison using the following expression: 
MM 
Fv =-e" [2.4.4] OD 
-ON 
F refers to the fraction of protein unfolded, 0 the observed ellipticity at a given 
temperature, and ON OD the ellipticity of fully folded and denatured species 
calculated from linear regression of the baselines before and after transition. 
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The relative ease of recording a circular dichroism spectrum allied to the ability 
to take measurements under a variety of conditions, makes CD a powerful tool 
for the study of the secondary conformation and stability of a protein. 
2.4.3 Sedimentation equilibrium analytical ultracentrifugation 
Background: In sedimentation equilibrium analytical ultracentrifugation speeds 
are controlled such that sedimentation and back-diffusion forces are of 
comparable magnitudes. This gives rise to an equilibrium distribution of solute 
concentration dependent on mass, with no net transport. This concentration 
distribution is independent of molecular shape, and therefore it is possible to 
accurately determine the molecular weight and degree of homogeneity of a 
protein preparation. Furthermore, for an interacting system, the distribution is an 
absolute function of the mass action relationship between species participating in 
the equilibrium, with concentration as well as molecular mass determining 
position. This means it is also possible to calculate the equilibrium affinity 
constant of an interacting system. Thus, sedimentation equilibrium analytical 
ultracentrifugation is an extremely valuable technique for studying 
protein: protein interactions. 
The forces placed on a molecule in the centrifuge are outlined in figure 2.5 and 




Figure 2.5: Diagram of a sedimentation experiment. The sector shaped cell spins about axis A at 
an angular velocity w. The molecule is acted on by centrifugal (Fe), buoyant (Ft) and frictional 
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In a rotor turning with an angular velocity w (radians per second) a molecule will 
experience a centrifugal force proportional to the product of its mass (m) and the 
distance (r) from the centre of rotation: 
Fý = w2rm [2.4.5] 
The molecule also displaces some solution, giving rise to a force equal to that 
exerted on the mass of solution displaced: 
F,, = -wzrmo [2.4.6] 
Finally, if as a result of these forces the molecule acquires a velocity (v) through 
the solution, a frictional force will be exerted: 
Fd =-fr [2.4.7] 
where f is the frictional coefficient. This situation will result in the molecule 




It is possible to substitue mo with the product of the particle mass (m) multiplied 
by its partial specific volume (v) and the solution density (p): 
mo = mvp [2.4.9] 
Therefore: 
tv2rm(1-vp)- fv=0 [2.4.10] 
If this is then multiplied by Avogadro's number and rearranged to place the 
molecular parameters on one side and the experimentally measured on the other: 
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M(1- vp) v 
- =s Nf w2r 
[2.4.11] 
This gives s, the sedimentation coefficient; s is measured in seconds and is 
experimentally determined as the ratio of velocity to centrifugal force. Values are 
commonly around Ix 10-13 seconds, and therefore every 1x 10"13 is referred to 
as a Svedberg unit (S). 
In an equilibrium situation this centrifugally driven force is balanced by a 
diffusion driven counterflow, D (cm2sec"1), which is also governed by the 




Where R is the universal gas constant and T the absolute temperature. The 
influence off on the individual magnitudes of S and D cancels within the ratio: 
S M(1- -vp) 
[2.4.13] 
D RT 
Therefore the parameter to emerge from the analysis of solvent distribution at 
sedimentation equilibrium is buoyant molecular weight: 
M(1-vp) [2.4.14] 
At equilibrium the concentration gradient for a single component in an ideal two 




C dr RT 
[2.4.15] 
where C is the concentration. 
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Integrating this between the meniscus (a) and point r shows that C depends on r 
in an exponential fashion: 




w2M(1-vp)(r2 -az) In 
C(a) 2RT 
[2.4.17] 
More simply, a plot of In concentration against the square of the radial distance 
will give a straight line, the gradient of which is proportional to molecular 
weight. 
Method: Experiments carried out as part of this thesis were performed using a 
Beckman XL-A. UV visible absorbance was measured as a function of radial 
position. During the experiment the solution redistributes such that an increasing 
concentration gradient travelling away from the centre of rotation is formed. This 
is read relative to a control cell that contains only the buffer into which the 
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Previous page. 
Figure 2.6: Diagram illustrating the concentration gradient observed in a two sector A UC cell 
In the Beckman XL-A measurements are made in absorbance units, therefore 
equation 2.4.16 becomes: 
A=A e[M(l-vp)wtl2RT](r2-r2o) A, 
r0 [2.4.18] 
where A, 0 is the absorbance at a radial reference point and A, is the absorbance at 
a given radial position. Absorbance is proportional to concentration according to 
the Beer-Lambert equation 2.3.1. 
In curve fitting, the term w2/2RT is constant (H) and a baseline term is added (E); 
this is obtained by performing an overspeed (42,000 rpm) spin and measuring the 
background absorbance in the cell. Thus: 
Ar = Aroe[[M0-vPXr2-r2o)1 +E [2.4.19] 
Values for solvent density (p) and (v) are determined prior to fitting, p from 
standard values and v from the following equation: 
N 
Fn; M1 , 
v= I= 
N [2.4.20] Y n; M; 
r=r 
where N is the number of types of amino acid, n; is the number of a certain type 
of amino acid, M; is the molecular weight of that amino acid and v; its partial 
specific volume. 
Fitting sedimentation data to equation 2.4.19 can yield a value for the buoyant 
molecular weight of a single ideal species. The fitting procedure can be carried 
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out using a computer and a non-linear least squares analysis, with a residual plot 
used to evaluate the quality of the fit (as applied for Biacore data, see section 
2.4.2). In the case of a single ideal system, plotting In A versus r2 will produce a 
straight line. If the plot observed is curved this indicates either a non-ideal 
system or mass action association between species. 
If the sample is simply a mixture of ideal species the observed distribution is a 
sum of the exponentials for each species 
Ar =E+ ArOleUHM(I-vp))i(r2-rzo)) [2.4.20 
where i refers to the iah component. 
If the system is interacting, for example in the case below 
A+ 2B H AB +BH AB2 [2.4.21] 
the sedimentation equilibrium profile as a function of radius can be described as 
the sum of the contributions of A alone, B alone, the AB complex and the AB2 
complex. This can be described as the sum of the exponentials as before: 
Ar =A d0 AeIHMA(1-VOxr2-rzo)] 
+ AO, 
Be[WB(1-"vpXr2-r2o)] 
+AO AA , BeOnk1H(MA+MBXI-vpXr2-rzo)) 
[2.4.22] 
2 Ilnk2H(M, 4+2MBXI-VpXr2-r2o)I + Ao, A ýAo, B) e+E 
The association constant KA for each of the reactions thus can be calculated from 
the apparent equlibrium constants kl and k2, as these are on an absorbance 
concentration scale: 
1n K,, B =1n kl + In 
6AEBI [2.4.23] 
6A + EB 
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z 
In KAB z =1n 
k2 + In [2.4.24] 
CA + 2eB 
where E refers to the molar extinction coefficients of each of the species and 1 is 
the path length of the cell. 
For IgE fragments interacting with sFccRIa, samples were exhaustively dialysed 
into PBS supplemented with 0.05% azide. Fragments were then mixed in molar 
ratios of 1: 1,2: 1 and 3: 1 FccRIa: Fcc3-4, with an overall loading corresponding 
to an A280 of -0.6. For an estimation of the molecular weight of the single 
species sample preparation was identical. Rotor speeds were adapted depending 
on the expected fragment or complex size using equation 2.4.25, incorporating an 
estimate of M(1- V p) as one quarter the molecular weight: 
2.336x10'2 
speed(rpm) _ [2.4.25] M(1-vp) 
In addition, I/ NF2 of this speed and the average of the two speeds was calculated 
to give three separate speeds to measure M (1- v p) accurately. Data were 
collected as an average of 25 absorbance measurements at a wavelength of 280 
nm and a radial spacing of 0.001 cm. 
2.4.2 Surface plasmon resonance 
Background: If two transparent media of different refractive indexes are taken 
and light passed through the material of higher refractive index towards that of 
lower refractive index, above a certain critical angle of incidence, total internal 
reflection occurs at the interface. When the incident light is totally reflected, an 
evanescent wave penetrates a short distance into the medium of lower refractive 
index. If the interface between the two is coated with a thin layer of metal, and 
the light monochromatic and polarised such that the electric vector component is 
parallel to the plane of incidence, the intensity of the reflected light dips at a 
specific incident angle due to excitation of surface plasmons propagating within 
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the gold surface. This phenomenon is known as surface plasmon resonance 
(SPR), with the angle at which the dip is observed known as the SPR angle. 
Glass Prism 




Figure 2.7: Under conditions of total internal reflection an evanescent wave propagates into the 
material of lower refractive index on the non-illuminated side. The angle of the minimum in 
reflected intensity has a sharp "shadow " at a specific point - this is the SPR angle X 
This phenomenon can be used for studying protein-protein interactions, as the 
SPR angle is dependent on a number of factors including temperature, the 
wavelength of the incident light and, critically, the refractive index of the 
medium into which the evanescent wave propagates (on the non-illuminated 
side). Therefore, if all other factors are controlled, it is possible to measure 
changes in surface concentration in real time by monitoring the SPR angle. 
In a Biacore instrument a biomolecule (ligand) is immobilised close to the 
interface and the binding of specific analyte is monitored as a result of the 
change in refractive index at the surface (see figure 2.8). 
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Figure 2.8: Changes in refractive index are monitored by the shift in the SPR angle. These 
measurements are proportional to the mass of ligand bound at the receptor surface. Therefore, 
real time interactions can be observed using the phenomenon of SPR. The yellow bar represents 
a sensor chip onto which the protein of interest is immobilised (red elipses), analyte is then 
flowed over the sensor chip (green elipses) and binding is monitored using a CCD to monitor the 
shift in SPR angle. 
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The ligand is commonly immobilised onto a carboxymethylated dextran matrix 
(CM5 sensor chip), itself thiol coupled to a gold surface that forms the interface 
between high and low refractive index media. Other surfaces such as nickel and 
streptavidin are also used for immobilisation - see below. 



























Figure 2.9: Coupling chemistries possible using a CMS Biacore sensorchip. 
A Biacore assay commonly follows a method in which the chip surface is 
exposed to analyte for a defined period of time; dissociation is then monitored 
when the flow is stopped, again for a defined period of time. This yields a trace 
known as a sensorgram with the association and dissociation of analyte 
corresponding to a rise and fall in the SPR angle measured in resonance units 
(RU). Bulk effects are also sometimes observed due to differences in buffers 
when analyte is injected. These artefacts are usually dealt with by carrying out 
control experiments in which a protein with similar properties, but no binding 
capability, is immobilised at identical levels on a separate surface. This enables 
the bulk effect to be subtracted from the signal; in addition it allows the removal 
of signal that corresponds to non-specific binding to the dextran matrix. From the 
curve it is then possible to derive kinetic parameters to describe the binding and 
dissociation phases of the observed interaction. 
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Figure 2.10: Schematic of a Biacore experiment to monitor real time binding of specific analyte 
to an immobilised ligand. 
Careful experimental design is crucial if curves are to be obtained that are truly 
representative of the interaction between ligand and analyte. One key factor to be 
controlled is mass transport. If the rate of mass transport of analyte to the surface 
is slower than the rate of interaction, then the observed SPR signal will be 
significantly affected. In this situation analysis of the data would provide 
incorrect kinetic constants. However, these artefacts can be minimised. Inside the 
flow cell the key feature to be dealt with is the diffusion distance to the ligand. 
Within the flow cell, a laminar flow effect is observed and therefore even high 
flow rates do not deliver ligand to the surface directly, but depend on diffusion 
from the area of laminar flow to the surface. By increasing the flow rate, the 
diffusion distance to the matrix can be decreased significantly, as the laminar 
flow region is extended closer to the matrix surface. 
In addition to diffusion distance, the initial interaction rate is critical. If there are 
a high number of sites available for interaction at the start of the assay, the 
process may be mass transport limited. By reducing the immobilisation level of 
ligand this effect is diminished. This reduces the consumption of ligand and 
therefore impacts positively on the problems associated with mass transport 
limitation due to diffusion. Furthermore, low immobilisation levels reduce the 
possibility of rebinding events that could also skew the data. Varying the flow 
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rate and immobilisation level, and monitoring the consequent shift in initial 
binding rates, can be used to assess the effects of mass transport. The balancing 
of these effects however has also to take into consideration the signal required to 
observe the interaction and the availability of material for analysis. 
A good dataset for analysis comprises a series of curves at different 
concentrations of analyte that cover a broad range, from near saturation to 
minimal binding. This is important because a variety of parameters are essential 
when deriving affinity constants. Using a high concentration of analyte will give 
an indication of the point at which maximal binding (R.. ) occurs. Before 
experimentation, the level of immobilisation can be used to estimate R,,,,,, as the 
SPR response is proportional to the mass concentration at the chip surface. For 
example, if a protein of 150,000 mw is immobilised at 500RU, and binding of a 
50,000 mw protein monitored which is known to bind with a 1: 1 stochiometry, 
the maximal theoretical response would be -160 RU. When fitting data the 
goodness of fit can then be assessed by comparing the observed and theoretical 
Rm values to those derived from the fitting procedure. Observation of saturation 
binding also provides a check on whether the surface has been compromised, by 
comparing the difference between theoretical and observed Rm. values. 
However, binding curves with higher analyte concentrations contain less 
information with respect to the association phase of binding. This is because 
saturation or equilibrium is reached too quickly. Therefore inclusion of lower 
concentrations into the dataset enables a more accurate assessment of the on-rate, 
as more information is available for fitting. Finally, a broad range of dissociation 
phases also provides a better assessment for the fitting of off-rates for the same 
reason. Commonly an analyte concentration range of between zero and 10 - 100 
times the KD is thought to be sufficient (van der Merwe, 2000) 
The on and off rates for the formation of a binary complex can be described by 
the following equations: 
A+B< >AB [2.4.26] 
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where the association rate is: 
d[AB] 
_ k0[AB] [2.4.27] dt 





At equilibrium, association and dissociation rates are equal: 
ka[A] [B] = kd[AB] [2.4.29] 
This equation can be rearranged to give the equilibrium dissociation constant: 
lu [A][B] 
=K L [AB] o 
[2.4.30] 




_ K4 [2.4.311 ke [A] [B] 
The equilibrium constant defines the balance of free components and complexed 
components at equilibrium, whilst the rate constants define how fast the forward 
and backward reactions occur. In the Biacore it is possible to obtain the 
equilibrium affinity constant simply by injecting different concentrations of 
ligand over the chip surface until equilibrium is achieved and then carry out a 
steady state analysis based on a plot of concentration versus ligand bound. 
However, the real advantage the Biacore has is that it is able to monitor the 
formation and decay of receptor ligand complexes in real time. Therefore it can 
provide a direct assessment of rate constants. Equilibrium constants can then be 
calculated from their constituent rate contants (see 2.4.30 - 31). For fitting 
purposes, terms used in SPR analysis can be substituted into the combined form 
of the rate equation. Thus (overpage): 
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d[AB] 
di = 
ka . [A][B] - ke[AB] [2.4.32] 
becomes: 
dR 
-L. C"(R. -R)-kd"R [2.4.33] dt 
where C equates to the concentration of ligand [A], Rm equates to the 
concentration of immobilised receptor [B] and R equates to the SPR signal 
associated with the formation of complex [AB]. The BlAevaluation software 
supplied with the machine can solve this differential rate equation. To do this the 
BlAevaluation software uses a standard least squares minimisation routine, 
which optimises parameter values by minimising the sum of the squared 
residuals. When a minimum is reached, a plot of the residuals between the fit and 
the data can assess the quality of the fit: points on this plot should be randomly 







Figure 2.11: Schematic to illustrate fit procedure for Biacore data. Dashed line represents the fit 
line; arrows indicate values taken from which sum of squares is calculated Dotted line 
represents a plot of the residuals. 
A x2 value can also be calculated from the residuals, which acts as a numerical 
indicator of the goodness of fit. To minimise error and the chance of obtaining 
unrealistic rate constants it is better to fit a concentration series globally rather 
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than individually. However, sometimes this is not possible, as small inconsistent 
variations in the dataset (such as differences in drift, injection artefacts or small 
deteriorations in the surface) mean it is not possible to resolve the data into a 
global minimum when fitting. In such cases curves can be fitted individually. 
However, care needs to be taken to ensure the fitting procedure does not produce 
too great an error in the determination of constants. Calculating the standard 
deviation of the average rate constant, and checking for trends related to 
concentration, can be used to assess this. 
Method: In the case of experiments described in this thesis, only CM5 chips 
were used to immobilise the (sFccRla)2-IgG4-Fc fusion protein via primary 
amine groups. (sFcsRla)2-IgG4-Fc fusion was used because amine coupling 
destroys sFccRIa binding capability (only a more complex, and less easy to 
control, hydrazide coupling method works for this protein, Cook et al, 1997). 
Immobilisation was achieved by activating the CM5 matrix with a 1: 1 mixture of 
N-hydroxysuccinimide (NHS) and N-ethyl-N'- (3-diethyl-aminopropyl)- 
carbodiimide (EDC) for 1 minute at a flow rate of 5µl/min. The ligand was then 
passed over the activated matrix at a concentration of 50gg/ml in 10mM sodium 
acetate pH 4.5 until the resonance signal reached approximately 500 RU. This 
immobilisation level corresponds to - 0.5 ng of protein per mm2 of the matrix. In 
fact the matrix extends for 100 nm from the chip surface, and therefore strictly an 
immobilisation of this degree is equal to a surface concentration of -5mg/ml. 
Once the correct response level had been reached, remaining activated sites were 
blocked with 35µl of I. OM ethanolamine-hydrochloride pH 8.5 and the surface 
washed with HBS at 5µl/min. A control surface was prepared in an identical 
manner using IgG4-Fc. 
Data were collected for IgE fragments within the concentration range 100 nM to 
6 nM using a 500 RU surface and a flow rate of between 10 and 30 P/min. This 
is sufficient to provide assessment of binding kinetics for IgE (McDonnell et al 
2001). 
The model previously described (equation 2.4.33) applies to a simple Langmuir 
isotherm for absorption to a surface, and is the simplest description of a 1: 1 
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interaction. However, it has already been demonstrated through both Biacore 
analysis and subsequent structural studies that the interaction of IgE with FcERI 
is more complex than this (Henry et al, 1997; Garman et al, 2000). A biphasic 
model better describes the interaction, but fitting involves a larger number of 
variables. It is important to choose the model that best describes the system. IgE 
binding to FccRI is a 1: 1 interaction that is formed by at least two distinct 
binding sites. The model that best describes this situation would incorporate 
biphasic kinetics and competition between the two sites. This model exists in the 
BlAevaluation software and can be described as follows: 
A+B( )AB 
plus: 
C+B <) )CB 
[2.4.34] 
[2.4.35] 
Where A and C represent the two different modes of IgE binding and B 
respresents FccRI. From this the following differential rate equations can be 
derived: 
dRi 
= /aI . CA . (R .- RI - Ri) - kclI " Ri . [2.4.36] dt 
dR2 
= ka2 - Cc (R - RI - R2) - kd2 R2 [2.4.37] dt 
The total response is: 
R=Ri+R2 [2.4.3 8] 
However, in this scheme the number of parameters to fit has obviously increased, 
and it is necessary to obtain values for not one, but two association and 
dissociation constants. A good fit can only be achieved in circumstances like this 
if a reasonable estimate of the constants is available initially. This is because as 
the number of parameters rises, so does the number of minima into which the 
fitting procedure can resolve itself. One method for controlling this issue is to 
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derive some of the components individually. The Rm should not vary between 
fits carried out using the same ligand on the same surface. Therefore the R.. 
should also ideally be determined experimentally, or by estimating a value based 
on the immobiliation and molecular weight of ligand (as detailed earlier). It is 
also possible to assess off-rates separately, as they can be fitted independently of 
concentration or knowledge of Rm.. Values can then be fed back into the full 
equation and used as constants, or the values compared to those derived from the 
simultaneous fitting of association and dissociation data. To enable the fitting of 
off-rates separately from on-rates it is necessary to derive an equation for the 
fitting procedure to solve. From a normal Langmuir isotherm that describes the 




the following expression can be derived: 
R= Ro -e -kd(t-10) [2.4.40] 
where R is the SPR response at time t and Ro is the response at to. However, the 
IgE: FcERI interaction is biphasic, and therefore the "off' phase must be treated 
as two independent events whose individuals rates can combine to form an 
overall response. This can be done by simply creating an expression for a dual 
exponential decay. The expression does not have to take into account the 
competitive step observed for the on-rate and is simply a parallel dissociation 
composed of two distinct kinetic events: 
R_ Rl , e-ka, (1-ro) + (R0 - R1). e-kI2(t_to) [2.4.41] 
where R1 is the contribution to Ro from component 1 and Ro - Rl is the 
contribution from component 2. The model calculates a value for R1. The relative 
contribution for each of the components can be assessed by the ratio of R1/Ro. 
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Biacore analysis provides a practical way of analysing protein: protein 
interactions with relatively small amounts of material, and is ideal for comparing 
panels of molecules with slight variations in structural features. The "real time" 
nature of the recording of the receptor: ligand interaction, in both association and 
dissociation, enables subtle differences to be observed that would not be obvious 
if only the overall affinity constant were derived. Furthermore, the method not 
only provides comparative data, but can also lead to the derivation of absolute 
rate constants, in addition to the affinity constants that can be obtained using 
other methods. The method also has drawbacks. In respect of mass transport, 
these can be circumvented by careful experimental design. However, there are 
intrinsic problems associated with the immobilisation of ligand by chemical 
coupling methods. Therefore, the experiments can appear compromised if 
compared to solution methods that do not require adaptation of one of the 
components (such as AUC). However, it is possible to check data by reversing 
the orientation of the experiment (something already achieved for IgE: Henry et 
al, 1997; Cook et al, 1997). Also, immobilised receptor is an approximation of 
the situation at the cell surface. If used alongside other techniques, and controls 
are carefully carried out, the comparisons possible from the direct observation of 
rate constants by surface plasmon resonance can provide a powerful tool in 
protein: protein interaction analysis. 
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Production and characterisation of 
a Fcc3-4 monomer 
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Chapter 3: Production and characterisation of a Fcs3-4 monomer 
3.1 Introduction 
An Fcs3-4 dimer of IgE-Fc can be produced from mammalian cells and is 
folded according to its circular dichroism (CD) spectrum (Keown et al, 1997). 
Furthermore, an E. coli expressed Fcc3-4 also refolds with an indistinguishable 
CD spectrum (Henry, PhD thesis, 1997), indicating that a bacterially expressed 
fragment has all the features necessary for folding Fcc3. However, an isolated 
Fcc3 fragment produced in E. coli is unfolded according to the same criteria 
(Henry et al, 2000). Therefore, given the aim to produce a fully folded FcE3 with 
the minimal structural requirements, which of the structural components present 
within the Fcs3-4 fragment are necessary to create a folded Fcs3 domain? 
The crystal structure of an (insect cell expressed) Fcc3-4 fragment 
(Wurzburg et al, 2000) has enabled the inter-relationship of Fcc3 with other 
domains to be determined within this fragment. This is clearly a very useful tool 
for suggesting what features may be essential for Fcc3 stabilisation. One area that 
could potentially be critical for the scaffolding of Fcc3 is the longitudinal 
interface between Fcc3 and Fcs4 domains within the same polypeptide chain. 
There are 14 contacts in this region, burying a surface are of - 873 A2 in each 
Fcc3-4 chain (Wurzburg et al, 2000), see figure 3.1. 
Figure 3.1: Contacts between Fcc3 and FcE4 within the same polypeptide chain (Fce3 = blue, 
Fce4 = red, contacts space-filled, C-a trace only for non contact residues). 
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There are no direct contacts between the two Fcc3 domains in either the 
unbound FcF-3-4 structure (Wurzberg et al, 2000), the Fcc3-4: FccRIa complex 
(Garman et al, 2000) or the full IgE-Fc (Wan et al, 2001). However, the 
carbohydrate chains attached to Fcs3 domains in the uncomplexed FcE3-4 crystal 
structure may make contact with each other, although no electron density is 
visible, and this region is presumably disordered. In the complex structure 
(Garman et al, 2000) no contact is seen between the carbohydrate chains, nor is 
there contact in the unbound IgE-Fc (Wan et al, 2002). This suggests that lateral 
contacts between Fcc3 domains may be less important for folding. The 
carbohydrate does cover a large surface area (450 A2 in the IgE-Fc) 
approximately half of which shields hydrophobic residues. However, as stated 
previously, the Fcs3-4 fragment can be refolded from E. coli inclusion bodies 
(Henry, 1997), indicating that carbohydrate is not essential for folding. In fact, 
the only lateral interaction observed in the crystal structures is that between 
opposing Fcc4 domains. This appears to be the region that enables dimerisation 
of the Fcc3-4 chains. The possible interactions necessary for stabilising Fcc3 are 
outlined in the schematic below, figure 3.2. 
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Figure 3.2: Possible contacts necessary for folding Fce3. A red ellipse represents each domain; 
arrows indicate contacts that could be essential for folding. 
If the factors that lead to the folding of Fcc3 are to be determined, it 
would appear a method in which the lateral and longitudinal contacts within the 
Fcs3-4 dimer could be isolated, might provide an answer. In order to isolate the 
effects of these contacts on the folding of Fcc3, novel sub-fragments were 
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designed and expressed in E. coli. Initially it was decided to investigate the effect 
of longitudinal contacts on the folding of Fcs3 to determine whether the broad 
interface between Fcs3 and Fcc4 could act as a scaffold for folding of Fcc3. 
3.2 Production of a FcE3-4 monomer 
To isolate the effect of longitudinal contacts from those of lateral contacts 
it was necessary to produce a monomeric Fcc3-4 population. To achieve this, the 
most promising way appeared to be disruption of the Fcc4: Fcc4 interface, as 
from the crystal structures this interaction seemed to provide the platform for 
non-covalent dimerisation of the Fcs3-4 fragment. It was hypothesised that if a 
single point mutation was introduced into the structure at the appropriate place, 
dimerisation could be prevented, thus yielding a monomeric fragment. When the 
interface was examined closely, the ideal candidate looked to be a phenylalanine 
at position 506. This packed closely with its twin in the opposing chain (see 
figure 3.3). It was predicted that introduction of a large, charged side chain such 
as arginine in its place would yield a monomeric fragment by like-charge 
repulsion. 
Figure 3.3: Fce4 dimer with phenylalanine 506 space-filled (opposing chains are coloured red 
and yellow- C-a only). 
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3.3 Introduction of the F506R mutation into pET C&3-4AC 
The phenylalanine to arginine (F506R) mutation was introduced into the 
Cc3-4AC pET vector using the QuickchangeTM system from Stratagene; this 
method is outlined in section 2.1. The Fcc3-4AC vector was engineered 
previously for expression of Fcc3-4 in E. coli (Henry, 1997), with the N-terminal 
cysteine residues removed to aid the refolding process by reducing the potential 
for aggregation due to the formation of non-native disulphides. Silent mutations 
were also incorporated into the vector using the mutation encoding primers to 
enable quick identification of F506R positive clones. These silent mutations 
knocked out a restriction site (BbsI). Digests of pre-and post mutation vectors 
can be seen in figure 3.4. 
Figure 3.4: 1% agarose gel of post- (lanes 1-2,4-5) and pre- (lane 6) mutated Fce3-4 pET 
expression vector digested with BbsI restriction enzyme. Lane 7 shows Hind III digested lambda 
DNA. 
It is clear from the gel that the silent mutation has been incorporated into 
the mutated vector due to the shift in digest pattern, indicating that the directed 
mutation process was successful. Subsequently, incorporation of the mutation 
and fidelity of replication was confirmed by sequencing of the targeted region, 
see figure 3.5. 
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Figure 3.5: Sequence profiles of wild type and mutated Fce4 in the domain interface target 
region. The black bar indicates the mutagenic primer target sequence. 
The sequence obtained from the mutated and wild type pET vectors were 
identical except for the shifts intended. The phenylalanine codon has been 
switched to an arginine codon in the mutated vector. In addition the restriction 
site BbsI had been knocked out with the silent mutation. Other coding regions 
were not mutated. 
3.4 Expression and purification of Fcc3-4 F506RAC 
After confirmation of the introduction of the mutation into the Fcc3-4 
vector, protein was expressed as an inclusion body in E. coli. (BL21 * DE3). 
SDS-PAGE of pre- and post induction cell pellets are shown in figure 3.6. 
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Figure 3.6: 12% SDS-PAGE of pre-induction (lanes 1 and 4) and post-induction (lanes 2 and 5) 
cultures of Fce3-44C (left) and Fcs3-4AC F506R (right), molecular weight markers lane 3. 
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Recovery of the inclusion body from the cell pellet was then carried out 
according to the method outlined in section 2.3.2, with a one-litre culture 
yielding between 20 and 40mg of GuHCI solubilised protein. At this stage the 
protein preparation took the form of a crude polypeptide solution solubilised in 
6M GuHCI containing 90-95% of the desired protein. 
Alongside the production of Fcc3-40CF506R (lane 5, figure 3.6), the 
Fcc3-4AC construct was also expressed (lane 2, figure 3.6). This was to act as a 
control, ensuring that the refolding process was working correctly and that a 
suitable species was available for comparison when characterising the F506R 
mutant. Once inclusion body material had been solubilised, a further purification 
step was carried out to isolate protein material from nucleic acid. This step is 
illustrated both for Fcc3-4tC and the F506R mutant in figure 3.7. The main 
benefit of this was that it enabled more accurate determination of protein 
concentration for the refolding process, which is critical for assessing the ratio of 
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Figure 3.7: Panel A= Fce3-44C F506R, panel B= Fce3-4AC Gel filtration (S300 - see section 
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After separation, material of the correct molecular weight was combined 
and subjected to the refolding protocol outlined in section 2.3.3. The material 
was also Western blotted with an anti-IgE polyclonal antibody (P293 - Dako) to 
ensure isolation of the correct species (see below): 
- 50 
- 2o 
Figure 3.8: Non-reducing SDS-PAGE (left) and corresponding Western blot (right) of Fce3-44C 
F506R. 
The blot in figure 3.8 shows a non-reduced sample of Fcc3-4AC F506R 
after refolding but prior to HPLC purification. Because this sample has not been 
treated with either DTT or mercaptoethanol, covalent aggregates can be seen 
above the major monomeric fraction at 26 kDa. To remove both covalent and 
non-covalent aggregate, refolded material was purified further by gel filtration 
chromatography. Figure 3.9 shows the separation of both species according to 
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Previous page. 
Figure 3.9: Panel A= gel filtration profile (above) and 12% non-reducing SDS-PAGE (below) of 
Fce3-44C F506R Panel B= identical to A except now the Fcs3-44C construct. Marks on the x- 
axis indicate fractions taken; these correspond to the fraction number shown at the bottom of 
each gel lane. Column - Superdex HR S200, run at 0.75 ml/min in gel filtration buffer - see 
section 2.1. 
To separate the desired material from aggregate it was sometimes 
necessary to repeat the gel filtration process, depending on the preparation. 
However, eventually a single species was isolated for both constructs according 
to both SDS-PAGE and gel filtration chromatography, see figure 3.10. 

















Figure 3.10: Panel A= F506R mutant HPLC profile and purified sample of protein on non- 
reducing 15% SDS-PAGE, panel B= unmutated Fce3-44C under identical conditions. Column - 
Superdex HR S75, run at 0.75 ml/min in gel filtration buffer - see section 2.1. 
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3.5 Characterisation of Fcc3-4 F506RAC 
Isolation of purified material enabled a more detailed characterisation to 
be carried out. Firstly the C&3-4tCF506R mutant was analysed by sedimentation 
equilibrium analytical ultracentrifugation to obtain an accurate assessment of the 
isolated protein's molecular weight. From this it would be possible to ascertain 
whether the material was truly monomeric in solution. A representative trace for 
















Figure 3.11: The lower panel shows absorbance across the centrifuge cell in relation to distance 
from the centre of rotation for Fce3-44C F506R. Open circles represent data points, the line is 
the fit for a single ideal species. The upper panel shows the residuals from the fitting procedure. 
Data was collected as outlined in section 2.4.3. 
The data obtained fitted a single ideal species model and yielded a 
molecular weight of 27500 ± 1100. This is a slight overestimate compared to the 
calculated molecular weight of 24,561 (Sedenterp), but does confirm the protein 
85 
6.9 !. 0 .. 1 
Chapter 3 Page 86 
to be monomeric, i. e. a single Fcc3-4 chain. The overestimate may be due to a 
small amount of aggregate forming in the sample over time; this was reflected in 
the fact higher speeds produced data that delivered more satisfactory fits. An 
explanation for this observation presented itself when the circular dichroism 
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Figure 3.12: Circular dichroism spectrum of purified Fce3-44C F506R. Data was collected as 
outlined in section 2.4.1. 
The spectrum is characteristic of a polypeptide preparation composed of a 
large proportion of random coil, suggesting that the monomeric species is 
unfolded. It is therefore of little surprise that some degree of aggregation 
occurred in the ultracentrifuge over the lifetime of the experiment (-3 days), 
probably due to hydrophobic interactions between the unfolded monomers. 
To ensure that these observations were due to the incorporation of the 
F506R mutation, rather than an incorrect refold procedure, they were compared 
to results from refolding the Fcc3-4AC dimer. This was carried out under 
identical conditions, see figures 3.12 and 3.13 
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Figure 3.12: The lower panel shows absorbance across the centrifuge cell in relation to distance 
from the centre of rotation for Fcc3-4d C. Open circles represent data, the line is the fit for a 
single ideal species. The upper panel shows the residuals from the fitting procedure. Data was 












18D 190 200 210 220 230 240 250 260 270 
Vvbvelength (nm) 
Figure 3.13: Circular dichroism spectrum of Fce3-44C. Data was collected as outlined in section 
2.4.1. 
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The molecular weight of refolded Fcc3-4AC was calculated using 
equilibrium AUC to be 51,307 + 1740, compared to a sequence calculation of 
49,106, i. e. it was a dimer. The dimer was non-covalent, as can be seen from 
previous non-reducing SDS-PAGE (Figure 3.10 B). Furthermore, the CD 
spectrum is characteristic of a folded beta-sheet protein and not random coil (see 
methods section 2.4). The centrifuge data for both fragments are summarised in 
the table below: 
Fc63-4A C F506R (n = 3) Fcs3-4AC (n = 5) 
Mean M(1- V p) 7590 +300 14115+480 
Solvent density (p) 1.00721 1.00721 
Partial specific volume (v) 0.7193 0.7197 
Mean molecular weight 27,500 + 1100 51,307 + 1740 
Molecular weight from sequence 24,561 49,106 
Table 3.1: Data for analytical centrifuge runs with mutated and unmutated Fcs3-4d C. 
3.6 Discussion 
The data presented in this chapter showed that the introduction of an 
arginine at position 506 of the Fcc4 domain successfully prevented dimerisation 
of the Fcc3-4AC polypeptide. Unfortunately, it did not succeed in producing a 
folded, isolated, Fcc3 domain. There are several scenarios that could explain why 
this result was obtained. It may be because the Fcc4 domain could not fold in the 
presence of the F506R mutation, due to the fact the mutation prevents 
dimerisation. The crystallographic structure of the IgE-Fc fragment supports this 
idea. The surface area between Fca4 domains in opposing chains is large (2326 
A2 - Wan et al, 2002) and contains many hydrophobic residues. It is therefore 
possible that prevention of an interaction by the F506R mutation between these 
complementary surfaces could destabilise the Fcc4 domain. The correct folding 
of the Fcc4 domain may normally provide a contact surface area for Fcc3 within 
the same chain to stabilise folding of the Fcc3 domain. Absence of a folded Fce4 
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might therefore mean that Fcc3 cannot fold, yielding a completely unfolded, 





Figure 3.14: Folding scheme for Fce3 in which folded, dimerised Fce4 is required as a contact 
surface to fold Fce3. Filled domains illustrate folded material, random coils indicate unfolded 
material. The upper row represents unfolded (or partially folded) Fce3-4 monomers coming 
together; the dimerised Fce4 domains fold completely and then provide contacts for Fce3 to fold 
In the second row the arginine mutation prevents dimerisation of the Fce4 domain and therefore 
the chain of events is disrupted, resulting in unfolded Fcc3-4 monomers. 
However, there are other possible explanations for the observed result. 
For example, it may be that Fcs3 requires lateral contacts to fold. The folded 
Fcs3 could then stabilise Fcc4 using the same intra-domain contacts described in 
figure 3.14. Thus, if the lateral contacts between Fcs3 domains are prevented due 
to the charge repulsion, the resultant unfolded Fcc3 might mean that Fcg4 
remains unfolded because there is no inter-domain interface. This is basically a 








Figure 3.15: Folding scheme for Fcc3 in which dimerisation is required for the folding of Fce3. 
Folded Fce3 then provides stabilising interactions that aid the folding of Fcc4. Introduction of 
the arginine residue prevents the Fce3 domains coming together and therefore the fragments 
remain unfolded. Filled domains illustrate folded material and random coils indicate unfolded 
material. 
This scheme is less likely as direct contacts between Fcc3 domains have 
not been observed in three IgE-Fc domain crystal structures (Garman et al, 2000; 
Wurzburg et al, 2000; Wan et al, 2002). Furthermore, the Fce3 domains are 
unable to pair together and fold in isolation, as demonstrated by work carried out 
on an isolated Fcc3 domain (Henry et al, 2000). 
A more complicated situation could also exist, in which a reciprocal 
relationship involving Fcc3 and Fcc4, dimerisation and intra-domain contacts are 
all necessary for folding. Put simply, if one or all of these stabilising factors is 
removed by the introduction of the arginine mutation it could cause the system to 
unravel. 
Finally, the F506R mutation may have a more direct effect on Fcc4 
folding by interfering with, or preventing initiation of the folding pathway of the 
domain itself. This would then have downstream effects on the folding of Fce3 
by removing any favourable inter- or intra-chain contacts that FcE4 can provide 
when folded either as a dimer or monomer, see figure 3.16. 
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Figure 3.16: Possible mode of F506R destabilisation of the Fce3-44C fragment. Introduction of 
the arginine mutation prevents the Fce4 domain folding and the downstream effect of this is that 
Fce3 cannot fold as a result of the prevention of favourable inter- or intra-chain contacts (or 
both) provided either directly by Fcc4, or by the fact that it causes the chains to dimerise once 
folded 
The most straightforward outcome from these experiments on the 
monomeric Fcc3-4 fragments would have been the observation of either two 
folded domains, or a polypeptide in which one domain was folded and the other 
was not. However, the whole fragment appears to be unfolded. Thus it is 
impossible to distinguish whether lateral contacts between Fcc4 domains, Fcs3 
domains, or a mixture of both effects are mediating folding, or indeed whether 
the F506R destabilises the fragment in a way that is not dependent upon contacts 
between Fcs4 domains. To help resolve the issue of the effect of F506R on Fcc4 
folding, it was decided to investigate the Fcs4 fragment in isolation. By 
incorporating the F506R mutation into a single Fcg4 domain, the effect of the 
mutation could be observed in the absence of any influence of unstructured Fcc3. 
Furthermore, folding of an Fc*4 wild type domain could also be studied for 
comparison, yielding information about the necessity of Fcc3 for the folding of 
wild type Fcs4. 
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Production and characterisation of 
Fce4 and Fcc4 F506R 
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Chanter 4: Production and characterisation of Fcc4 and Fcc4 F506R 
4.1 Introduction 
In Chapter 3 it was shown that the introduction of a phenylalanine to 
arginine mutation at position 506 (F506R) of the Fcc3-4 polypeptide chain 
yielded a completely unfolded monomeric protein fragment. However, it was not 
clear how the mutation was destabilising the Fcc3-4 fragment. It was therefore 
concluded that the folding of an isolated Fcs4 domain would be investigated. By 
introducing the F506R mutation into Fcc4 alone it would be possible to identify 
whether this mutation was directly responsible for destabilising the Fce4 domain. 
Furthermore, by expressing the wild type Fcc4 domain in parallel, it would be 
possbile to determine whether Fcc3 has any role to play in the stabilisation and 
folding of Fc84. 
In order to analyse the effect of the F506R mutant on Fcc4 it was 
necessary to express the wild-type domain in isolation. Although an isolated 
FcE3 domain had been expressed (Henry et al, 2000), Fcc4 had not been 
produced before. This was essential in order to determine whether any 
destabilisation observed in a F506R mutant was solely due to the incorporation 
of the mutation, rather than removal of beneficial Fce3 contacts. It would also 
ensure that the refolding process was functioning correctly for the truncated 
fragment. 
If the Fcs4 domain folded in isolation it would indicate that this domain 
has the potential to structure itself first within the Fcc3-4 fragment. It could then 
perhaps serve to facilitate Fcc3 folding. Evidence from the crystal structures 
(Garman et al, 2000; Wurzburg et al, 2000; Wan et al, 2002 - as discussed in 
Chapter 3) indicates the Fcc4 region is responsible for dimerisation. However, it 
is not clear what relation this dimerisation process has to folding. In Chapter 3 it 
was proposed that one possible reason for the observed results was that 
dimerisation is essential for Fc&4 folding. However, if a folded Fcc4 monomer 
were obtained it would indicate dimerisation was not essential for folding. It 
would also imply a more complex process of dimer formation involving Fcc3. 
Thus, expression of an Fc&4 domain in isolation would provide more information 
regarding the FcE3-4 folding pathway, in addition to providing a basis for 
evaluating the effect of the F506R mutation (see figure 4.1). 
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Figure 4.1: Schematic indicating possible results from folding Fce4 in isolation. 
4.2 Expression and purification of a Fcc4 domain 
The Fcc4 domain had previously been cloned into the pET 15 expression 
vector (Alistair Henry - unpublished). This construct included a hexa-histidine 
tag at the C-terminus to enable easy purification of the fragment. The pET 15 
vector was otherwise used in an identical fashion to the pET 5a vector. However, 
this construct had not been fully characterised previously and therefore the first 
step was to express the protein and isolate pure material for biophysical 
characterisation. Initially, purification was carried out according to the same 
protocol used for the larger Fcc3-4 fragments, rather than a nickel affinity 
column method. This involved isolating and solubilising inclusion bodies over- 
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Figure 4.2: Gel filtration profile (S300 - see section 2.3.2 for conditions) indicating pooled 
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Once inclusion body material had been prepared it was possible to refold 
the denatured protein. The method used was identical to that described for Fcs3-4 
fragments in Chapter 3. The HPLC profiles and SDS-PAGE of isolated fractions 















789 10 11 12 13 14 Pre M'' 
Figure 4.3: Panel A- Elution profile from a Superdex HR S75, run at 0.75 ml/min in gel 
filtration buffer - see section 2.1.; tick marks above x-axis indicate fractions taken. Panel B- 
non-reducing 20% SDS-PAGE of fractions from gel filtration purification, including pre- 
purification material and Mark 12 molecular weight markers. Numbers in panel B refer to the 
fraction number and correspond to the upper tick marks in panel A. 
Fractions relating to the HPLC profile peak were combined and 
concentrated yielding high purity material (see figure 4.4). 
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Figure 4.4: Elution profile from a Superdex HR S75, run at 0.75 ml/min in gel filtration buffer - 
see section 2.1. and a non-reducing 20% SDS-PAGE (inset) of purified Fce4. Black dotted lines 
indicate elution points for Fce3-4 dimer (before peak) and Fca2 monomer (after peak). The Fcc2 
monomer had been previously produced for NMR structure determination (McDonnell et al, 
2001). 
The gel in figure 4.4 indicated that the material isolated from the refold 
process was of the correct molecular weight and monomeric. However, the 
analytical HPLC profile showed a sharp peak at -15 minutes on a S75 column. If 
this elution profile is compared to that of previously analysed fragments it 
appears that a dimer was formed. The line before the peak on the profile shows 
where Fcc3-4 elutes (MW -48,000) and the line after the peak indicates where a 
monomeric FcE2 domains elutes (MW -12,000 - characterised in McDonnell et 
al, 2001). However, this method has inaccuracies; for example the elution time 
of an unfolded protein (Fcc3-4AC F506R) appeared very similar to its folded 
partner (Fcs3-4AC) even though it was half the molecular weight - see Chapter 
3. Fortunately, the purity of the Fcc4 material made it suitable for further 
biophysical analysis in order to confirm the folding and dimerisation state. 
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4.3 Characterisation of Fc£4 
Firstly the material was assessed for folding by CD. The spectrum 
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Figure 4.5: Circular dichroism spectrum of isolated and refolded Fcc4. Data was 
collected as outlined in section 2.4.1. 
The CD spectrum for the isolated fragment is characteristic of a folded ß- 
sheet protein, with a strong positive peak around 195nm falling to a minimum at 
215 nm, and rising again to plateau at zero ellipticity at longer wavelength. 
Therefore the elution profile in the gel filtration experiments was not due to the 
species being unfolded, and is more likely to reflect a dimeric species. To 
confirm this, analytical ultracentrifugation was used. This would also enable 
accurate assessment of molecular weight. If the material was completely dimeric, 
as would be expected from previous experiments, the distribution profile should 
fit that for a single ideal species of approximate molecular weight 24,000. A 
representative fit and data obtained for FcE4 are shown in figure 4.6 and table 4.1 
respectively. 
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Figure 4.6: Plotted sedimentation equilibrium data, fit (lower panel) and residuals from the fit 
(upper panel) are shown for a single ideal species of molecular weight -26,000. Data was 
collected as outlined in section 2.4.3. 
The data obtained from a series of sedimentation equilibrium experiments 
fitted a single ideal species model. The best fit data yielded an average molecular 
weight that agreed with that calculated for a Fcc4 dimer; these data are 
summarised in table 4.1. 
FcE4 (n = 9) 
Mean M(1- vp) 7339 ± 421 
Solvent density (p) 1.00721 
Partial specific volume (v) 0.7225 
Mean molecular weight 26,953 + 1547 
Molecular weight from sequence 24844 (dimer) 
Table 4. l: Data obtained from single ideal species fit for Fce4 sedimentation equilibrium data 
(n = number of datasets analysed). 
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Therefore, in conclusion, the Fcc4 domain can fold in isolation to form 
non-covalent dimers. This indicates that Fcc4 does not require Fcc3 to fold and 
that dimerisation may be an essential requirement for stabilising the Fcc3-4 
fragment. 
4.4 Production of Fcc4 F506R 
As Fcc4 refolded in isolation using identical methods to Fcc3-4, it was 
thus possible to examine the effect of the F506R mutation in the Fcc4 domain 
alone. 
The F506R mutation was introduced using the QuickchangeTM system 
from Stratagene as described previously (see section 2.21). Silent mutations were 
also incorporated into the vector using the mutation encoding primers. These 
silent mutations removed a restriction site (BbsI). Digests of pre- and post- 
mutation vectors can be seen in figure 4.7; these were used to enable quick 
identification of F506R positive clones. 
Figure 4.7: 1% agarose gel of pET 15a FcE4 vectors pre (lane 2) and post (lanes 3-6) 
mutation digested with Bbs!. Hind/I/ digested lambda DNA lane 1. 
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From the digests in lanes 3,4 and 6 it was clear that mutation of the 
vector DNA had been successful, but not for the reaction in lane 5. Subsequently 
the fragment sequence for successfully altered fragments was verified by DNA 
sequencing (data not shown). From this a single clone was isolated and the 
plasmid DNA prepared for transformation. 
4.5 Expression and purification of Fcc4 F506R 
Once the relevant mutation had been incorporated, the material was again 
over-expressed and purified from inclusion bodies. The process used was 
identical to that described previously. Figure 4.8 shows the final product of the 
inclusion body extraction procedure, and this was almost identical in yield and 





Figure 4.8: Reducing 20% SDS-PACE of inclusion body purified Fcc4 F506R 
This material was subjected to the refolding protocol used for all previous 
fragments. The dilute refolded material was then concentrated and HPLC 
purified by gel filtration on a S75 HR column. The elution profile for the 
refolded product alongside SDS-PAGE of the fractions is shown in figure 4.9. 
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Figure 4.9: Panel A- Gel filtration elution profile of refolded Fce4 F506 run on a Superdex HR 
S75 at 0.75 ml/min in gel filtration buffer - see section 2.1.; upward ticks on the x-axis indicate 
fractions collected. Panel B- non-reducing 20% SDS-PAGE of HPLC fractions and pre-injection 
material. Numbers in panel B refer to the fraction number and correspond to the upper tick 
marks in panel A. 
The profile obtained for Fcs4 F506R was very different from that of wild 
type Fcc4. The SDS-PAGE of the refolded product prior to gel purification 
shows a number of covalent aggregates, identifiable by a ladder of species of 
different molecular weight in panel B of figure 4.9. This material formed a 
precipitate that could be removed from the protein solution by filtration prior to 
injection onto the gel filtration column; this explains the absence of covalent 
aggregates in the elution profile. The remaining protein represented only a small 
fraction of that subjected to the refold (less than 0.5 mg from a total 20 mg). This 
kind of aggregation and covalent oligomerisation is behaviour charateristic of an 
unfolded protein, sich as Fcs3 (Henry, PhD thesis, 1997). The elution point of 
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the protein was also later than would be expected, even for a folded monomer, 
see figure 4.10. 

















logo molecular weight 
Figure 4.10: Plot indicating peak elution times for different IgE-Fc fragments and 
molecular weight markers (Sigma). 
As discussed previously, the behaviour of unfolded fragments is very 
different in gel filtration from those that have formed globular domains. The 
peak elution time for F506R Fcc4 mutant is much later than that for a folded 
Fcc4, and but earlier than that of a single Fcc2 domain. This is very similar 
behaviour to the unfolded, monomeric Fcc3-4 F506R construct. Therefore, from 
the gel filtration elution profile it was concluded that Fcc4 F506R was unfolded 
and was unable to form dimers in solution. Fortunately, enough covalently 
monomeric material was obtained from the refold to carry out circular dichroism 
analysis on the fragment to categorically determine the folded state of the 
protein. 
4.6 Characterisation of Fcc4 F506R 
Although recovery levels were poor, the Fcs4 F506R could be analysed at 
lower concentrations in a longer path length cell than that normally used 
(10mm). The material was not amenable to concentration, and thus it was not 
possible to carry out the complementary sedimentation equilibrium experiments 
that require a concentration of around 0.5mg/ml. Therefore the CD spectrum of 
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Fc£4 was also recorded at low concentration, to act as a control. The CD traces 
can be seen in figure 4.11. Although the signal obtained was sub-optimal it is 
clear that the spectrum for Fcs4 F506R is characteristic of a random coil, with a 
minimum close to 200nm and no positive signal in the peptide backbone region 
(200- 240nm). When compared to the spectrum for wild type Fcc4 (blue), which 
can still clearly be seen to be characteristic of folded ß-sheet, the difference 
between the two fragments is striking. This comparison, taken alongside the 
drastically different behaviours of each of the constructs in refolding, is strong 
evidence indicating that the F506R mutation has the same destabilising influence 






Figure 4.11: Circular dichroism spectra of Fce4 wild type and Fce4 F506R. Trend-line 
for each set of data (points also plotted individually) calculated using adjacent averaging. Other 
than concentration (protein concentration was determined to be 50 pg/ml by absorbance) and 
cell pathlength (10mm), data was collected as outlined in section 2.4.1. 
4.7 Discussion 
The aim of the work detailed in this chapter was to analyse the folding of 
Fcc4 in isolation from Fcc3 and use this as a basis for assessing the effect of the 
F506R mutation. Fes4 folded fully in the absence of Fcc3 to form non-covalent 
dimers. This result demonstrated that Fcc3 was not essential for stabilising Fcc4 
and confirmed the Fcc4 domain as a key mediator for dimerisation of the IgE-Fc. 
In comparison, the Fcc4 F506R mutant was extremely difficult to handle. This 
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construct did not fold properly (as judged by CD) and remained monomeric in 
solution (according to gel filtration data), indicating a strong relationship 
between stability and dimerisation. This result confirmed that the effect of the 
F506R mutation on Fcc3-41\C was due to destabilisation of Fcs4, and that Fcs4 
would appear to have a role in stabilising Fcc3. 
The behaviour of the Fcc4 F506R mutant was very similar to that of an 
isolated Fcc3 domain (Henry, PhD thesis, 1997) that also does not fold. The Fcc4 
F506R fragment was notably harder to handle than the larger unfolded Fcc3-4AC 
F506R mutant. On refolding, a larger proportion of Fcc4 F506R was found to 
precipitate compared to Fcc3-4 F506R, and furthermore, stability over time was 
also poor compared to the larger fragment. The fact that unfolded Fcc3 and Fcc4 
domains in isolation behave differently to the larger unfolded Fcg3-4 further 
suggests that the intra-chain interface between the two may have a role to play in 
stabilisation prior to full folding. 
From observation of the behaviour of these different fragments, a 
possible pathway for the folding of Fcc3 in Fcc3-4 now appears. It is most likely 
Fcc4 folds and stabilises itself through dimerisation and this then forms a surface 
with which the Fcc3 domains can then interact as they fold. It thus appears that 
the catalyst for full folding is the dimerisation and full structuring of the Fce4 
domains (see figure 4.12 for schematic). 
nuý 
Figure 4.12: Suggested pathway for the folding of Fcs3. 
One problem with this scheme is that it is not clear how the two Fcc4 
domains that are unfolded could come together before folding. It is apparent 
from the CD spectra of Fcc3-4 F506R (figure 3.12) and Fcs3 (figure 1.6) that 
although these fragments are not completely folded, neither are they a complete 
random coil (see figure 2.4 in section 2.4.1), as the ellipiticity observed at shorter 
wavelengths is less negative than that for a pure random coil. This could 
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represent a residual structuring of the domains. The intra-domain disulphide of 
Fcc3 is also known to be crucial to maintaining the binding capacity of this 
essentially unfolded fragment (Henry et al, 2000), further indicating that there is 
some structuring at least at the core of the domain. Such a core of structuring 
may exist for Fcc4, although at present there is no evidence for this. If this were 
true, it is possible that this minimal structuring of the fragments may provide 
motifs for recognition that are sufficient to allow initial contact to be made 
between monomers and the folding pathway to continue to completion. The 
presence of a large charge in the chain, in the form of the F506R mutation, may 
prevent these contacts and therefore stall the folding process. 
Fcc4 monomers were not seen in solution either by gel filtration or 
analytical centrifugation, confirming that this domain is a key mediator in 
dimerisation. Furthermore, the lack of monomers is consistent with a necessity 
for dimerisation to complete folding. This observation is supported by an 
examination of the Fcc4 dimer interface. The interface between Fcc4 domains 
buries a surface area of 2326 A2, of which 63% is non-polar and no water 
molecules are trapped (Wan et al, 2002). In contrast, for Fcc2, a domain that 
does fold as a monomer (McDonnell et al, 2001), the interface between Fce2 
domains is 1760 A2, and crucially only 25% is non-polar, with nine water 
molecules are buried at the interface (see figure 4.13). 
Figure 4.13: Fcc2 (left) and Fce4 (right) domain pairs (one space-filled the other a Ca trace) 
from the Fc crystal structure (Wan et al, 2002). Hydrophobic residues are green; hydrophilic 
residues white; yellow non-contact in Fce4; blue non-contact in Fcc2 (yellow in Fce2 are 
cysteines). 
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Although the results so far indicate that the F506R mutation prevents 
folding due to interfering with favourable Fc84: Fcc4 domain interface 
interactions, there is still the possibility that the F506R mutation affects folding 
simply by disrupting local domain structure, rather than domain pairing. This is 
an important question to consider when assessing whether forming a fully folded 
Fcg3-4 monomer is at all possible. 
Previous work carried out on IgG has shown that the homologous Fcy3 
domain interface is amenable to point mutation (reviewed in Carter 2001). Carter 
showed that alteration of residues in this interface to create complementary 
"knobs" (for example trytophan) and "holes" (for example valine) can be used to 
form bispecfic antibodies. In fact, one of the key residues used in this method is a 
tyrosine at the position homologous to phenylalanine 506 of Fcc4. This residue in 
Fcy3 makes a stabilising hydrogen bond with a threonine in the same chain, as 
well as packing closely with the opposing chain, so in terms of domain stability it 
appears to be as important as phenylalanine 506 in Fcs4. Yet, mutations in this 
region that are complementary with respect to interaction with the opposing 
domain do not cause unfolding. 
Investigation of non-complementary mutations has shown that these do 
alter the stability of the domain (Dall'Acqua et al, 1998). Mutations formed on 
one side of the Fcy3 domain to create a cavity in the domain interface reduced 
the stability of the dimer as judged by circular dichroism spectroscopy combined 
with GuHCI denaturation. These constructs however still formed dimers, but 
since these subtle mutations did alter the domain stability, a more drastic 
mutation that would completely prevent dimerisation fully by charge repulsion 
(such as F506R) could easily be expected to completely destabilise the fragment. 
Therefore, although these results were obtained for the IgG-Fc, taken alongside 
observations regarding the F506R mutation and the very high homology between 
the Fcs3 and Fcy2 domains, it is strong evidence that pairing of domains is 
necessary for folding. 
In conclusion, the Fcc4 domain does not require Fcc3 for folding, as an 
isolated fragment refolds from E. coli expressed inclusion bodies to display a 
circular dichroism spectrum characteristic of a fully folded domain. Furthermore, 
this fragment spontaneously forms non-covalent dimers, confirming this region 
as the key mediator of dimerisation for the Fc fragment. The fact that no 
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intermediate species (i. e. folded monomers) were observed in solution (as judged 
by AUC and gel filtration chromatography), and that the incorporation of like 
charges at the domain interface prevents folding (Fce4 F506R construct) suggests 
that the dimerisation process is integral to the folding of the Fcc4 domain. The 
results obtained for Fcs3-4AC F506R show that without a folded Fcc4 domain, 
the Fcs3 domain in this construct could not fold (see Chapter 3), whereas a 
dimeric Fcc3-4AC does fold. It is therefore concluded that the minimum scaffold 
required for a fully folded Fcc3 domain must include a dimer of Fc84 domains 
and that Fcc4 may play a role in promoting the folding of Fcc3. 
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Production and characterisation of 
a Fce4-Fce3-4 heterodimer 
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Chapter 5: Production and characterisation of a Fc*3-4-Fcc4 heterodimer 
5.1 Introduction 
In Chapter 4 it was shown that Fcc4 only folds correctly as a dimer. Thus, 
in order to discover whether a single Fcc3 will fold when attached to a folded 
Fcs4 domain, it was necessary to create a heterodimer of Fcc3-4 and Fcc4. In 
such a fragment, the single Fcs3 domain is free from any lateral contact with 
another Fcc3 domain, and so the effect of the longitudinal contact with Fcc4 
alone can be investigated. 
If contact from a folded Fcc4 is the sole requirement for the stabilisation 
of FcE3, a fully folded Fcc3-4: Fcs4 heterodimer (referred to as Fcc3-4(4)) would 
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Figure 5.1: Cartoon illustrating the various Fc sub-fragments described in Chapters 3 and 4, 
alongside the heterodimer (Fce3-4(4)). 
5.2 Refold and purification trial 
E. coli expression and refolding had previously provided clear results for 
both folded and unfolded IgE fragments, and therefore this system was also used 
for the heterodimer experiments. The protocol devised for isolating the 
heterodimer is outlined in figure 5.2. 
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Figure 5.2: Process for isolating Fce3-4(4) from a mixed refold population. The blue star 
indicates a His-tag, ellipses folded domains and random coil unfolded polypeptide chain. 
The aim of the experiment was to isolate Fcc3-4(4) from a mixed refold 
population. Starting with a crude mixture of GuHCI solubilised Fc63-4AC and 
Fcc4 (1: 1 molar ratio, 10mg of total protein), the preparation process was 
identical to that described in previous chapters. After refolding, the first step in 
the purification was gel filtration, to isolate covalent aggregates from monomeric 
refolded material, i. e. material that was a single species of either Fcc4, Fcc3-4AC 
or Fcs3-4(4). All alpha chain binding fragments (i. e. those that contain an Fcc3 
domain) were then captured using a a-, y affinity column ((sFccRIa)2IgG4Fc 
amine coupled to Fast Flow Sepharose (Pharmacia)). The folding status of Fcs3 
at this point is not critical as the domain maintains FccRI binding capability even 
when not fully structured (Henry et al, 2000). Positively selected material was 
then passed over a nickel affinity column, thus isolating only His-tagged 
material. Only the Fcc4 vector attaches this motif. From this selection procedure 
it should only be possible to isolate a Fcc3-4(4) heterodimer, as by the time of 
the nickel affinity step all Fcc4 dimers should have been removed due to their 
inability to bind the a-y fusion column. 
To ensure that the purification process worked in the intended manner, a 
number of control experiments were carried out. The results of these are 
displayed in figure 5.3. Panels A-C illustrate gel filtration profiles of the 
purification products from different runs over the nickel affinity matrix. Panel A 
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describes a test run in which refolded Fcc3-4AC was passed over the nickel 
matrix in the standardised affinity purification buffer (50mM sodium phosphate, 
500mM sodium chloride pH 7.4). This test was important to establish the 
specificity of the nickel column. In fact, under these conditions Fcc3-4AC 
appeared to bind to the column and elute as if it was His-tagged. In the light of 
this observation the purification strategy was adjusted slightly by the addition of 
50mM imidazole to reduce non-specific binding. Panels B and C show the effect 
of this change on the purification of both Fcc4 and FcE3-4AC respectively. The 
addition of imidazole does not alter the purifcation process for Fcs4, with 
recovery of loaded material, and no protein appearing in the pre-elution wash due 
to a drop in the affinity of the column for the His-tag (panel B). However, the 
addition of imidazole did stop the Fcs3-4AC sticking to the column, as all the 
loaded material came through in the wash and none in the elution fraction (panel 
C). 
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Previous page. Figure 5.3: Control experiments for the Fcs3-4(4) isolation process. A-C are 
traces from analytical gel filtration using a Superdez HR S75, run at 0.75 ml/min in gel filtration 
buffer (see section 2.1) of fractions collected from nickel Hi-trap columns loaded with either 
Fcs3-4dC or Fce4. Traces from the affinity purification are shown alongside a control profile of 
the relevant IgE fragment to indicate expected elution time. Panel A: Fce3-44C applied to the 
nickel matrix in standardised buffer. Panel B: Fee4 applied to nickel matrix in imidazole buffer. 
Panel C: Fce3-4IC applied to nickel matrix in imidazole buffer. All buffer compositions are 
outlined in 2.3.4. Pre-elution represents the unbound fraction, eluate the bound fraction and post 
elution the fraction collected after initial elution (shown to illustrate all material had been 
removed from the column). Panel D: 15% SDS-PAGE (non-reducing) of Fce3-44C and Fce4 
fragments applied as a mix to a-y fusion and nickel columns. Lane 11 = mix prior to purification, 
lane 1= a-y eluate, lane 2= nickel column unbound fraction, lanes 3-6 = nickel column eluate, 
lanes 7-10 nickel column wash. 
Finally, it was also established that the a-y column did not allow cross 
contamination due to non-specific binding. The results are outlined in panel D of 
figure 5.3. Here the two fragments (Fcs4 and Fcz3-41 C) were mixed together 
(lane 11) and then passed over the a-y fusion column and eluted (lanes 1 and 2). 
In lanes 1 and 2 it can be seen that Fcs4 does not stick but the Fc6-4 fragment 
does. Subsequently Fcc3-4AC was passed over the nickel affinity column, 
confirming its inability to bind to the nickel matrix (lanes 7 and 8 represent the 
column drop through and wash). 
With the specificity of the purification process confirmed, a trial refold 
was carried out to determine whether the isolation technique could yield 
sufficient material for analysis. In this trial run only 10 mg of GuHCI solubilised 
material was used (1: 1 ratio of Fce4: Fcc3-4). Using less material allowed a 
greater dilution factor at the rapid dilution step of the refold process. This is the 
point at which the glutathione is competed-off and the native disulphides are 
formed (see method section 2.3.3). It was hoped that lower concentrations would 
prevent some of the covalent aggregation seen in previous preparations of larger 
(Fcc3-40C) or unfolded (Fcc4 F506R) fragments. A greater dilution should 
reduce the probability of single fragment molecules encountering free 
sulphydryls from another molecule and forming cross-links prior to formation of 
the correct intra-chain disulphide. The refold was carried out using the same 
protocol as established for other IgE fragments (Henry, 1997) and was then 
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subjected to gel filtration to remove covalent aggregate. The gel filtration elution 
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Figure 5.4: Panel A: Gel filtration profile of Fce3-44C and Fcc4 mixed refold run on a Superdez 
HR S75, run at 0.75 mUmin in gel filtration buffer - see section 2.1. Upward ticks on x-axis 
indicate fraction collection points. Panel B: 15% non-reducing SDS-PAGE of fractions, numbers 
correspond to tick marks on the profile in panel A. 
The SDS PAGE profile in panel B shows the pre-purification sample 
(second from right) and the subsequent eluted fractions. It is clear from the pre- 
purification sample that much of the protein still aggregated, visible in the higher 
molecular weight bands that indicate covalent aggregates and smearing in the 
gel. The subsequent recovery of much of the sample confirmed this (-3mg 
protein total prior to the two-step affinity purification, as assessed by absorbance 
at 280nm). Fortunately the gel filtration step enabled all of this aggregate to be 
113 
05 10 15 20 25 30 
Time (minutes) 
Chester 5 Page 114 
removed from the eluted fractions. After gel filtration, fractions containing Fcc4 
and Fcc3-4AC identified by SDS-PAGE were combined and then passed over the 
a-y affinity column; eluted fractions were recombined and passed over the nickel 
column. The results of these purification steps are shown in figure 5.5. 
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Figure 5.5: Top panel: eluted fractions collected from a-y fusion column (lanes 1-11). Bottom 
panel: Fractions collected from nickel column after purification of collected material eluted from 
a-y fusion purification step. Lane 1-6 = eluate fractions, lanes 7-11 = unbound fractions. 
The SDS-PAGE of the a-y and nickel columns clearly shows that the 
isolation process has captured heterodimeric fragments. The a-y column would 
not be able to co-elute FcE4 with Fcc3-4 unless the two had associated. This 
association was non-covalent as the gels run are non-reducing. The positive 
selection process is most clear in the nickel column step, with lane 9 showing 
Fcc3-4AC coming though in the column wash, and the Fcc3-4(4) material 
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appearing in the eluted fraction (lane 4). Unfortunately only very small amounts 
of material were obtained. In total -50µg was recovered, which was sufficient for 
detection using SDS-PAGE, but represented only a fraction of the intial 10mg of 
GuHC1 solubilised material. Due to the very low recovery, no biophysical 
analysis could be carried out. 
5.3 Preparative refold 
As the purification system appeared to be functioning, but yields were 
poor, it was decided to increase the initial amount of GuHC1 solubilised starting 
material. Commonly 20mg of material is refolded in a single preparation. This 
provides a good balance between the level of dilution required to obtain 
covalently monomeric material and the amount of time that it takes to 
concentrate the material before gel filtration. In the test refold, a greater dilution 
factor was applied in an attempt to reduce covalent aggregate, and this was 
achieved by lowering to 10mg the amount of starting material used. This 
modification was not completely successful, although monomeric material was 
still separated, albeit at a low yield. This increased dilution factor could not be 
applied for the larger refold as the increase in concentration time would be too 
great. Therefore, in an attempt to counteract the effect of increased protein 
concentration, the ratio of GuHCI solubilised Fcs4: Fc63-4AC was altered (to 
1.5: 1) such that the equilibrium was shifted towards the formation of Fcc4. This 
was because Fcc4 yields much less aggregated material when refolded than Fce3- 
4AC, thus lowering the potential for the appearance of nucleation points for 
aggregation. The refold should then also favour the formation of Fcc3-4(4) over 
Fcs3-4AC due to the excess Fcc4 in the mix. This might result in a small drop in 
the yield of Fcs3-4(4), but by reducing the potential for aggregation and 
increasing the total protein, it was anticipated that the experimental yield would 
be higher. 
After gel filtration and isolation of the covalently monomeric fraction 
(data not shown), the refolded material was affinity purified by the same two- 
step procedure, the results of which are presented in figure 5.6. Again 
monomeric fragments co-purified, indicating the formation of a heterodimer. 
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Figure 5.6: Top panel: a-y fusion purification step in Fcs3-4(4) refold: lanes I and 2 are 
unbound fractions (note Fce3-4 appears in the drop through due to saturation of the a-y matrix), 
lanes 3-9 wash fractions and lanes 10 and II eluted fractions. Bottom panel: nickel column step 
from Fce3-4(4) purification: lane 1 pre purification sample, lanes 2-7 unbound fraction, lanes 8 
and 9 eluted fractions. 
Unfortunately, the increase in the amount of protein meant that the 
preparation appeared to be more prone to covalent aggregation, as can be seen in 
the smearing in the gel and higher molecular weight bands corresponding to 
covalently linked fragments (lanes 10 and 11 in the top panel, lanes 8 and 9 in 
the lower panel; smears from 36kDa and upwards according to the markers - 
figure 5.6). This occurred after elution from the a-y fusion column as the material 
that was applied was composed of monomeric material collected from the gel 
filtration step. 
Once all purified material had been combined, there was sufficient 
material for biophysical analysis, but recovery levels meant it was not possible to 
re-purify the material by gel filtration to reduce the amount of covalent 
aggregate. An analytical gel filtration profile of the material collected was 
obtained; this can be seen in figure 5.7. A total yield of less than 200µg was 
recovered from a refold of 20mg, due to the aggregation problems. 
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Figure 5.7: Gel filtration profile (Superdex S75 HR column, run at 0.75 ml/min in gel filtration 
buff er - see section 2.1) of Fce3-4(4) material isolated from a preparative scale combined refold 
of GuHCI solubilised Fce4 and Fec3-44C fragments. 
Of the total yield -10% appeared to be aggregate. Although not ideal, the 
recovery did provide enough material to carry out further structural and 
functional characterisation. 
5.4 Characterisation 
The first step in characterising the heterodimer was circular dichrosim 
spectroscopy. This was carried out using a larger path length cell because the 
material obtained was dilute and prone to precipitation if concentrated. The result 
of this was a noisy spectrum, as observed for Fcc4 F506R. Therefore the trace is 
cut off at 200nm because from that point onwards the data was not of sufficient 
quality. As a control, the spectrum for a fully folded Fcs3-4 \C fragment was 
also recorded at an identical protein concentration. The values were then scaled 
to account for the longer path length cell and lower protein concentration. After 
scaling, the results obtained for the control were (virtually) identical to those 
collected under ideal conditions (Chapters 3 and 4; figures 3.13 and 4.5) 
indicating that the correction process had worked satisfactorily. The data can be 
seen (both Fcc3-4AC and Fcc3-4(4)) in the top panel of figure 5.9. It is clear that 
both fragment preparations are composed of folded material, with the 
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characteristic minimum of beta-sheet seen at -215 nm. However, the heterodimer 
does have a slightly different signal, especially at the shorter wavelengths. The 
spectrum for a fully folded Fcc3-4(4) is expected to be slightly different from 
that of a fully folded Fcc3-4AC, as is Fcs4 for example (compare figures 3.13 
and 4.5). Therefore it is difficult to draw any firm conclusion regarding the 
degree of folding, and whether these differences are due specifically to the 
structuring of Fcc3. To address this problem, a trace was simulated to provide a 
fair comparison of the observed spectrum. This was achieved using previously 
recorded spectra for Fcc3-4AC and Fcc4 (see figures 3.13 and 4.5). The values 
were adjusted such that the quantification was in molar terms (i. e. multiplied by 
the number of residues) and then a subtraction was made to obtain the values for 
a single folded Fcc3 when part of a fully folded Fcs3-4AC. This was then 
subtracted from the Fce3-4AC spectrum to yield a theoretical spectrum for Fcc3- 






Figure 5.8: Process of subtraction used to create a simulated spectrum for a fully folded 
Fce3-4(4). Firstly the spectrum for the Fce4 dimer was subtracted from that of Fcc3-4AC to give 
the spectrum for a folded Fce3. This value was then adjusted to provide the spectrum for a single 
folded Fce3 domain, and was then subtracted from the original Fce3-44C spectrum to yield the 
theoretical value for Fcs3-4(4). 
The result of this simulation is displayed in the middle panel of figure 
5.9, alongside the experimental trace for a fully folded Fcc3-4AC. The data are 
plotted together with a trend line calculated using an adjacent averaging 
algorithm. This enables a straightforward comparison to be made between the 
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simulated and collected datasets (see bottom panel for collected data presented in 









Figure 5.9: Top panel: Data collected at low protein concentration for Fcs3-44C and Fcc3-4(4). 
Middle panel: Simulated Fce3-4(4) and observed high concentration Fce3-44C data. Bottom 
panel: Data identical to panel A except that a trend line is added to enable comparison with 
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Comparison of the simulated trace for Fcc3-4(4) (middle panel figure 5.9) 
with the experimental data (lower panel figure 5.9) shows that there is a shift 
upwards in the experimental data at the 215 nm minimum, and a shift downwards 
in the positive region at shorter wavelengths. The conclusion that can be drawn 
from this regarding the folded status of the preparation is that the majority of the 
material present is folded beta sheet, but that there is a fraction of the preparation 
that is unfolded. 
Previously experiments have been carried out under ideal conditions to 
establish the effect of random coil on the beta sheet signal, notably the work by 
Fasman (Greenfield and Fasman, 1969). Their results are reproduced in figure 
5.10. 
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Figure 5.10: Effect of random coil on the beta sheet circular dichroism signal, reproduced from 
Greenfield and Fasman, 1969. 
It is clear that the a contribution from unfolded polypeptide could account 
for the differences between the data collected for Fcc3-4(4) and the simulated 
spectrum. The question is whether these differences are due to the presence of an 
unfolded Fcc3 domain, or whether they are due to the presence of unfolded 
material that has resulted from the process of aggregation. It is extremely 
difficult to estimate the overall effect that aggregate would have on the signal for 
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the folded species, as it may represent a mixture of partially folded material 
alongside random coil. It must also be noted that if the Fcs3 were unfolded it 
would be very prone to aggregation. However, from Fasman's data it is clear that 
the difference between the observed and calculated spectrum represents a 
contamination of less than 20%. If the Fcc3 were fully unfolded one would 
expect to see a 33% decrease in signal, assuming no aggregate. Since it may be 
assumed that the aggregate material is likely to be unfolded it indicates that the 
Fcc3 domain within Fcc3-4(4) is at least partially folded for the signal to be as 
strong as it is (aggregate makes <10% of the final preparation, see figure 5.7). 
Equally, it is clear that the fragment isolated is not completely folded. It therefore 
appears that the presence of Fce4 is having a beneficial effect on the folding of 
Fcc3, but is perhaps not sufficient to completely stabilise the preparation. It may 
even be that the aggregate is the result of an incomplete stabilisation of the Fce3 
domain. 
Further analysis was undertaken with this fragment to estimate its affinity 
for FceRI using SPR. Unfortunately, either due to the aggregate, the unstable 
nature of the preparation, or both, it was not possible to collect data due to the 
non-specific accumulation of material on the chip surface - see figure 5.11. This 
behaviour was not unlike that seen for Fcc3-4 F506R (data not shown), adding 
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Figure 5.11: Biacore trace obtained for Fce3-4(4) passed over immobilised a-y fusion protein. 
Blank refers to a coupled surface (1gG4Fc only) that acts as a control for non-specific binding. 
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Several attempts were made at repeating the preparation to obtain a 
smaller amount of aggregate, but unfortunately it appears that the method is only 
able to yield material that is prone to this type of behaviour. The consistent 
appearance of aggregate suggests an inherent instability of the Fcc3-4(4) 
fragment. 
5.5 Discussion 
The data presented in this chapter indicate that longitudinal contact 
between a folded Fcc4 and FcE3 domain at least partially stabilises the folding of 
the latter. This does therefore also imply that the Fce3 domain of IgE-Fc is not 
able to completely fold in the absence of lateral contacts. However, FcE4 is able 
to stabilise Fcs3 to some degree, and the Fcc3-4(4) fragment is clearly more 
folded than the monomers described in previous chapters. Unfortunately the 
fragment obtained from the mixed refold method is not stable in solution for 
prolonged periods. This prevented storage and the accumulation of material that 
would have enabled a more rigorous analysis to be undertaken. 
The Fcc4 domains were presented in such way that they were expected to 
fold, as discussed in previous chapters. It is therefore reasonable to assume that 
the problems observed with the Fc&3-4(4) are the result of the behaviour of Fcc3. 
One possible reason for this effect may the absence of carbohydrate. Although 
the fragment commonly folds without glycosylation in the form of Fcc3-40C, it 
may be that the carbohydrate normally provides a stabilising effect. Without the 
presence of these sugars that cover hydrophobic residues, the Fcc3 domain may 
become less stable, less folded and prone to aggregation. It may be that when 
there is an FcE3 domain present in the opposing chain, as there is in Fcc3-40C, 
the other Fcs3 can act as a surrogate shield. This has been suggested to happen in 
carbohydrate-free fragments of IgG-Fc (Radaev and Sun, 2001) and is something 
that will be expanded on in later chapters. 
One method for circumventing this effect, and perhaps avoiding the 
problems associated with aggregation on refolding, might have been the 
engineering of fragments in a mammalian system. Unfortunately, mammalian 
systems have only yielded fragments when the protein can fold and/or solubilise 
correctly; little success was achieved when expressing Fcc3 for example (R. 
Young, personal communication), or fragments without glycosylation at Asn 394 
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(Nettleton and Kochan, 1995; Sayers et al, 1998). Previously, the fragments 
produced in E. coli had provided unequivocal answers regarding folding status, 
both for fully folded and unfolded proteins. E. coli expression was therefore the 
appropriate system, especially as carbohydrate had not been essential for the 
folding of other IgE-Fc fragments (Geha et al, 1985, Helm et al, 1988). 
However, it may be that the production of a heterodimer, following the strategy 
of Carter (Carter, 1997), by engineering the Fcs4 domain interface to favour the 
association of heterodimers, could be used to produce a Fcc3-4(4) with a 
glycosylated Fcc3 domain. Such a fragment might provide a more definitive 
answer regarding the need for longitudinal contacts. 
Given the result obtained with Fcc3-4(4), it appears that the Fcc3-40C 
fragment remains the minimal fragment of the IgE-Fc within which Fcc3 folds 
completely. Therefore, the functional properties of this fragment were 
investigated further in an attempt to discover why Fcc3 remains stable within this 
context, but becomes increasingly unstable when further structural features are 
removed. 
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Chapter 6: The effect of disulphide linkage and Slycosylation on high 
affinity receptor binding and folding of Fcc3-4 
6.1 Introduction 
The results presented in chapter 5 indicated that it is not possible to fold 
Fcc3 completely without lateral contacts. Therefore the minimal fragment within 
which Fcs3 appears to be fully structured remains the E. coli expressed Fce3- 
4AC. This fragment is particularly interesting in that it lacks two structural 
features of the more extensively studied mammalian Fcc3-4; disulphide linkage 
at the N-terminus (Cys 328) and glycosylation at Asn 394. Previously it has been 
suggested these are of little consequence with respect to stability and the binding 
of FccRI (Henry, PhD thesis, 1997; Basu et al, 1993). However, the results 
described in Chapter 5 indicated the possibility that carbohydrate may have an 
important role in the stabilisation of Fcc3. Furthermore, it has recently been 
discovered that the disulphide pairing present in the mammalian FcE3-4 fragment 
is not replicated in the full Fc (Wan et al, 2001). In the light of these recent 
findings, it appeared that a re-examination of the properties of this molecule 
might yield vital clues as to the basis of the high affinity of Fcc3-4 for FccRI, and 
the stability of Fcc3 within the FcE3-4 fragment. 
6.2 Expression and purification of mammalian Fcc3-4 
To enable a fair examination of the E. coif Fcs3-4AC, it was also 
necessary to produce a mammalian Fcc3-4 fragment, i. e. an Fcs3-4 fragment that 
is glycosylated at Asn 394 and disulphide-linked at the N-terminus. The 
mammalian fragment was expressed from permanently transfected NSO mouse 
myeloma cells, a procedure previously established for a number of investigations 
within the laboratory (Keown et al, 1997, Shi et al, 1997). This fragment has an 
identical number of residues (328-547) to Fc83-4AC, but has an Asn-Gln 
mutation at 371 so that the fragment is only glycosylated at Asn 394. The Cys is 
maintained at 328 to allow covalent linkage of the homodimer. The method for 
isolating material involved a simple two-step purification using a a-y fusion 
affinity column (as used in Chapter 5), followed by gel filtration on an HPLC 
system, as outlined in section 2.3.5. The final isolated fragment is shown in 
figure 6.1 as a single band on a non-reducing 15% SDS-PAGE in comparison 
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with an isolated Fcc3-4AC fragment run under identical conditions. Crucially, 








Figure 6.1: 15% non-reducing SDS-PAGE of mammalian Fce3-4 (left) and E. coli Fcs3-44C 
(right). 
The formation of the disulphide was confirmed by reducing the fragments 
(inset figure 6.2), lowering the apparent molecular weight of the mammalian 
fragment from around 50 kDa to less than 30 kDa. This agreed closely with the 
size of Fcc3-4AC, although the band for the mammalian material was slightly 
higher due to the presence of glycosylation (confirmation of the glycosylation 
status can be found in Chapter 7, section 7.2). Finally, the purified fragments 
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Figure 6.2: Gel filtration profile (Superdex S200 HR column, run at 0.75 ml/min in gel filtration 
buffer - see section 2.1) of mammalian Fce3-4 (red) and E. coli Fce3-44C (black). Inset: 15% 
reducing SDS-PAGE of mammalian Fcc3-4 (left) and E. coli Fcc3-44C (right). 
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Under analytical gel filtration conditions the apparent molecular weight 
of mammalian Fcs3-4 was slightly higher than that of E. coli Fc63-4AC, with a 
time difference of -- 30 seconds. This difference was larger than expected given 
the minor shift seen on SDS-PAGE. This could be the result of a difference in the 
conformation of the Fcs3-4AC molecule compared with mammalian Fcc3-4, i. e. 
to one that is more compact, due to the release of the constraints imposed by the 
disulphide bond at position 328, or the absence of carbohydrate. It is not the 
result of the "monomerisation" of Fcc3-4AC, as this fragment has already been 
confirmed to be a dimer in solution - see Chapter 4, section 3.3.2. 
6.3 Folding and stability of mammalian FcE3-4 and E. coli Fcc3-4AC 
Initially the interest in these two fragments stemmed from speculation 
that the absence of carbohydrate could be having a negative impact on the 
structuring of the Fcc3 domains. Therefore the two isolated fragments were 
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Figure 6.3: Circular dichroism spectra of E. coli Fce3-44C (red line) and mammalian expressed 
Fcc3-4 (black line). Data were collected according to the method outlined in section 2.4.1. 
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In comparing the spectra it is clear that there is a difference in the 
magnitude of the signal between 195nm and 205nm. This region corresponds to 
the signal obtained from an ordered arrangement in the peptide backbone. If the 
protein is disordered (i. e. random coil), a strong negative band is seen; a strong 
positive signal is observed in a folded protein (see Chapter 2, figure 2.4). The 
lower signal in this region may be explained for E. coli Fcc3-4AC by the 
presence of a small amount of residual random coil from the refolding process, 
but the beta sheet signal is of an identical magnitude. If the drop at 200nm were 
due to the presence of random coil, it would be associated with a change in the 
magnitude of the signal in the ß-sheet region (see the Greenfield and Fasman 
data reproduced in Chapter 5, figure 5.10). It is therefore difficult to rationalise 
the difference in these terms. It may be that the absence of the inter-chain 
disulphide bridge has reduced the signal in this region, either directly, or by 
altering the relative disposition of the domains and/or their conformational 
freedom (which could be due to the absence of the carbohydrate also). It might 
also be simply the product of poor signal to noise, as a close examination of the 
spectra shows more noise for the Fcc3-4AC trace. All the spectra in this thesis 
are shown unsmoothed to enable such comparisons. 
To ascertain whether there was any difference in the stability of the E. 
coli Fcc3-4AC protein compared to mammalian Fcc3-4, the CD signal at 215nm 
(ß-sheet minimum) was monitored for both fragments as a function of 
temperature, see figure 6.4 and table 6.1. 
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Figure 6.4: Thermal denaturation profile of E. coli Fce3-44C (red) and mammalian Fcc3-4 
(black) based on the monitoring of the CD signal of each protein at 215 nm; sigmoidal curve 
fitted to demonstrate transition between folded and unfolded baselines. 
Fragment I T. (C) 
Fcc3-4 56.7 
Fcc3-4AC 47.6 
Table 6.1: Melting points for E. coli Fce3-4AC and mammalian Fcs3-4. Temperatures represent 
the point at which protein is 50% unfolded according to the circular dichroism signal at 215nm. 
It is apparent from the transitions that the E. coli Fcc3-4AC fragment is 
not as stable as the mammalian Fcs3-4 fragment. It may be that this is due to the 
absence of carbohydrate, the inter-chain disulphide, or a combination of both. At 
the wavelength at which denaturation was monitored (215nm), the signal 
recorded was identical for the two fragments prior to denturation (see figure 6.3, 
recorded at room temperature). This wavelength represents the point at which 
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beta structure is normally assessed by CD, and thus there are obvious differences 
between the two fragments that relate to their stability of their ß-sheet structures 
(this is in contrast to the less well defined region where divergence was observed 
for the full spectra; here differences in signal are much harder to attribute to 
specific structural features). These fragments were also examined for their 
binding capabilities to see if these differences impacted on overall binding 
function. 
6.4. Binding studies of mammalian Fcc3-4 and E. coli Fcc3-4AC 
The two fragments were analysed firstly for their ability to bind FcERI 
immobilised on a Biacore chip, in the form the of a-y fusion protein 
((sFccRla)2IgG4-Fc). The binding profiles and fits obtained are shown in figures 
6.5 and 6.6. 
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Figure 6.5: Biacore binding profiles for a concentration series of Fce3-4AC (IOOnM to 6.25nM) 
showing binding to blank (red) and FcERI (black) surfaces. Inset is the steady state fit (Rey versus 
concentration) used to derive affinity constants. 
Surface KA (M-' + SE) Rn, (RU) 
a-y fusion (436 RU) (2.66 ± 0.24) x 10 180 (± 5) 
a-y fusion (216 RU) (3.43 + 0.30) x 107 104 (+ 3) 
Table 6.2: Affinity constants derived from steady state analysis of Fcc3-44C. Two surfaces were 
used at different immobilisation levels, with five concentrations for each surface. 
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Figure 6.6: Biacore binding profiles for a concentration series of mammalian Fce3-4 (IOOnM - 
6.25nM). Fits based on a 1: 1 biphasic competition model are shown as a red dotted line (visible 
superimposed on black data line) for each concentration and residuals for the fits are shown in 
the bottom panel. 
Fragment FcE3-4 mammalian 
kai (-'s') (4.77 ± 1.88) x 10 
kd, (s-') (1.21 + 0.19) x 10-2 
ka2 (M-'S') (3.08 ± 0.65) x 105 
kd2 (s-') (6.26 ± 1.29) x 10-4 
Kai (M') 3.94 x 107 
Ka2 (M ') 4.92 x 108 
Ri/Ro 0.15+0.03 
Overall KA (M ) 4.2 x 10 
Table 6.3: Affinity constants derived from kinetic analysis of mammalian Fce3-4. The R, /Ro ratio 
describes relative contribution from each component of the biphasic fit; the overall KA represents 
an average of the two individual Ka based on this ratio. 
Striking differences can be seen when the E. coli Fcc3-40C and 
mammalian Fcs3-4 binding profiles are compared. The Fcs3-4AC fragment has 
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very fast on and off rates and appears to be a simple monophasic interaction. 
Because the kinetics were so rapid, they could only be fitted to a steady state 
model, yielding only the equilibrium association constant. This is very different 
to the data collected for the mammalian Fcc3-4. This could be subjected to a full 
kinetic analysis, and fitted best to a biphasic competitive association model. 
Using this model, the mammalian Fcc3-4 yielded very similar affinity constants 
to those derived in previous studies (overall KA of -5x 108 M"I; Cook et al, 
1997; McDonnell et al, 2001). This confirmed that the behaviour of the Fcc3- 
4AC was a result of the fragment's properties and was not due to the chip surface 
used in these experiments. 
The equilibrium constant Kai of mammalian Fcc3-4 was calculated to be 
very close to the overall KA for Fcc3-4AC. The interaction between FccRIa and 
Fcc3-4 occurs at two overlapping binding sites on the basis of the crystal 
structure of the complex (Garman et al, 2000). The observation of this two-site 
interaction is a strong justification for the application of the biphasic binding 
model. In this crystal structure, one of these interaction sites is composed almost 
solely of the N-terminal linker and it was therefore a concern that some, or all, of 
this region might be missing from the fragment expressed in E. coli. For the 
mammalian fragment it is easy to ensure the integrity of this region after 
purification, as any loss of residues would result in a shift in apparent molecular 
weight. This is because the N-terminal residue in the linker region is the cysteine 
that forms the disulphide bridge between the two chains, and therefore a large 
shift would be seen under non-reducing SDS-PAGE. However, in Fcs3-4AC this 
disulphide bridge is not present, and therefore it is difficult to tell if important 
binding residues are still present, as the loss of a part of the linker would not lead 
to a dramatic shift in molecular weight. If this site were absent, a gross change in 
binding kinetics would be expected. The fragment would still be active in 
binding FccRIa, as the other binding sub-site within the Fcc3 domain would still 
be present, but loss of the N-terminal residues might be expected to lead to a 
difference in affinity and loss of biphasicity. In fact, a significant difference 
between the gel filtration profiles of the two fragments had already been noted 
(see figure 6.2), although this was thought to represent a difference in 
conformation. Therefore, to confirm that the difference in kinetics and gel 
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filtration profile was not simply due to the loss of important N-terminal residues, 
the Fcc3-4AC fragment was subjected to examination by mass spectrometry. 
6.5. Mass spectrometry of Fcc3-4AC 
The homogeneity and integrity of the refolded Fcc3-4AC preparation was 
assessed by nanospray mass spectrometry (figure 6.7 courtesy of Malcolm Ward 
of the proteomics unit, Institute of Psychiatry). The analysis gave a final value 
within 2 Da of the expected molecular weight for Fcc3-4AC (MW 24557 with 
the N-terminal Cys mutated to Ser). This confirmed that the fragment had not 
lost any of the N-terminal residues. 
Figure 6.7: Readout from nanospray mass spectrometric analysis of Fce3-44C. See section for 
2.3.3 for the method 
6.6. Analytical ultracentrifugation of Fcc3-4, Fcc3-4AC and sFcsRla 
Once the Fcc3-4AC fragment was shown to be intact it was important to 
investigate the binding properties of both fragments under different conditions, to 
ensure that the differences observed so far were not an artefact of the Biacore 
assay. Therefore Fcc3-4AC binding to sFccRla was analysed under equilibrium 
conditions in the analytical ultracentrifuge. Previous studies of the mammalian 
R0 -4 fragment in the analytical centrifuge had yielded data demonstrating a 1: 1 
stochiometry with sFcERIa (Keown et al, 1997). Once the data were collected for 
E. coli Fcc3-4AC, a very different behaviour was immediately apparent. During 
the fitting of the equilibrium data to various interaction models, it became clear 
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that a 2: 1 stoichiometry between Fcg3-4AC and sFcsRla was occurring (compare 
top and middle panels in figure 6.8). Although the residual distribution is similar, 
statistically the best fit to the data yielded was a mix of 2: 1 and 1: 1 
stoichiometries (see lower panel figure 6.8). The affinity data extracted from this 
fit are shown in table 6.4. 
1: 1 Interaction 
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Figure 6.8: Sedimentation equilibrium analytical ultracentrifugation datasets for E. coli Fce3- 
4dC binding to sFcsRlaa Data fits based on an interaction stoichiometry of either 1: 1,2: 1 or 1: 2 
are shown for mixes of Fce3-4AC: sFceRIa at 1: 1,2: 1 and 1: 2. Residuals for each fit are shown 
in adjacent panels. 
Equilibrium constant Value 
K, (1.8+0.4)x 10 M" 
K2 (7.2 ± 2.2) x 102'M-' 
Table 6.4: Affinity constants for the 1: 1 and 2: 1 complexes formed between sFceRla. Fcs3-44C 
and sFceRIa based on data collected in the analytical ultracentrifuge. 
The two affinity constants derived from the fitting procedure are not 
completely equivalent, the first is -2x 105 M-1, whereas the second is 7x 105 M- 
1. These values correspond to the scheme below: 
A+2Bi AB+B< K2 >ABZ 
Figure 6.9: Scheme for the formation of a 2: 1 complex between Fce3-4 and sFceRla showing 
interactions that correspond to the affinity constants K1 and K2. 
There is a variation between the affinities observed for K, and K2 
however, the two values are of the same order of magnitude, and are close when 
errors are taken into account. The difference observed therefore is most likely a 
product of a slight deviation in the fitting procedure. 
To ensure that the interaction observed during the centrifuge run was not 
the product of degradation or aggregation of the sample in the cell, the contents 
were also run on non-reducing SDS-PAGE, see figure 6.10: 
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Figure 6.10: 15% non-reducing SDS-PAGE of Fce3-4AC: sFcERla mixes from the ultracentrifuge 
cell after 100 hour sedimentation equilibrium experiments. Each lane is the protein from a 
different cell. The smeared band represents sFceR/a (smeared due to heterogeneous 
glycosylation) and the resolved is band Fee3-4d C. 
From the SDS-PAGE there appeared to be no evidence of a gross 
breakdown of fragments occurring during centrifugation, nor was there covalent 
aggregation. In fact, any significant degree of aggregation in the cell would have 
interfered with the model fitting procedure to an extent that no data fitting would 
have been possible. 
6.5 Discussion 
In this chapter, a comparison of Fcc3-4AC expressed in E. coli, and 
Fcc3-4 expressed in a mammalian cell line yielded striking differences. It 
appears that the absence of disulphide linkage and/or carbohydrate has a 
deleterious effect on the affinity of Fcc3-4 for FccRI. In the Biacore and AUC 
analyses the mode of interaction with FccRIa appeared to be altered drastically. 
In solution Fcc3-4 \C was able to bind sFceRIa with a mixture of 1: 1 and 2: 1 
stoichiometries. In the Biacore, which is a surface interaction assay, the binding 
only showed a 1: 1 stoichiometry. This conclusion is based on the values derived 
for the RR, ax in the steady fit, as these were equivalent to the Rm. expected for the 
amount of immobilised a-y fusion protein based on the ratio of each proteins's 
molecular weight. In both cases the overall affinity observed was significantly 
lower than that recorded for the mammalian expressed fragment that possesses 
these two structural features. 
The functional properties of the Fcc3-4AC fragment could be the result of a 
combination of structural factors. For example, the cysteine 328 disulphide acts 
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as a bridge between the two binding sites used to interact with FccRI (as revealed 
in the crystal structure). Due to the asymmetric nature of the interaction with 
FccRI, the two binding sites are composed of some residues which are exclusive 
to each particular site and others that are represented in both (Garman et al, 
2000). Many of the residues that compose these sites are in the linker region of 
the Fcc3-4 molecule, which is to some degree constrained by the disulphide 
linkage. Therefore, removal of this structural feature present in the linker would 
be expected to have some effect on binding. 
The extremely rapid kinetics and potential for 2: 1 stoichiometry seen for 
Fcc3-4AC may be explained in terms of only one site, or one particular set of 
residues, being engaged. In FcE3-4, steric hindrance is responsible for preventing 
a second sFccRla from binding, but if non-disulphide linked Fcc3-4 can engage a 
second receptor, there must be a greatly increased distance between the binding 
sites. A clue to how this may arise lies in the crystal structures of the Fce3-4 
fragment. If the unbound state of FcE3-4 (Wurzburg et al, 2000) is compared to 
that of the bound (Garman et al, 2000) a large conformational shift is necessary 
to engage receptor, with the FcE3 domains moving from a "closed" to an "open" 
conformation. This assumption is supported by the crystal structure of the full Fc 
(Fce2-4, Wan et al, 2002), as this displays an intermediate structure in which one 
domain is "open" and the other "closed". If the unbound and bound structures are 
examined further, there appears to be evidence for an inherent flexibility within 
the Fcc3 domains, especially when compared to that of the homologous IgG-Fc 
(Wurzburg et al, 2000). It is possible that without the constraint of either a 
disulphide bridge at residue 328, attached carbohydrate, or a combination of 
both, that an even greater degree of freedom could be observed for Fcs3 
domains, allowing the binding of a sFcsRIa molecule to each Fcc3 domain. 
Further evidence for a conformational difference between Fcs3-4 and Fcc3-4AC 
appears in the gel filtration data (figure 6.2). In comparison to mammalian Fcc3- 
4, the non-disulphide linked construct has a smaller apparent molecular weight 
that suggests a more compact structure. If the Fcc3 domains in Fcc3-40C were 
compacted to a high enough degree, it is easy to imagine that the two sub-sites 
(one on each Fcs3 domain) would be too far apart to both contact a single 
sFcERIa, but that being far apart they could each bind an sFccRla using only one 
It 
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of the sub-sites. Thus the Fcc3 domains might "roll" past one another as the 













Figure 6.11: Schematic illustrating a potential interaction model for sFcsRla with Fce3-44C and 
mammalian Fcr3-4. Blue stars indicate binding sites on individual FcE3 domains, yellow ellipse 
indicates carbohydrate at Asn 394. There are in fact two sub-sites on each Fce3 domain, but from 
the experiment carried out it is not clear which site is being engaged and therefore the single 
blue star represents both sites in this case. 
A possible role for carbohydrate in determining these conformational 
differences is apparent if work carried out on the IgG-Fc is taken into account. 
Deglycosylation of IgG-Fc leads to a closing of the molecule (Jefferis and Lund, 
2002). In fact, on complete deglycosylation, the IgG-Fc is thought to close to 
such an extent that engagement of a receptor is not possible at all due to 
occlusion of the binding site. This closing results in a shift in apparent molecular 
weight (Radaev and Sun, 2001) similar to that seen for Fcs3-4AC. It was 
suggested this closing could be a result of the need to cover hydrophobic residues 
normally shielded by the core glycosylation. A similar mechanism may be at 
work for Fcc3-4AC, in figure 6.11 the black inward facing arrows in the bottom 
left illustration indicate such a potential movement. 
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If the CD data for both fragments is examined it is clear there are structural 
differences between the two molecules, notable especially in terms of their 
relative stabilities. As the Fcc3-4AC and Fcc3-4 come from different sources (E. 
coli and mammalian respectively) it is possible that the differences observed are 
due to the refolding procedure required for the former. However, if the T,, values 
are compared to those measured for a mammalian expressed IgG-Fc that was 
then modified by treatment with alkylating agents (to remove the linker 
disulphide) and the deglycosylating enzyme PNGaseF (to remove core 
glycosylaytion), the trend is the same (Mimura et al, 2000; Mimura et al, 2001 - 
see table 6.5). This suggests that the refolding procedure is not responsible for 
the differences observed, and that there is a role for carbohydrate and/or the 
disulphide in maintaining stability of the Fc region. 
Species Melting temperature T. (°C) 
IgG-Fc (native) 71 (Cy2 value)* 
IgG-Fc (deglycosylated, reduced 63.5 (Cy2 value)* 
and alkylated) 
Fcc3-4 (mammalian) 56 
Fcc3-4AC (E. coli) 48 
Table 6.5: DSC (IgG-Fc) and CD (Fce3-4) thermal denaturation values. DSC can provide 
individual T. values for each domain and therefore the lower value for Fcy2 is given (*Data from 
Mimura et al, 2000; Mimura et al, 2001). 
It is also worth noting from these data that the relative thermal stabilities of 
these isotypes are very different, with the IgE-Fc values 15°C lower than those 
for their IgG-Fc homologues in each case. It could be that the flexibility of Fcc3 
compared to that of Fcy2 in IgG is reflected in a lower overall thermal stability. 
Some of the results obtained for Fce3-40C with different techniques are 
seemingly at odds with one another. In the Biacore assay although the affinity 
and binding mode were altered, as was the case in the centrifuge experiments, 
only a single mode of engagement was observed. The reason for this is likely to 
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be that the ligand spacing between either the Fab arms that hold each sFccRla 
subunit, or the spacing between active immobilised a-'y fusion at the chip surface, 
would have prevented Fcc3-40C being able to contact two sFccRla domains at 
the same time. In the centrifuge 2: 1 is more likely because the experiment was 
carried out using the smaller sFccRIa construct and neither component was 
immobilised. 
In addition to differences in the stoichiometry, a difference in the overall 
affinities obtained using AUC and Biacore was also observed (Biacore - 107 M"1, 
AUC - 105 M-1). This is not the first time that such a difference has been 
observed, and may again simply be a result of the way in which ligand is 
presented to the receptor. In AUC experiments on CD23, analysed using the 
same model applied here, the affinity of a single binding site on the IgE-Fc was 
determined to be - 105 M-1 (Shi et al, 1997), whereas in a Biacore assay the 
affinity of the same construct was determined found to be - 107 M"' (McDonnell 
et al, 2001). 
Previous experiments carried out either using this Fcc3-4AC construct 
(Henry, PhD Thesis, 1997), or a similar mammalian AC construct (Basu et al, 
1993) also highlighted differences in the affinity of non-disulphide linked Fc63-4 
for FccRI compared to the wild type molecule. In cell binding assays a three-fold 
reduction in the affinity of the AC construct was observed by Basu et al (with the 
shift attributed to an increase in the off-rate of the molecule). This change is not 
as drastic an effect as described in this thesis. The difference in results could be 
explained by the assay approaches applied. Basu et al used a saturation cell- 
binding assay. In this system an avidity effect could have been seen due to the 
bivalent nature of the non-disulphide linked construct, as suggested by the results 
obtained from the centrifuge experiments described in this thesis. In fact 
saturation binding levels determined with their non-disulphide linked form of 
Fcc3-4 (329-547) were almost always half of the value for their disulphide linked 
Fcs3-4 (315-547). This indicates a very different mode of binding for the Fcs3-4 
(329-547) construct. In fact, when assayed in competition ELISA (Henry, PhD 
thesis, 1997) the Fcc3-4AC fragment gave similar IC50 values to those of Basu et 
al (see table 6.6). This suggests that these two molecules (Fce3-4AC and Fce3-4 
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329-547) are functionally very similar, if not identical, and that it is only the 
method of assay that leads to differences of affinity. 
Species I IC5o (nM) 
Fcc3-4 wt (Henry, PhD thesis) 
Fcc3-4 AC (Henry, PhD thesis) 
Fcc3-4 315-547 (Basu et al) 





Table 6.6: Table comparing the IC5o values obtained for Fce3-4zC (Henry, PhD thesis, 1997) 
and Fce3-4 329-547 (Basu et al, 1993) in competition ELISA and cell binding assay respectively. 
Results shown are + standard error. 
One exciting result to come from the experiments carried out on Fce3-40C is 
that because a 2: 1 stochiometry has been observed, this has enabled the affinity 
of a single folded Fcs3 domain for sFcsRla to be measured. This value is either 
-2 x 105 M"1, or -2 x 107 M"', depending on the method used for measurement 
(AUC or Biacore). These values bracket that quoted for a single unfolded Fcc3 
domain (5 x 106 M"1, Henry et al, 2000), as measured by Biacore. This highlights 
the interesting proposition that the affinity of a single folded Fcc3 is no greater 
than that of an unfolded isolated domain. This will be discussed further in the 
next chapter. 
Finally, one further question that needs to be addressed is to what degree the 
carbohydrate and disulphide-bridge contribute to the effects reported in the 
chapter. Possible roles for both have been outlined in this discussion with respect 
to constraint of the N-terminal linker, and conformational changes with respect to 
the FcE3 domains. To determine the individual contribution that each of these 
structural features makes to the interaction with FccRIa, experiments were 
carried out on a molecule lacking just one of these components. The results of 
these experiments will be described in Chapter 7. 
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Distinguishing the effects of 
disulphide linkage and glycosylation 
on high affinity receptor binding 
and folding of FcE3-4 
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Chapter 7: Distinguishing the effects of glycosvlation and disulphide linkage 
on high affinity receptor binding and folding of FcE3-4 
7.1 Introduction 
In Chapter 6 it was demonstrated that E. coif-expressed Fcs3-4AC has a 
reduced stability and a lower affinity for FceRI than a mammalian expressed 
Fcc3-4 fragment. Furthermore, the mode of interaction of Fcc3-40C with FccRI 
compared to that of mammalian Fcc3-4 was altered such that a single 
monophasic binding relationship was observed when assayed by SPR, and a 2: 1 
stochiometry was observed when assayed in solution by analytical 
ultracentrifugation. The Fcc3-4AC fragment lacked two structural features 
present in the mammalian expressed Fcc3-4 fragment - disulphide linkage at the 
N-terminus and glycosylation at Asn 394. It was not clear from the comparison 
made in chapter 6 to what degree the differences observed for Fcc3-4iC were 
due to the absence of carbohydrate or the absence of the disulphide bridge. 
Therefore mammalian expressed fragments were prepared with and without 
carbohydrate to distinguish the roles of glycosylation and disulphide linkage on 
the interaction with the high affinity receptor. 
7.2 Deglycosylation of mammalian Fcs3-4 
Fcg3-4 was expressed and isolated from mammalian culture as described 
in the previous chapter. This fragment runs on non-reducing SDS-PAGE at about 
the 55kDa marker. There are three discernible glycoforms, dependent on the 
preparation (see figure 7.1 A). Treatment with the endoglycanase PNGase F 
resolves this pattern into a further lower band corresponding to the 
deglycosylated form; this can be seen in the partial digest in 7.1 B. This process 
of carbohydrate removal has been investigated in detail previously, with PNGase 
F established as the most suitable enzyme (Basu el al, 1993; Keown, PhD thesis, 
1997; Bjorklund et al, 1999). During this treatment, much of the material is lost 
as precipitate, as has also been described by others (Basu et al, 1993). A sample 
of this precipitate can be seen on non-reducing SDS-PAGE in panel C. All the 
Fcc3-4 material corresponds to the lower band in the precipitated sample, 
143 
Chester 7 Page 144 
suggesting that it is the loss of sugars that has a deleterious effect on the 
solubility of the fragment. 
66 - 66 
55 - ýý 55 
36 - 
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Figure 7.1: 15% non-reducing SDS-PAGE of Fcc3-4 mammalian samples at various stages of 
deglycosylation. Lane A= prior to digestion, lane B= partial digestion, lane C: precipitated 
material. For method see section 2.3.6. 
Repeated digestion with PNGase F finally resolves all the protein into the 
lower band. In figure 7.2 a partially digested fragment resolved by SDS-PAGE 
can be seen both Schiff stained (stains only carbohydrate) and Coomassie stained 
gels (all protein). The two upper bands stain with the Schiffs reagent, whereas 
the lower band does not. In the two right hand panels a completely 
deglycosylated sample is shown; no Schiff staining is seen for this fragment, 
with a single band resolved in the Coomassi stained sample. 




Figure 7.2: Coomassie (blue) and Schiff (pink) stained Fc fragments (the full Fc, Fcc2-4, and 
Fce3-4) 15% non-reducing SDS-PAGE. 
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Prior to a final round of PNGase F digestion, the upper and lower bands 
of the partial digest (figure 7.1 - panel B) were analysed for their carbohydrate 
composition (R. Boehm - Oxford Glycobiology Institute). In figure 7.3 the 
profile for the upper band can be seen, showing clearly a high mannose structure. 
This is the common glycoform for all IgE antibodies and their mammalian 
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Figure 7.3: HPLC profile of released carbohydrate from glycosylated Fce3-4 after initial 
PNGase F treatment. 
Figure 7.4 shows the carbohydrate profile of the lower band from the gel 
shown in figure 7.2, i. e. the non-Schiff stained band. Here virtually all of the 
high mannose structures have been removed, and only a residual core fucose and 
a small amount of mannose remains, indicating that the lower band that appears 
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Figure 7.4: HPLC profile of released carbohydrate from lower, non-Schiff staining Fce3-4 band 
seen in figure 7.2. 
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Once deglycosylation was complete, with all material resolved into the 
lower band, the remaining FcE3-4 was re-purified by gel filtration. To confirm 
the purity, the material was run out on both reducing and non-reducing SDS- 
PAGE alongside glycosylated Fcc3-4 and E. coli expressed Fce3-4AC. The 
deglycosylated material runs smaller than the glycosylated, with reduction 
resolving the deglycosyated material to the position of Fcc3-4AC. Over time it 
appeared that a natural trimming of the carbohydrate took place, as can be seen if 
the Fcs3-4 bands are compared in figures 7.1 (lane A) and 7.5 (lane A). This did 
however stop prior to complete deglycosylation, and eventually, most of the 
mammalian Fcc3-4 resolved into the lowest band of the three seen in figure 7.1 
(lane A). This band still runs higher than both Fcc3-4 fragments without 
carbohydrate (figure 7.5, compare reduced Fcs3-4 samples; glycosylated - lane 
D, complete PNGase F treated material -lane E, Fcc3-4AC - lane F) and it is this 
band that corresponds to that identified as high mannose by the glycosylation 
analysis illustrated in figure 7.3. 
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Figure 7.5: Non-reducing (left panel) and reducing (right panel) 15% SDS-PAGE of Fcc3-4 
fragments. Left = mammalian Fce3-4, middle = deglycosylated mammalian Fce3-4, right = 
Fcc3-44C (E. coli). 
In addition to SDS-PAGE, the fragments collected for analysis were 
compared by gel filtration using an S200 column, as shown in figure 7.6. It is 
apparent from these profiles that the difference in elution time between the E. 
coli Fcc3-4AC and mammalian Fcc3-4 highlighted in Chapter 6 is not the result 
of deglycosylation. Furthermore, the analytical profile confirmed that once 
separation had taken place, the deglycosylated material remained free from 
aggregation and contamination with PNGase F. In fact, once isolated, the Fcs3-4 
dh deglycosylated mammalian material remained as stable in solution as the 
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glycosylated material, an observation seemingly at odds with the precipitation 
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Figure 7.6: Gel filtration elution profiles of Fcc3-4 fragments (Superdex S200 HR column, run at 
0.75 mi/min in gel filtration buffer - see section 2.1). Black = mammalian Fcr3-4, red = 
deglycosylated Fce3-4, green = E. coli Fee3-4d C. 
7.3 Folding and stability of deglycosylated Fcs3-4 
Once a carbohydrate free fraction of Fcc3-4 had been isolated, its circular 
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Figure 7.7: Circular dichroism spectra of deglycosylated and glycosylated mammalian expressed 
Fce3-4. Data were acquired as outlined in section 2.4.1. 
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In addition, a thermal denaturation profile was recorded and the mid- 
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Figure 7.8: Thermal denaturation profile of mammalian FcE3-4 glycosylated (black) and 
deglycosylated (red). Sigmoidal fits are shown from which temperature of melting mid-points 
were derived. Data was acquired as outlined in section 2.4.1. 
Fragment T. (C) 
Fcc3-4 56.7 
Fcc3-4 deglycosylated 52.8 
Table 7.1: Thermal denturation midpoint of glycosylated and deglycosylated mammalian 
expressed Fcc3-4. 
It is clear from the circular dichroism experiments that the absence of 
carbohydrate has a significant effect on the stability of Fcc3-4 and only a minor 
effect on its CD spectrum. However, the loss of stability is not as pronounced as 
that when combined with the absence of the disulphide from Fcc3-4 (see Chapter 
6, table 6.1, figure 6.2). The data presented here are intermediate between those 
for E. coli Fcc3-4AC and glycosylated mammalian Fcc3-4 (see Chapter 6, figure 
6.4, table 6.1). 
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7.5 Effect of glyscosylation on the interaction with Fcr-RI 
The binding capabilities of deglycosylated Fcs3-4 were measured using 
the Biacore and AUC assays as before (see Chapter 6). 
7.5.1 Biacore analysis of deglycosylated mammalian Fcc3-4 
The profiles obtained from the Biacore for this fragment, and the kinetic 
data compared with those for the glycosylated material, are shown in figure 7.9 
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Figure 7.9: Biacore binding profiles for a concentration series of deglycosylated mammalian 
Fce3-4 (/OOnM - 6.25nM). Fits based on a 1: 1 biphasic competition model are shown as a red 
dotted line for each concentration and residuals for the fits are shown in the bottom panel. 
Constant Fcc3-4 glycosylated Fcc3-4 deglycosylated 
ke, (M- s) (4.77 + 1.88) x 10 (4.88 ± 1.97) x 10 
kdi (S-1 ) (1.21 + 0.19) x 10'2 (1.50 + 0.29) x 10-2 
k2 (M"'s"1) (3.08 + 0.65) x 105 (1.97 + 0.15) x 105 
kd2 (s'1) (6.26 + 1.29) x 10-4 (1.73 + 0.23) x 10"3 
Ka, (M-') 3.94 x 107 3.25 x 107 
K. 2 (M-1) 4.92 x 108 1.14 x 108 
R, /Ro 0.15+0.03 0.38+0.03 
Overall KA (M) 4.2 x 10 8.1 x 10 
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Table 7.2: Kinetic parameters derived from SPR analysis of deglycosylated mammalian Fce3-4 
compared with those of its glycosylated counterpart. 
From the kinetic analysis it is clear that the behaviour of deglycosylated 
Fc63-4 is similar to that of glycosylated material. The fit is biphasic, and most of 
the kinetic parameters are identical. However, there are differences, and the 
overall affinity has dropped by a factor of five. This is due principally to an 
increase in the off rate of the second component (kam) and a shift in the relative 
contribution this component makes to the interaction, as demonstrated in the 
increase of the R1/Ro ratio. It is worth noting here that the affinity constant for 
the ka2 component is very close in magnitude to that derived for Fcc3-4AC by a 
steady state analysis in the Biacore (3.25 x 107 M-' compared to 3x 107 M''). 
These findings indicate that carbohydrate does have a role to play in the affinity 
of Fcs3-4 for FccRI; however, it is the removal of the disulphide bridge that 
results in the more dramatic results outlined Chapter 6. 
7.5.3 AUC analysis of the mammalian Fcs3-4: sFc*RIa complex 
To establish whether the 2: 1 stochiometry seen between E. coif Fcc3-4AC 
and sFccRla in the analytical ultracentrifuge was wholly due to the removal of 
the disulphide, or whether it was a result of a combination with the effect of 
deglycosylation, fragments lacking just one of these two components thought to 
be critical (carbohydrate or disulphide linkage at Cys 328) were analysed with 
respect to their binding to sFc&Rla. 
Deglycosylated mammalian Fc63-4 binding to sFccRIa was found to fit 
best to a model that describes a single ideal species. This is because above 
affinity constants of -l08M" the majority of the complexes formed prior to 
analysis do not dissociate. In the case of this single ideal species, the molecular 
weight corresponded to that of a single sFccRla bound to a single Fcc3-4, i. e. a 
1: 1 stoichiometry (see left hand panel of figure 7.10). This result confirmed that 
the absence of carbohydrate is not responsible for the 2: 1 stoichiometry seen 
between E. coli Fcc3-4AC and sFccRIa. 
The disulphide linked, deglycosylated fragment was then compared to a 
mildly reduced, i. e. non-disulphide linked, but glycosylated Fcc3-4 under 
150 
Chapter 7 Page 151 
identical conditions. The disulphide linkage at Cys 328 was disrupted with DTT. 
The minimal concentration of DTT required to achieve reduction of this single 
disulphide was determined by titrating Fcc3-4 (at the concentration used in AUC 
experiments) with DTT and running it out on SDS-PAGE (see figure 7.11). The 
minimum concentration of DTT for reduction of the inter-chain disulphide was 
0.4 mM. According to previous disulphide mapping studies, this concentration is 
insufficient to reduce the internal disulphides (Takatsu et al, 1975). After 
reduction, samples were placed in a nitrogen-purged AUC cell to stop oxidation. 
The results obtained are compared with those for deglycosylated Fcs3-4 in figure 
7.10. 
Deglycosylated Fc63-4 
Non-interacting 1: 1 complex 
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Figure 7.10: Sedimentation equilibrium analytical ultracentrgation datasets. Residuals from 
fits based on a interaction stoichiometry of either 1: 1 or 2: 1 + ]: 1 mix for three differing ratios 
of Fce3-4 (deglycosylated or partially reduced) to sFcsRIa (1: 1 - A, 2: 1 - B, 1: 2 - Q. 
1 _'± i. 1 1'. 2 CI. 1 i', i iý. 
a 
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Figure 7.1/: 15% SDS-PAGE of Fce3-4 treated with various concentrations of D1T (mAf) to 
determine the transition point from covalent dimer to monomer due to the reduction of the Cys 
328 inter-chain disulphide bridge. 
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From the fitting procedure for the AUC data it was clear that the reduced 
sample adhered to the 1: 1 + 2: 1 interaction model. The scheme describing the 






Figure 7.12: Scheme for the formation of a 2: 1 complex between Fcs3-4 and sFccRIa showing 
interactions that correspond to the affinity constants K, and K2. 
The K, value for the reduced but glycosylated Fcc3-4 fragment was 
higher than that derived for E. coli Fcc3-4AC, with K2 value also altered, but this 
time lower (table 7.3). 
Constant I E. coli Fcc3-4AC Reduced mammalian Fc83-4 
K, (1.8 ± 0.4) x 10' M' (1.3 + 0.05) x 10° M' 
K2 (7.2±2.2)x 10 M- (1.0±0.16)x 104 M 
Table 7.3: Affinity constants for the 1: 1 and 2: 1 complexes formed between sFcERIa and partially 
reduced but glycosylated Fcc3-4 derived from data collected in the analytical ultracentrifuge. 
The partially reduced Fcs3-4 sample was run out on SDS-PAGE after the 
completion of the centrifuge run to check whether any degradation had occurred 
and whether the Fcr, 3-4 had remained monomeric, as shown in figure 7.13. 
66 
55 
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Figure 7.13: 15% non-reducing SDS-PAGE of Fcc3-4: sFceRla mixes from ultracentrifuge cells 
after 100 hour sedimentation equilibrium experiments under reducing conditions. The three lanes 
correspond to the three different protein loading ratios used in the experiment. 
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From the gel it is clear that the majority of the Fcc3-4 inter-chain 
disulphides remained reduced. There is a very small amount of higher molecular 
weight material that corresponds to covalent dimer, visible as a faint band above 
the smeared sFccRIa band. It is unlikely that this small amount of material would 
have interfered with the fitting procedure. It must be noted that there are 
differences between the figures obtained for E. coli Fcc3-4AC and the reduced 
mammalian Fcc3-4. However, such a pronounced effect may well be the result of 
the engagement of the second site being severely hampered by the presence of a 
first sFceRla, and it is this that leads to a reduction in its affinity constant. This 
will be discussed further in section 7.6. 
7.6 Discussion 
The aim of the work described in this chapter was to distinguish the role 
of carbohydrate and disulphide linkage in the interaction of Fcc3-4 with FccRI. 
Kinetic analysis of Fcs3-4 lacking carbohydrate, but with the disulphide bridge at 
Cys 328 intact, showed a shift in the magnitude (a four fold reduction) and the 
relative contribution (38% compared to 15%) of the second component, Kam, to 
the biphasic fit compared to the wild type Fcc3-4 (see table 7.2). According to 
the sFccRla: Fcc3-4 complex crystal structure only 100A2 of the total 1850A2 
interaction surface is accounted for by contact with the first N-acetylglucosamine 
residue attached at Asn394, no other carbohydrate contacts are made. The effect 
removal of carbohydrate has on binding contrasts with the minimal contact 
observed in the crystal complex, thus suggesting glycosylation must exert its 
effect by other means also, possibly by altering the topology of the molecule so 
that when removed full engagement, and therefore full affinity, cannot be 
attained. According to Wurzburg et al (2000) the Fcc3-4 fragment needs to go 
through a large conformational change involving the Fcc3 domains to enable full 
engagement of FccRI. This would contribute to a slower phase of association; the 
K. 2 of the biphasic fit represents such a phase. It is precisely in this second phase 
of the interaction that the decrease in affinity after deglycosylation is observed. 
Within the large contact area between Fcc3-4 and sFcdRla there are a 
number of specific interactions that could be affected by the absence of 
carbohydrate. At the "top" of each Fcc3 domain (figure 7.14) sit three loops 
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containing important contact residues, including proline 426 that forms a 
"sandwich" with trytophan 89 and 113 of FcERI, and a set of loops, structurally 
similar to CDRs, that make contact with another key residue of FccRI, tyrosine 
131 (Garman et al, 2000). 
Figure 7.14: The crystal structure of the Fce3-4: sFceRla complex (Garman et al, 2000). Soluble 
FccR! alpha chain is shown in green (ribbon format). Fce3-4 is shown in yellow and red 
(coloured by chain, ribbon format). Carbohydrate at Asn 394 is also coloured yellow. Proline 
426 and interacting FccRI residues, and tyrosine 131 of FceRI and interacting residues, are 
shown space filled on the left and right hand side of the binding site respectively. 
It is possible that only a minor shift in the way these clusters of residues 
were presented may significantly alter the overall nature of the complex by 
preventing the full engagement of one or more units that stabilises the 
interaction. Studies on truncated IgG Fc glycoforms, which have significantly 
altered receptor binding capabilities, have shown small shifts in the positions of 
the homologous loops at the "top" of the Fcy2 domain depending on the level of 
glycosylation (Krapp et al, 2003). Glycosylation also determines the separation 
between opposing Fcy2 domains, with sequential removal of carbohydrate 
residues causing a gradual closing (Mimura et al, 2001; Krapp et al, 2003). 
However, Fcr-3-4 is already very closed in comparison (Wurzburg et al, 2000), 
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and perhaps this is why deglycosylation has a relatively minor effect in the IgE- 
Fc compared with IgG. Certainly, on complete deglycosylation a large shift in 
the size of Fcc3-4 is not seen in gel filtration analysis, although a large change is 
seen for IgG (Radaev and Sun, 2001). This does not however discount the subtle 
changes noted by Krapp et al (2003) when sugars are only partially removed 
from IgG. In earlier deglycosylation studies of the full IgE-Fc subtle changes in 
the binding of a panel of mAbs to Fcs3 were observed, suggesting that small 
structural rearrangements may take place when sugars are removed (Bjorklund et 
al, 2000). 
The region of Fcc3 in which carbohydrate is most likely to have an effect 
is in the BC and DE loops. These form part of binding site 1 (including the 
region that binds Tyr 131, right hand side in figure 7.14). A highly structured 
region like this might be more susceptible to minor structural changes than 
others. This region has been suggested to establish specificity across the Ig 
receptor family (Wurzburg and Jardetzky, 2002). The overall contribution of 
these residues to the interaction is not large, and therefore loss of some, or all, of 
the contacts in this region may not lead to an enormous drop in affinity. Thus we 
have found that even though the kinetic differences are significant, the impact is 
only an -3 fold increase in off rate when the relative contributions from the 
biphasic fit are taken into account (see table 7.2 for individual values; the overall 
kd for each fragment can be calculated using a weighted average based on the 
relative contribution of each component according to the Ri/Ro ratio, when this is 
done Fcc3-4 wild type has an off-rate of --6 x 10"3 s"' and deglycosylated Fcc3-4 
has an off rate of -2 x 10-3 s-'). 
When observed in the analytical ultracentrifuge, the complex between 
purified deglycosylated Fct3-4 and FceRI still appears to be a single species. It 
must therefore still be considered "high-affinity", especially in comparison to the 
receptor complexes of IgG and the effects seen when IgG-Fc is deglycosylated, 
which experiences a total loss in binding capability. This explains why in assays 
which cannot assess binding in real time, effects of the removal of carbohydrate 
may have been difficult to detect (Basu et al, 1993; Henry, PhD thesis, 1997; 
discussed in Chapter 6, see table 6.6). Interestingly, studies in mice using an 
enzyme from humans that is known to deglycosylate IgE have shown that 
removal of carbohydrate disrupts effector function, but not antigen recognition 
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(Masuda et al, 2001). It may be that the body has already discovered an anti- 
allergic mechanism that involves deglycosylation, as by affecting the 
glycosylation status of the IgE-Fc it may be possible to dampen the 
hypersensitivity response that is dependent on the priming of FcERI on the 
surface of mast cells and basophils with antigen-specific IgE. However, the mode 
of action is still to be determined, for although reduced persistence of receptor 
binding due to an increase in the off-rate is one possibility, another may simply 
be that removal of carbohydrate leads to aggregation and more rapid clearance of 
IgE. 
The removal of carbohydrate was also confirmed to have an effect on the 
stability of the Fcc3-4 fragment. In comparison to the findings in Chapter 6, an 
intermediate result in terms of thermal denaturation mid-point (T, ) and CD 
spectrum was observed. This suggests that both disulphide linkage and 
carbohydrate contribute to maintaining the structure and stability of the Fcc3-4 
fragment. In the previous chapter it was noted that this trend was also seen in 
differential scanning microcalorimetry studies carried out on IgG-Fc (Mimura et 
al, 20001; Mimura et al, 2001), suggesting a common pattern for 
immunoglobulin Fc fragments. The further result, reported in this chapter, with 
disulphide linked but deglycosylated Fcc3-4 fits well with this pattern, as shown 
in table 7.4. 
Species I Melting temperature T. (°C) 
IgG-Fc (native) 
IgG-Fc (deglycosylated) 
IgG-Fc (deglycosylated, reduced and 
alkylated) 
Fcc3-4 (mammalian) 
Fcc3-4 (mammalian deglycosylated) 
Fcc3-4AC (E. coli) 
71 (C-y2 value)* 
65.7 (Cy2 value)* 




Table 7.4: DSC (IgG-Fc) and CD (Fcs3-4) thermal denaturation values. DSC can provide 
individual T. values for each domain, and therefore the lower value for Fcy2 is given (Data from 
Mimura et al, 2000; Mimura et al, 2001). 
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The results obtained in the centrifuge for the glycosylated, but non-disulphide 
linked fragment, demonstrated that the 2: 1 stochiometry, as observed for the 
Fcc3-4AC, is entirely due to the removal of any tethering at the N-terminus. 
Interestingly, there was a difference in the affinity constants obtained for the first 
component of the fit (K1 = 1.3 x 106 M"' for deglycosylated Fcc3-4; Kl 1.8 x 105 
M"' for Fcc3-4AC). This could be the result of the carbohydrate enhancing the 
affinity of a single Fcc3 domain by increasing the ordering of the N-terminal 
loops used for receptor engagement (as was found for IgG-Fc by Krapp et al 
2003 - as discussed earlier). 
The K2 affinity constant for each fit was also different (1.0 x 104 M"' for 
reduced mammalian Fcc34 compared to 7.2 x 105 M"' for E. coli Fcc3-4AC). 
This may reflect the fact that engagement of the second FcE3 domain by a second 
sFc&RIa fragment is more difficult for the glycosylated but reduced mammalian 
Fcs3-4. It is possible this is the result of the glycosylation introducing more 
rigidity into the Fcc3 domains and therefore reducing the conformational 
freedom that allowed the Fcc3-4AC fragment bind two sFccRIa domains. In the 
model proposed in Chapter 6 (see figure 6.11), where the Fc83 domains "roll" 
past one another to present the Fcc3 domains in such a way that it is possible to 
bind two sFccRIa fragments, this process may be enhanced for the E. coli Fcs3- 
4AC fragment as a result of the need to find a way of shielding hydrophobic 
residues normally covered by the carbohydrate attached at Asn 394. The result of 
this requirement may be a greater than normal adjustment in the positioning of 
the flexible Fcc3 domains relative to one another. The need to cover hydrophobic 
residues in the cavity between opposing domains in the Fc effecting a 
conformational change has already been proposed as a mechanism for the 
compacting of the IgG-Fc (Radaev and Sun, 2001). The 2: 1 stoichiometry is still 
seen for the glycosylated Fcc3-4 fragment because when the constraining 
disulphide is removed the Fcc3 domains are still enabled with a greater degree of 
conformational freedom (as a result of their inherent instability / flexibility), but 
because the carbohydrate is present the effect is not as dramatic as that seen for 
the E. coli Fcc3-4AC. Certainly, what could be interpreted as a strong 
requirement to shield the hydrophobic patch between the Fcc3 domains is 
apparent during the deglycosylation process, as much of the mammalian Fcc3-4 
came out of solution during the PNGase F treatment process, all of this 
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precipitated material corresponded to the band observed for deglycosylated Fc63- 
4 in SDS-PAGE (see figure 7.1). 
The results reported in this chapter have allowed the contributions of 
carbohydrate and disulphide linkage to be distinguished. If the disulphide bridge 
is lost, so too is the high affinity interaction, and thus the disulphide linkage at 
the N-terminus has a critical role in enabling full engagement of FcERIa and a 
1: 1 stoichiometry. The carbohydrate appears to have a subtler, but still 
significant part to play in establishing a high affinity interaction. The 
experiments described here, combined with those in the preceding chapter, show 
that independent of glycosylation state, N-terminal disulphide linkage is a key 
determinant in the affinity and mode of interaction of Fcc3-4 with FcERI. 
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Chapter 8: Discussion 
In the introduction to this thesis two questions were highlighted. The first 
was: What determines the correct folding of the Fc*3 domain in the IgE 
molecule? 
In the course of investigation it was discovered that to fold Fcs3, Fcs4 
needs to be structured, and this can only be achieved when it is part of a 
homodimer. This was determined using a site-directed mutation that prevented 
dimerisation of the Fcc4 domain. Neither a monomeric FcE4 domain, nor a 
monomeric Fcc3-4 was able to fold. In contrast, dimeric Fc84 and Fcs3-4 did 
fold. Furthermore, a heterodimer of Fcc3-4 and Fcg4 appeared not to fold 
completely, but was stabilised to a greater degree than the FcE3-4 monomer. This 
led to the conclusion that, in addition to Fcc4, some form of lateral contact is 
required for FcE3 to fold fully, either from an adjacent Fcs3 domain, or 
glycosylation. It was clear however that Fcc4 was the major contributing factor 
to the stability of Fcc3. The minimal fragment within which Fcc3 can fold fully 
is therefore a dimer of Fc83-4, either with or without carbohydrate, or possibly a 
Fcc3-4: Fcs4 heterodimer which is glycosylated. The pursuit of a folded 
heterodimer was not maintained, as the main aim of folding an individual Fcc3 
domain was to determine the affinity of a single folded Fcc3 for FccRI, and this 
was addressed by the study of the Fcc3-4AC fragment. 
Folded 
Papioju(1 
Figure 8.1: Overview of the fragments expressed in Chapters 3-5. The two lower fragments 
represent Fce3-44C F506R and Fce4 F506R (monomeric fragments), the middle fragment is 
Fce3-4(4) (the heterodimer) and the top two fragments are the Fce4 and Fce3-44C homodimers. 
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The second question to be addressed was: What are the minimal structural 
requirements for a fully active Fcc3 domain? 
To obtain an IgE fragment that retains native affinity it is necessary to 
glycosylate and disulphide link the receptor binding Fcs3 domains. If the Fcc3 
domains are not disulphide linked they are able to function independently of one 
another, leading to a 2: 1 stoichiometry between the receptor and the Fcg3-4 
homodimer. The observation of a single Fcc3 domain engaging FcaRI has 
enabled the affinity of a single folded Fcs3 domain to be determined (- 107M"' 
by Biacore, 106 M"' by AUC), and this contrasts with an affinity of between 108 
-109 M"' for a disulphide linked FcE3-4 (depending on glycosylation state). The 
value for a single Fca3 domain binding was close to that measured for an 
unfolded Fc83 domain (5 x 106 M"' by Biacore - Henry et al, 2000). Therefore, to 
achieve native affinity for FccRI, it is necessary for two domains to be present, 
but the affinity of these domains is not as greatly enhanced by their folding status 
as perhaps would be expected. In addition to a difference in the affinity between 
glycosylated and deglycosylated disulphide linked Fcc3-4 fragments, the affinity 
of the non-disulphide linked Fcs3-4 also depended on glycosylation state (- 106 
M"' glycosylated, 105 M"' unglycosylated, for a single Fcc3 domain binding 
FcaRI in the AUC). This result suggests that glycosylation has a direct role to 
play in presenting receptor-binding regions, and is not simply important for the 
correct juxtaposition of the Fcs3 domain pair. If the structural requirements were 
ranked in relation to their contribution to generating full binding affinity for 
FcaRI, the engagement of both receptor sub-sites is most important, which only 
occurs fully in a N-terminal disulphide linked dimer. It is less crucial that the 
Fcs3 domains are glycosylated and folded by virtue of interdomain contacts with 
Fce4 (and carbohydrate and/or Fcc3). However, full native affinity can only be 
achieved with these further structural enhancements. 
In the introduction to this thesis the differences in the behaviour of non- 
disulphide linked and deglycosylated IgE-Fc and IgG-Fc fragments was 
highlighted. It is now clear that disulphide linkage and glycosylation do have a 
role to play in affinity, but that Fce3 has qualities that the receptor-binding region 
(Fciº2) of IgG-Fc does not. A clue to how IgE manages the removal of these 
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structural features better than IgG may lie in data collected for the thermal 
stability of the IgE-Fc fragments. 
The thermal stability of the IgE-Fc fragments, when compared to data 
collected for the IgG-Fc fragments (Mimura et al, 2000; Mimura et al, 2001), 
was found to be greatly reduced. The pattern observed for fragments that lacked 
certain structural features (glycosylation / disulphide linkage) within either IgE- 
Fc or IgG-Fc was however maintained. It is may be that this relative instability of 
IgE-Fc is a product of the necessity for greater flexibility required for full 
engagement of FceRI with both Fcc3 domains. The crystal structures have 
already illustrated an array of conformations for the Fcc3 domain pair. The 
results described in this thesis show this flexibility at work (i. e. the potential for 
2: 1 stoichiometry). Perhaps the higher affinity shown by Fcc3-4 for FcsRI, 
compared to IgG-Fc for Fey receptors, is enabled by this flexibility. When the 
structures of the IgE and IgG crystal complexes are compared there is - 360 A2 
more buried surface area attributable to the domain interface for IgE than for 
IgG. Having more "fluid" domains may be the only way that the greater variety 
of contacts shown by the Fcs3 domains can be accommodated. This is in contrast 
to the IgG-Fc, which has a greater degree of contact in the linker region and a 
reduced domain interface area. The linker regions are flexible because they are 
not constrained by a domain structure, although they cannot provide as broad an 
interface as the domains can, which display contact residues on several loops 
rather than a single continuous surface. 
Given the observation of 2: 1 stoichiometry between non-disulphide 
linked Fcc3-4, it is perhaps not surprising that IgG has evolved a reduced intra- 
domain flexibility. In the full IgE-Fc it appears that the presence of the Fcc2 
domains would be sufficient to prevent engagement of a second receptor, and 
thus cross-linking and signalling in the absence of antigen, if the inter-chain 
disulphides were not formed. In IgG, the insurance against this happening may 
be reduced intra-domain flexibility, at the expense of a reduction in the potential 
affinity that IgG-Fc can show for its receptor; the more rigid domains of IgG may 
be unable to make the same contacts as the more flexible Fcs3 domains of IgE. 
This relative rigidity may also mean the IgG-Fc is less able to cope with 
modifications (such as deglycosylation) that alter the way in which the receptor 
binding site is presented. 
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How do these observations for the Fcc3-4 fragment sit within the broader 
context of the binding of the whole IgE-Fc (Fc82-4) to FccRI? For example, what 
is the relevance of the disulphide bridge? As alluded to in the previous 
paragraph, it may be that in the truncated fragment (Fcs3-4), the parallel 
disulphide (Cys 328-Cys 328) is playing part of the role that Fcs2 carries out. In 
the structure of the full Fc, one Fce2 domain is folded back onto the Fcs3 of the 
opposite chain of the homodimer. To engage both sites it necessary to displace 
the Fcc3-bound Fcc2 domain. Therefore the Fcc2 domain only allows a single 
site to be seen by FcERI, and then on receptor binding, it reveals the second site. 
In Fcc3-4 the parallel Cys 328-Cys 328 disulphide bridge tethers the sites 
together, with the result that once one sub-site is engaged, the second can only be 
bound by the opposite Fc63 of the homodimer. In essence they both act to 
channel the Fc dimer towards the high-affinity complex. For IgE, the "cost" of 
retaining an extra domain within the Fe is justified, as Fcs2 has another role to 
play and makes contact with FccRI after initial engagement via Fc&3 (McDonnell 
et al, 2001). 
The presence of covalent linkage of opposing chains in the N-terminal 
region of the truncated Fca3-4 fragment appears to allow enough freedom for the 
full engagement of both Fcs3 domains with FccRI (Garman et at, 2000). 
However, given the fact that the disulphide arrangement in such fragments is 
incorrect (Cys 328-Cys 328, rather than Cys 328-Cys 241), and that evidence is 
presented in this thesis that demonstrates that the presence of the disulphide is 
critical for the correct engagement of sFccRIa. It may well be that the inclusion 
of a parallel disulphide bridge in previous Fcc3-4 fragments used in biophysical 
studies of the FcERI: IgE complex represents a fortunate addition. The inclusion 
of the Cys 328-Cys 328 disulphide has revealed what is almost certainly the 
correct mode of engagement of the Fcc3 domains of IgE-Fc with FccRIa 
(Garman et al, 2000). However, it is now clear that the formation of the 
IgE: FcsRI complex actually comes about via a much more complicated process 
also involving Fcc2 (Wan et al, 2002). Therefore, it is clear that the true nature of 
the interaction between IgE and its high-affinity receptor will only be resolved by 
crystal structures of a complex composed of the whole Fc (Fcc2-4) fragment and 
sFccRIa. Such a structure, in addition to resolving fully the role of Fcs2, may 
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also shed further light on the reasons for maintaining such a complex 
arrangement with respect to the inter chain disulphides. 
Since the structure of the Fcc2-4 fragment reveals that the presence of 
Fcc2 would prevent the binding of a second receptor subunit, this suggests that 
the disulphide is less important in the full Fc. To some degree this statement is 
supported by a set of AC mutants made by Helm et al (Helm et al, 1991). Here 
the full Fc was made with and without the inter-domain disulphide bridges. In 
this study it was found that the complete AC mutant (i. e. a Fc82-4 construct with 
the interchain 241 and 328 disulphides removed) displayed 20-fold lower affinity 
for FcERI. The less drastic difference in affinity observed in these experiments, 
compared with those obtained for Fcc3-4, may be the result of a secondary role 
that the disulphide plays in local structuring of the linker in Fcc2-4, as opposed to 
pinning the FcE3 domains together, as in the Fcc3-4 fragment. 
The study of IgE-Fc fragments with differing post-translation features 
and domain structures has demonstrated a complex web of inter-domain contacts, 
covalent and non-covalent, that are organised to bring about the uniquely high 
affinity of IgE for FccRI. Further work is now required to take the results from 
these experiments, and those carried out in the past, to focus on specific regions 
of IgE related to its binding to FccRI, with the overall aim of inhibiting the 
interaction. Given these observations how can they be used to target the 
interaction? 
Glycosylation would not appear to off much potential regarding 
inhibition of the formation of the IgE: FccRI complex. A fragment that is 
deglycosylated is still seen as high affinity in the analytical centrifuge, for 
example. However, it should be noted that a deglycosylating enzyme has been 
identified in the urine of allergies (Masuda et al, 2001). This enzyme renders IgE 
non-functional with respect to receptor binding, although the mechanism by 
which this occurs is unclear. One aspect of the result obtained with 
deglycosylated Fc83-4 that is particularly interesting is the fact that the 
carbohydrate may act in a similar fashion to the disulphide bridge. From the 
Biacore data it is clear that there are two components to the interaction, one 
lower in affinity than the other. This is consistent with the crystal structure of the 
FceRI: Fc83-4 complex that revealed binding across two sub sites in the Fcc3-4 
dimer. The differences between the two components occur mainly in the off- 
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rates. When carbohydrate is removed it appears that fewer molecules are 
channelled to the higher affinity state, as is clear from the shift in the R1/Ro ratio 
(see table 7.2). The reasons for this may be two-fold. Firstly, the carbohydrate 
may aid in the contact of FccRIa with the second sub site by virtue of orientating 
the Fcz3 domains with respect to one another. Secondly, as suggested by the 
affinities obtained from the AUC data, individual domains may also vary in 
affinity depending on their glycosylation state (the interaction of a single Fcc3 
domain in Fca3-4 with a single sFc6Rla is described by the K, affinity constant, 
this value rises from 1.8 x 105 M-1 to 1.3 x 106 M'1 when the fragment is 
glycosylated). This may reflect ordering of contact residues in loops due the 
presence of carbohydrate. This region is thought to distinguish affinities between 
antibody isotypes (Wurzburg et al, 2002), and is more extensive in the IgE: FccRI 
complex compared to IgG: Fc'RIII. Therefore, this region may represent an IgE 
specific target. 
The necessity for IgE specific targets is particularly important if the 
similarities in binding modes, and therefore potential overlap in residues used by 
the different antibody isotypes is taken into account. Many peptides have been 
described in the past that inhibit IgE binding to FccRI (for example Hamburger, 
1975, Stanworth et al, 1990, McDonnell et al, 1997; reviewed in Beavil et al, 
1993 and Helm et al, 1997). The most recent of these are a set of "zeta" peptides 
that present a small constrained peptide unit whose function is dependent on the 
presence of a proline residue at their centre (Nakamura et al, 2001; Nakamura et 
al, 2002). These peptides, despite their high affinity (30 nM), have not been 
advanced as a therapeutic option. This may be because they target the proline 
sandwich, which is a common motif for IgG as well as IgE. Certainly non- 
specificity has been seen previously with peptides, notably with linker peptides 
targeted to the IgG Fcy interaction (Radaev and Sun, 2001). In these experiments 
it was found that an IgE linker peptide that has little sequence homology to the 
IgG peptide also inhibited IgG binding its receptor. This issue may be related to 
the folding of the domains. Minimally structured regions potentially yield a large 
amount of binding energy, as supported by the results obtained with the 
unstructured Fcc3 domain. However with this may come a degree of non- 
specificity. These initial interactions may represent only the first step, to be 
followed by more structure specific events lead to a channelling of the interaction 
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towards a high affinity state, for example those co-ordinated by carbohydrate or 
adjustment of the Fcc3 domain pair. Therefore, targeting the events subsequent to 
the initial interaction may be the key to inhibiting IgE binding to FccRl without 
disrupting other isotypes binding to their respective receptors. 
One such approach may be the pursuit of novel inhibitors of 
conformational change. This had previously been suggested by Wurzburg et al 
(Wurzburg et at, 2000) with respect to the flexing of the Fce3 domains, and is 
equally relevant with respect to Fcc2. The work outlined in this thesis presents 
very striking evidence for an inherent flexibility of the Fcc3 domain pair, and it 
also shows that if a single binding site could be inhibited there is a potential for a 
1000-fold reduction in affinity. If this observation is allied to those made with 
respect to the orientation of the Fcc2 domains in the full Fc, where it appears that 
only a single Fcs3 domain is open to binding, and that a conformational change 
is required to access the second site, there is an indication that it is not only direct 
inhibitors of binding that could work, but also inhibitors that act to prevent the 
accessibility of binding sites due to conformational change. For example, if the 
Fc could be locked into the conformation in which only one site is open for 
binding, the potential for disruption of receptor engagement is very apparent. 
Figure 8.2 illustrates the three different positions seen for opposing Fcs3 
domains from the three known crystal structures of the IgE-Fc (Garman et al, 
2000; Wurzburg ei al, 2000; Wan et al, 2002). 





Figure 8.2: C-a backbones of Fce3-4 complexed (red) and uncomplexed (green) superimposed on 
the Fce3-4 of the full Fc (blue). This diagram shows that in the unbound full Fc one Fce3 domain 
is open, and able to bind FceRI, whereas the other is closed and cannot (based on Wan et al, 
2002). 
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There is at present no direct evidence for the proposed conformational 
change, although the results reported in this thesis do reinforce the observations 
made with respect to the different crystal forms, i. e. that the Fc has an inherent 
flexibility. Therefore, one key focus for future work must be a method for testing 
the conformational change hypothesis. Such experiments could also form the 
foundation for assessing the potential of inhibitors of these conformational 
changes. The potential for stopping these events occurring is clear, as it is now 
possible to attach some quantitative figuies to the likely effects of such inhibition 
As a the result of observing the interaction of a single Fcc3 domain with FccRI in 
the experiments described in this thesis, it is clear that restricting receptor 
engagement to only one sub-site in IgE-Fc could lead to at least a 1000-fold 
reduction in binding affinity. 
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